Content
Yahoo Finance Community
09/15
Comment
Want to comment this again, seeing if I can get any replies: if tonix has fear of price being <.10 for 10 days (delist) they will RS. With investor sentiment already so poor, they would only do the minimum: a 1:10 RS to get the price to compliance ($1), right? That would still be horrible because we would miss out on ALL % gain of it climbing from cents to dollars (e.g. bought at .10, 1,000% gain if it naturally climbed to $1). Even if their fear gets to them, and they RS to regain compliance long enough for drug approval, I can’t see them RS for more than 1:10. Do we think that it will fall <.10 after the hypothetical RS from $1 that quickly again? If so then RS will be more than 1:10. Maybe I’m just coping, but thoughts???...
Yahoo Finance Community
09/15
Comment
It's looking like Nasdaq is finally showing some ballz.Under the proposal, Nasdaq would amend the rules such that a request for a hearing of the delisting determination would not stay the suspension of the shares from trading if a company is afforded the second 180-day compliance period but fails to regain compliance with that period. Thus, a company’s shares would automatically be suspended from trading during the hearings panel’s review. The hearings panel would continue to have the discretion to provide an exception for up to 180 days from the termination of the second 180-day compliance period.If a company’s shares are suspended, the shares may be traded in the over-the-counter market while the company’s appeal is pending.EXCESSIVE REVERSE STOCK SPLITSCurrently as a prevailing practice, if a company fails to comply with the Minimum Bid Price Requirement, it may use a reverse stock split, which combines multiple outstanding shares into one …...
Yahoo Finance Community
09/15
Comment
The Special Meeting is being held for the purposes of: 1.The approval of a proposal to authorize the Company’s Board of Directors (the “Board”), in its discretion at any time within one year after shareholder approval is obtained, to effect a reverse stock split of then-outstanding shares of the Company’s common stock, at a ratio of not less than one-for-two (1:2) and not greater than one-for-hundred (1:100), with the exact ratio to be determined by the Company’s Board and included in a public announcement (the “Reverse Stock Split Proposal”);...
Yahoo Finance Community
09/15
Comment
I know I sound like a glass is half empty kind of a person most of the time, so to prove that I can be impartial, here is a rosy perspective on that glass of water. After Friday's bombshell announcement, I would imagine management will be in damage repair mode which means odds are really good they will issue another super duper extra fluffy PR tomorrow morning. Just don't stay too long. Their rallies have a tendency to fizzle out rather quickly. Caveat EmptorAs always, treat'em as a trade.... a quick trade.GLTA...
Votes:
2
0
Yahoo Finance News
09/16
Tonix Pharmaceuticals Announces That its Single Dose Mpox Vaccine Candidate TNX-801 Aligns with WHO’s Newly Issued Preferred Target Product Profile for Mpox Vaccines in Global Health Emergency
Tonix Pharmaceuticals Announces That its Single Dose Mpox Vaccine Candidate TNX-801 Aligns with WHO’s Newly Issued Preferred Target Product Profile for Mpox Vaccines in Global Health Emergency Tonix P...
Polygon News
09/16
Tonix Pharmaceuticals Announces That its Single Dose Mpox Vaccine Candidate TNX-801 Aligns with WHO’s Newly Issued Preferred Target Product Profile for Mpox Vaccines in Global Health Emergency
Tonix Pharmaceuticals announced that its single-dose mpox vaccine candidate TNX-801 aligns with the WHO's preferred target product profile for mpox vaccines, which includes characteristics like single...
Yahoo Finance Community
09/16
Comment
One would think with all the giddy giddy news TNXP releases that Blackrock. State Street and all the majors would be gobbling up all the stock they can get. NDA is coming in October. One would assume it's buy time. Oops, I forgot they all been triple burnt and don't want the quad. IMO...
Votes:
2
0
Yahoo Finance Community
09/17
Comment
My thoughts: TNXP has RS meeting end of October in case the early Oct. NDA filing doesn’t result in a pump. Why not make meeting end of September?? This meeting/RS will secure they don’t delist before drug approval. My only optimism is that they don’t RS if stock pumps and remains after NDA submission. Thoughts?...
Yahoo Finance News
09/18
New Hope for Mpox? How TNX-801 Could Meet the WHO's Vaccine Targets for a Safer, Single-Dose Solution
New Hope for Mpox? How TNX-801 Could Meet the WHO's Vaccine Targets for a Safer, Single-Dose Solution Tonix Pharmaceuticals Holding Wed, Sep 18, 2024, 7:30 AM 7 min read In This Article: TNXP This pos...
Yahoo Finance Community
09/18
Comment
My opinion, this company is worth at least 200M market cap, based on their pipeline. Currently suffering from trust issues with investors. Would that improve ? Looks like they are trying hard this time, but not working. We don't know what else they are trying? Only way out is to build partnerships and work hard to gain trust...
Votes:
1
1
Polygon News
09/19
Tonix Pharmaceuticals Announces Issuance of U.S. Patent by the United States Patent and Trademark Office Covering the Intranasal Delivery of FDA-Approved Tosymra® to Treat Migraines
Tonix Pharmaceuticals has been issued a U.S. patent covering the intranasal delivery of its migraine treatment drug Tosymra®. The patent is expected to expire in 2030, further solidifying Tosymra's ma...
Yahoo Finance News
09/19
Tonix Pharmaceuticals Announces Issuance of U.S. Patent by the United States Patent and Trademark Office Covering the Intranasal Delivery of FDA-Approved Tosymra® to Treat Migraines
Tonix Pharmaceuticals Announces Issuance of U.S. Patent by the United States Patent and Trademark Office Covering the Intranasal Delivery of FDA-Approved Tosymra® to Treat Migraines Tonix Pharmaceutic...
Quantexa News
09/19
Tonix Pharmaceuticals Announces Issuance of U.S. Patent by the United States Patent and Trademark Office Covering the Intranasal Delivery of FDA-Approved Tosymra® to Treat Migraines
Tonix Pharmaceuticals Announces Issuance of U.S. Patent by the United States Patent and Trademark Office Covering the Intranasal Delivery of FDA-Approved Tosymra® to Treat Migraines Tonix Pharmaceuti...
Yahoo Finance News
09/19
Tonix Pharmaceuticals Secures US Patent for Migraine Treatment -- Shares Rise Pre-Bell
PREMIUM Tonix Pharmaceuticals Secures US Patent for Migraine Treatment -- Shares Rise Pre-Bell MT Newswires Thu, Sep 19, 2024, 6:52 AM In This Article: TNXP Tonix Pharmaceuticals Secures US Patent for...
Yahoo Finance Community
09/19
Comment
They are better off finding a buyer for their two drugs in the market to someone and focus on the pipeline. They bought these two drugs so that they have access to sales channel. IMO a bad strategy. They can partner with others for sales instead of buying. They also need to sell their facilities. For such a small company why do they need facilities or offices arround the world. They need to downsize!...
Yahoo Finance Community
09/19
Comment
In the last 10Q they reported sales revenue for the 1st half of the year at $4.7m and the cost of the revenue was $5.0m. Meaning that they barely sell any of the two marketed drugs they foolishly bought last year and indeed they are losing money on them. Tosymra is an old drug that has been on the market for some time and doesn't seem to be going anywhere. So I wouldn't get too excited about a patent covering Tosymra....
Yahoo Finance Community
09/19
Comment
Tale of The Bot Tape.Here is a breakdown on all of today's trades, as of 11am.Shares bought ...... 7,611,983Shares sold .....9,227,011Neutral trades ..... 703,824Looks like Seth and company are back to what they do best.... selling shares on the news. However, I suspect a second bounce will happen within the next hour. Just don't stay too long. As I'm sure you all have noticed how quickly these bounces tend to disappear.Caveat EmptorAs always, treat it as a trade.... a quick trade. GLTA...
Votes:
2
0
Quantexa News
09/19
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Awarded Patent Covering Intranasal Delivery of FDA-Approved Tosymra to Treat Migraines
September 19, 2024 at 11:26 AM EDT , a fully integrated biopharmaceutical company with marketed products and a pipeline of development candidates, has been awarded a patent by the United States Paten...
Yahoo Finance Community
09/19
Comment
It’s comical how you can literally see on the chart where they took profits for their new drug funding. Will they do this after NDA news? Will they even keep TNXP above a $1 should it rise that much? Are they anticipating a RS because they know they will greedily dilute any gains, preventing this stock from flying?? At this rate, I’m starting to believe that if TNXP somehow rose to $5/share, it will go alllllll the way back down to cents due to Seth stealing investor gains before they can approve/sell their new drug. Please give us something Seth. Spare change?? Spare change?...
Yahoo Finance Community
09/19
Comment
Don't be fooled by today's PR. Extending a patent for another 6 years on a product that cost nearly 10 times more than it closest competitor isn't going to help a whole lot. People are always looking to save a few extra bucks, especially during these high inflation times.Sumatriptan (Imitrex) is an inexpensive drug used to treat migraines. It is more popular than comparable drugs. It is available in generic and brand versions. Generic Sumatriptan is covered by most Medicare and insurance plans, but some pharmacy coupons or cash prices may be lower. Get sumatriptan for as low as $10.77, which is 91% off the average retail price of $117.80 for the most common version, by using a GoodRx coupon....
Votes:
2
0
Yahoo Finance Community
09/19
Comment
If Tonix submits NDA in October as stated, then the drug will be approved by August 2025. And if they apply for priority, it will be by April 2025. Why wouldn’t they just extend their listing notice another 180 days in Feb? That will keep them safe until August. Even if they RS by Oct, that will only keep them safe until May! Approval deadline is August! Regardless, they have until early October 2024 to conduct a RS, or they have to extend the notice and risk price falling <.10. If there’s ANY bright side to this, it’s that this will be Tonix’s FINAL RS. It’s crazy how this is playing out, never seen a story like it in the market. Will the fear of <.10 make them RS? We’ll see. GLTA...
Votes:
1
1
Yahoo Finance Community
09/19
Comment
Not only is it one of the most expensive prescription drugs on the market for migraines,($658) but most insurance plans won't even cover it either.Yahoo keeps rejecting my posts whenever I mention a specific prescription drug by name or a drug company. The drug I am referring to above is the drug mentioned in today's PR. Go to Good Rx to read more on the price comparison between 14 of the most popular migraine prescription drugs.Tonix's drug is near the bottom of the list and is nearly 55 times more expensive than the most popular drug at only $12....
Yahoo Finance Community
09/19
Comment
I had a dream last night that TNXP was $35, but at the end of the dream when I was getting ready to sell my shares, I realized I only have 35 shares left from 35000 shares I had purchased in 2021. That’s when I woke up bad mouthing the company management who stole 99% of my shares through RS....
Yahoo Finance Community
09/20
Comment
For those who may be wondering why TNXP never seems to climb, the answer is simple, the company continues to sell shares. They sold almost 10m shares just last week alone.This was dropped last Friday after the bell." On the Record Date, September 12, 2024 there were 127,874,517 shares of common stock outstanding and entitled to vote.And here is tonight's bomb.As of September 19, 2024, there were 137,256,441 shares of our common stock issued and outstanding."They are a well oiled mean, green selling machine. And if that isn't bad enough, now Seth wants to sell even more shares. Possibly as much as up to $300,000,000. They're going to need a much bigger selling machine. Much much bigger. This latest news pretty much guarantees another reverse split is on its way.Caveat EmptorAs always, treat this stock selling you know what for what it is ..... a quick trade....
Votes:
4
0
Yahoo Finance Community
09/20
Comment
As what seems to be a common theme with this stock, more bad news was released after the bell this Friday evening. As most of you may recall, a few weeks ago Seth increased their stock offering from $50m to $150m, well now they have completely lost their minds. See for yourself:"We may offer and sell, from time to time in one or more offerings, any combination of common stock, preferred stock, warrants, or units having an aggregate initial offering price not exceeding $300,000,000."Read tonight's SEC filing for more info. I would post it here, but the Yahoo police will immediately delete it....
Votes:
2
0
Yahoo Finance Community
09/22
Comment
Will Seth issue a super duper extra fluffy PR in the morning to offset Friday evening's S-3 filing of potentially selling up to $300,000,000 worth of new shares? I suspect so and if there is a PR will it actually stick to the wall this time? We shall see. GLTA...
Votes:
1
0
Yahoo Finance News
09/23
Tonix Pharmaceuticals Announces Data Presentations on TNX-102 SL for Fibromyalgia at the 11th Global Conference on Pharmaceutics and Novel Drug Delivery Systems (PDDS 2024)
Tonix Pharmaceuticals Announces Data Presentations on TNX-102 SL for Fibromyalgia at the 11th Global Conference on Pharmaceutics and Novel Drug Delivery Systems (PDDS 2024) Tonix Pharmaceuticals Holdi...
Yahoo Finance Community
09/23
Comment
139,987,122 is the latest amount of shares outstanding, as of 9/20/24. That is an increase of an additional 2.7m shares from just the day before."As of September 19, 2024, there were 137,256,441 shares of our common stock issued and outstanding."Like I said, this company is a finely oiled mean green selling machine. They just keep printing new shares day after day, week after week, month after month. It never ends.I wonder what kind of fluffy news we should expect to see from Seth tomorrow morning? Will tomorrow's PR be the one? The one that has some substance, the one that won't give everything back within the first hour of trading? We shall see.Caveat EmptorAs always, treat these one hit wonders for what they were made for... a quick trade.GLTA...
Yahoo Finance Community
09/23
Comment
The ONLY optimism with Tnxp is this will likely be their final RS. So if you’re up for it, buy after the RS for a “bankruptcy or not” gamble. Lottery ticket. My guess is the max RS (1:100) to make the stock $10 then dilution and offerings until it’s near $1. Thoughts??...
Yahoo Finance Community
09/24
Comment
“If the company fails to comply If the conditions that triggered the deficiency notice are not met in time, the NASDAQ will then send the company a delisting letter, which must be disclosed to the public within four business days. There is an appeal procedure that a company can use, if it feels that it doesn't deserve to be delisted or if it can regain compliance in a reasonable amount of time. Once the company receives the delisting letter, it has seven days to request a hearing with the NASDAQ listing qualification panel to present its case, which postpones the delisting process until the panel makes a decision. Unless an appeal is filed, the company's stock is halted, and then delisted after seven days. If the appeal is rejected, the company also has the option to appeal to the SEC or in federal court. The NASDAQ gives the company an …...
Yahoo Finance Community
09/24
Comment
this was $20 before solid phase 3 fibro data was released Dec, 2023 and now .13 , what a utter disaster the company and seth is a huge crook, he has bent over so many shareholders over past 10 years, i am shocked no disgruntled shareholder has elminated him yet...
Yahoo Finance Community
09/24
Comment
Tonix Pharmaceuticals Holding Corp. has announced a Special Meeting of shareholders to be held virtually on October 30, 2024. The meeting will address two key proposals: a reverse stock split of the company's common stock and an amendment to increase the authorized shares of common stock to 1 billion if a reverse stock split is effectuated prior to the approval of the Reverse Stock Split Proposal. Shareholders of record as of September 12, 2024, are entitled to vote at the meeting. The reverse stock split aims to reduce the number of outstanding shares, with the exact ratio to be determined by the Board, to meet Nasdaq's continued listing requirements. The amendment to increase authorized shares is a contingency if the reverse stock split occurs before shareholder approval, ensuring the company can raise additional financing, retain key personnel, and potentially make strategic acquisitions. Proxy materials will be furnished to shareholders on …...
Votes:
1
1
Yahoo Finance Community
09/25
Comment
On 30 June there were 10m shares outstanding, and as of 24 September there were 140m shares outstanding. So during that time they sold 130m shares. If the average price at which they sold shares was $0.30, then they would've raised $39m during that time. We'll see the 3Q data in early November, but expect it to show that they aren't about to run out of cash. However at the rate they spend, expect the dilution to continue nonetheless....
Yahoo Finance Community
09/25
Comment
For me Tnxp is just a joke. You know the joke can never be trusted. You never know when it is going to make you sad smile laugh and cry. So be in reality. Joke is joke and so TNXP. I think, behind this joke, jokers are the one who are playing with us . If they are real jokers then they themselves will also be never happy. With last few splits I think these jokers are not seriously helping investors rather than they are enjoying investors' money. But they know ultimate result. Just hope for the best. Good luck . Just my opinions. Cheers...
Yahoo Finance Community
09/26
Comment
Hey folks. They probably won't RS until 10 May 2025. They did a 1:6.25 RS on 10 May 2023 and a 1:32 RS on 10 June 2024, so the combined RS since 10 May 2023 is 1:200. They will get delisted from NASDAQ if they do more than 1:250 RS in 2 years, so I would expect no RS until 10 May 2025 and then a big RS (1:32? 1:100?).They will also get delisted if stock price stays below $0.10. So expect continued selling from Tonix as long as stock price is above $0.10, but, to maintain their listing they might buy if price goes below $0.10 to prop up the price. When they file NDA they will probably sell a huge volume of shares, so any pump likely to be short-lived and surprisingly limited. And of course I could be totally wrong!...
Votes:
2
1
Yahoo Finance Community
09/26
Comment
Who the helll buys just 1 share, especially one that trades for less than 14 cents a share? lol.At the rate Seth is selling shares,( 1 share at a time) it will take a trillion years for him to raise the $300,000,000..... from last week's increased stock offering.In my best Tony Montana voice while holding a well oiled machine gun, "Say hello to my little Bot friend." lol....
Polygon News
09/27
Tonix Pharmaceuticals Announces Issuance of U.S. Patent Covering the Subcutaneous Delivery of FDA-Approved Zembrace® SymTouch® to Treat Migraines
Tonix Pharmaceuticals has been issued a U.S. patent for the subcutaneous delivery of its FDA-approved migraine treatment Zembrace® SymTouch®, which is expected to provide market exclusivity until 2036...
Yahoo Finance News
09/27
Tonix Pharmaceuticals Receives US Patent for Migraine Treatment; Shares Rise
PREMIUM Tonix Pharmaceuticals Receives US Patent for Migraine Treatment; Shares Rise MT Newswires Fri, Sep 27, 2024, 8:07 AM In This Article: TNXP +6.88% Tonix Pharmaceuticals Receives US Patent for M...
Yahoo Finance Community
09/27
Comment
What we have right now is a game of musical chairs being played in a house of cards. Congrats to those who made a little something this morning. The company is most definitely selling new shares into this head fake. Who will be the last person standing when the music stops in about 20 minutes?Caveat Emptor...
Yahoo Finance Community
09/27
Comment
Tale of the tape, as of 11am.Shares bought....... 76,054,646Shares sold..........80,264,068Neutral shares traded.... 11,418,467I wonder how many of those 80m shares sold are from the company? I'm going to guess 20m.Caveat EmptorAs always, treat it like Seth treats it... as a trade.GLTA...
Votes:
1
0
Yahoo Finance Community
09/27
Comment
Anybody care to guess when this was first published?Zembrace SymTouch currently has patent protection to 2036.I'll give you a hint...it wasn't this year.Give up?The answer : June 26th 2023. Apparently, Seth is rehashing news from over a year ago. It worked. Well, at least it worked long enough to rope in some new sheep.Caveat EmptorAs always, treat these rehashing, stock selling turdds for what they were made for .... a quick trade.GLTA...
Votes:
1
1
Yahoo Finance Community
09/27
Comment
read the SEC FILINGS before you invest - they are printing hundreds of millions of shares and dumping them on the open market in an ATM plus Jessica Morris is snorting cocaine in the office and Alliance Global is printing hundreds of millions of shares...
Votes:
3
1
Yahoo Finance Community
09/27
Comment
Looks like Toxic did it again, they roped in a whole new herd of sheep. Why am I not surprised.Like I was saying earlier this morning, who is going to be left standing when the song stops playing?The Party's Over (Hopelessly in Love)Song by Journey"Welcome back my friends to the show that never ends"...Karn Evil9, song by Emerson, Lake and PalmerBoth songs seem to fit this dog beautifully....
Votes:
1
0
Quantexa News
09/27
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Short Interest Update
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) saw a large drop in short interest during the month of September. As of September 15th, there was short interest totalling 467,200...
Quantexa News
09/27
Short Interest in Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Declines By 70.2%
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) was the target of a significant drop in short interest in September. As of September 15th, there was short interest totalling 467,...
Yahoo Finance Community
09/28
Comment
TNXP food for thought: yesterday, BMS got FDA approval on a new schizophrenia drug, the first in 17 years. It's reported based on studies to be a friendlier drug with fewer side effects. The stock went up 3% on the news. Not $20 or $30 but a minimal gain. If by comparison 102 is approved, will you see the same tired small paltry increase. Similarities of the two were eye brow raising. IMO...
Yahoo Finance Community
09/28
Comment
Maybe this has been said before over the past 12 years but I’d argue next month is probably one of the most vital, strategic and critical months to date for this company. NDA is on the way as advertised, buyback, RS, mpox, other phase 3, patent protections. Who knows what will happen whether long or short. GL...
Votes:
1
0
Yahoo Finance News
09/30
Tonix Pharmaceuticals Announces Participation in Endpoints Panel at the Long COVID Workshop and RECOVER TLC Workshop Convened by the Foundation for the National Institutes of Health (FNIH) and the National Institute of Allergy and Infectious Diseases (NIA
Tonix Pharmaceuticals Announces Participation in Endpoints Panel at the Long COVID Workshop and RECOVER TLC Workshop Convened by the Foundation for the National Institutes of Health (FNIH) and the Nat...
Yahoo Finance News
10/01
The Rush for Non-Addictive Painkillers to Counter the Opioid Crisis Puts Two Companies Close to FDA Decisions
Read full article ACCESSWIRE The Rush for Non-Addictive Painkillers to Counter the Opioid Crisis Puts Two Companies Close to FDA Decisions Tonix Pharmaceuticals Holding Tue, Oct 1, 2024, 7:30 AM 8 min...
Quantexa News
10/01
The Rush for Non-Addictive Painkillers to Counter the Opioid Crisis Puts Two Companies Close to FDA Decisions
This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp. with financial support from Tonix. The two organizations...
Quantexa News
10/01
The Rush for Non-Addictive Painkillers to Counter the Opioid Crisis Puts Two Companies Close to FDA Decisions
This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp. with financial support from Tonix. The two organizations...
Yahoo Finance Community
10/02
Comment
Food for thought: 75% of fast track drugs get approved. Over 50% of priority review drugs get approved. Tnxp is submitting for priority review and already fast tracked; if approved for priority review, wouldn’t that make FDA approval for 102 near 100% odds? If priority is granted, approval will occur by April 2025. Tnxp has to be above $1 by Feb 2025, BUT they can file an extension that will certainly get nasdaq approval (reason being a drug is under FDA review). The only reasons for another RS is fear of falling <.10 for 10 days straight and plans for further dilution. Tonix will likely dilute until 2026 since they won’t have sustainable cash flow from 102 until then, however I think dilution will lessen as time moves on due to institutional buying/increased sales after 102 is submitted/approved. Will Tonix RS? Who knows.. I do know that it will be …...
Yahoo Finance Community
10/02
Comment
Will this fall below 13 cents today? We shall see. It's looking like the MM's are filling the gap left over from this morning's pre-market trading. For those not aware, TNXP traded as low as .125 this morning in the pre-maket. Caveat EmptorAs always, treat it as a trade.GLTA...
Yahoo Finance Community
10/02
Comment
Same old Seth ,he co -writes an article lauding the " benefits " of his useless pipeline candidate because no one else cares .Nobody from big pharma has donated a dime to his candidates .This is deplorable desperate behaviour from a man on the verge of unleashing his 9 th reverse split....
Votes:
2
0
Yahoo Finance Community
10/03
Comment
Voting is now at the forefront. You should all vote no but I know that Kris and Lassos and every other rainbow believer will vote to give Seth more money for his pocket. I will just say that I know I have lost my investment and you should too. This guy is a spin doctor and you are a class a rear end if you haven’t realized this by now. Stop the madness vote no...
Votes:
1
0
Yahoo Finance Community
10/03
Comment
Who is buying and who is selling past 3 months for volume to be this high. This company has bad past but looks like it coming back track with two marketed drugs and a pipeline. Heavy volume before and after market is not certainly retail. So who is selling and who is buying. Managment has told they would sell up to 150 million shares, only to ones who can invest 1 million at a time to private investors. Is that what is happening. looks like it. Why that desperation, i don't understand. We need answers from the company regarding their plans other than stupid marketing material they put out. Whenever a news comes, stock goes down again. If company management is reading this for the good of stakeholders, release a communication assuring investors....
Votes:
2
2
Quantexa News
10/07
Tonix Pharmaceuticals Holding Corp (TNXP) Shares Soar Above 1-Year High
The stock price of Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has surged by 10.63 when compared to previous closing price of 0.13, but the company has seen a -4.52% decline in its stock price o...
Yahoo Finance News
10/08
Tonix Pharmaceuticals Announces AI Collaboration with X-Chem to Develop Broad-Spectrum Antivirals
Tonix Pharmaceuticals Announces AI Collaboration with X-Chem to Develop Broad-Spectrum Antivirals Tonix Pharmaceuticals Holding Corp. Tonix Pharmaceuticals Holding Corp. Tue, Oct 8, 2024, 8:30 AM 7 mi...
Quantexa News
10/08
Tonix Pharmaceuticals Announces AI Collaboration with X-Chem to Develop Broad-Spectrum Antivirals
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announce...
Quantexa News
10/08
Tonix Pharmaceuticals Holding Corp. Announces AI Research Collaboration with X-Chem to Develop Broad-Spectrum Antivirals
Tonix Pharmaceuticals Holding Corp. announced that it has entered into an AI and ML research collaboration with X-Chem, Inc. (X-Chem) to accelerate development of Tonix?s oral broad-spectrum antiviral...
Yahoo Finance Community
10/08
Comment
Shocking...these crooks have not been arrested! Every few months, there is a new potential drug, but nothing ever gets approved. The chief medical officer goal is to come up with the next number for the next drug in a few months.. wild guess tx4300. 43 unsuccessful drugs and 43 r/s. just look at the last 5 yrs....
Votes:
1
0
Yahoo Finance Community
10/09
Comment
joke pharma company. all they have is a weak ph3 trial .. of which , even if approved in 2-3 years, will need a large partner and many millions of marketing.. and even then the sales will be a joke , if ever approvedthe medical community knows they have very little chance of approval and/or sales in the next 2-3 years, thus a 13cent stock pricethis company's main mission is performing champagne conferences. company should be delisted...
Yahoo Finance Community
10/09
Comment
Kris, I'm starting to think these guys might have a point. You know I got out of this about a month ago, overall in the black, but lost a few hundred on my last trade. I thought I would let that rinse then get back in. Now I'm not so sure. It looks like Bill got out, although I bet he still checks in like I do. That NDA should have been submitted months ago, right after they got the fact track designation. The fast track might not even be valid anymore. Bill warned us about all these things, and although I didn't like being called a paid bull pumper, we eventually came to terms. I actually think the NDA is already factored into the price. It might get a little bump, but like everything else here, they usually don't make it through the day. Good luck to you, my …...
Yahoo Finance Community
10/09
Comment
TNXP hit a low of .132 in the early pre-market followed by a high of .145 a few hours later. The gap on the low end got filled this morning in the regular hours of trading. Now the question is, will the gap on the high end get filled during the regular hours? We shall see. Current price is .1396. Wash, rinse, repeat.Caveat EmptorAs always, treat this highly manipulated, stock selling turdd for what it was made for ...... a quick trade.GLTA...
Quantexa News
10/10
Can Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Still Be Considered A Loss When It's Down -98.89% YTD?
During the recent session, Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)'s traded shares were 4.0 million, with the beta value of the company hitting 2.09. At the last check today, the stock's pric...
Yahoo Finance Community
10/11
Comment
If filing NDA sometime this month is supposed to make the stock go up, why isn’t anyone buying it now that it’s dirt cheap? The answer is no trust in the company and its management nor its future. A total Sham. Gimmick. These guys never taken any drugs into the market and don’t look like they will any time soon....
Votes:
1
1
Quantexa News
10/11
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Sees Large Increase in Short Interest
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) saw a significant growth in short interest in September. As of September 30th, there was short interest totalling 8,290,000 shares...
Yahoo Finance Community
10/14
Comment
I wonder if Sethan and company have sold enough shares yet to cover the astronomical fee for the NDA? Anybody care to guess how much it cost to submit an NDA in 2024? I'll give you a hint...it's about half the amount of money they supposedly plan on buying back in shares. Give up?"The cost of filing a New Drug Application with the US FDA has pushed above the $4 million mark. That is a remarkable rate of increase from the original $100,000 fee set in 1992"...
Votes:
1
0
Yahoo Finance Community
10/15
Comment
Anybody in DRUG stock? Good grief. That stock was under a buck just a few days ago and today the momo and fomo crowd ran it up to close at $38.49. It hit $54 in the after hours. Will that happen to TNXP? I doubt it, but these days you never know. Anything is possible.ps... Hey pecunia, looks like I found ya the mother of all stocks to short. What goes up quickly for no reason can come down just as fast. Looks like Huey Lewis found what he was looking for.. a new drug. Best of luck to all....
Yahoo Finance News
10/16
Tonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration (FDA)
Tonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration (FDA) Tonix Pharmaceuticals Holding Corp. Tonix Pharma...
Quantexa News
10/16
Tonix Pharma (TNXP) Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration
October 16, 2024 8:05 AM EDT Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP ) (Tonix or the Company), today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Admin...
Quantexa News
10/16
Tonix Pharmaceuticals Holding Corp Announces Submission of the TNX-102 SL New Drug Application for Fibromyalgia to the U.S. Food and Drug Administration
Tonix Pharmaceuticals Holding Corp. announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for TNX-102 SL (cyclobenzaprine HCl sublingual tablets) 5.6...
Yahoo Finance Community
10/16
Comment
Fudsters will spread misinformation surrounding events until it actually happens. Even to the point to say that a company can’t afford to do it even though evidence through ATMing showed what they were gearing up for. GL, this is only the beginning for this company....
Votes:
1
1
Yahoo Finance News
10/16
Tonix Pharmaceuticals Files New Drug Application With FDA for TNX-102 SL to Treat Fibromyalgia
PREMIUM Tonix Pharmaceuticals Files New Drug Application With FDA for TNX-102 SL to Treat Fibromyalgia MT Newswires Wed, Oct 16, 2024, 4:31 PM 1 min read In This Article: TNXP +12.77% Tonix Pharmaceut...
Yahoo Finance Community
10/16
Comment
NDA submitted as expected. They would focus of rest of the pipeline.Now they have experience submitting NDA without a problem, they might have a better chance in finding investors and partners. I also expect little more attention from analyst.All said, there are other steps in NDS submit. FDA has to accept the submission. Then they need to set a date for the review. FDA typically has a 60-day filing review period to determine whether the submitted NDA is complete and accepted for review. If FDA accepts the NDA for review, the Company expects a 2025 date for an FDA decision on approval, based on the Prescription Drug User Fee Act (PDUFA).I only hope this stock will quickly reach $1 and stay above it so that there would not be another RS....
Yahoo Finance Community
10/16
Comment
I see they finally released a PR on the monumental news of them submitting an NDA with the FDA. It shows the news was released 4 hours ago on Yahoo, but there is no way I would have missed seeing that PR. Am I the only one who is just now getting this news on my Yahoo browser?...
Votes:
1
0
Yahoo Finance Community
10/16
Comment
Now its submitted to NDA , there is now a light after all dark moments and reverse split… if it will go to $1, more investors and pharmaceutical drug company will invest on this plus the $34M funding from the government for anti viral and the migraine products . All in all this would be a billion dollar market capital in expand of 6 months....
Votes:
1
0
Yahoo Finance Community
10/16
Comment
I wonder who was at fault here for the delay in releasing the news this morning, the company or Yahoo? They say timing is everything and with the way they botched today's news, delivering to us 3 hours later, it's like a waiter bringing us a sizzling hot Kobe steak 3 hours late and served on a trash can lid. They really botched this PR big time. Hopefully, there will be a delayed bounce this afternoon.Caveat EmptorAs always, treat these stock selling turdds for what they were made for .... a quick trade.GLTA...
Votes:
2
0
Yahoo Finance News
10/16
Empery Asset Management LP Acquires Shares in Tonix Pharmaceuticals
Empery Asset Management LP Acquires Shares in Tonix Pharmaceuticals GuruFocus News Wed, Oct 16, 2024, 1:01 PM 3 min read In This Article: TNXP +12.77% Overview of the Recent Transaction On September 3...
Yahoo Finance Community
10/16
Comment
Tonix Pharmaceuticals Holding's earnings in 2024 is -$149,012,000. On average, 2 Wall Street analysts forecast TNXP's earnings for 2024 to be -$396,074,862, with the lowest TNXP earnings forecast at -$750,121,780, and the highest TNXP earnings forecast at -$42,027,944....
Quantexa News
10/16
Empery Asset Management LP Acquires Shares in Tonix Pharmaceuticals
3-min read In this article: Overview of the Recent Transaction On September 30, 2024, Empery Asset Management, LP Trades Portfolio ), a notable investment firm, expanded its portfolio by acquiring...
Yahoo Finance Community
10/16
Comment
Here’s the facts: -TNXP can’t be <$.10 for ten consecutive days -TNXP has to be >$1.00 for ten consecutive days to avoid delisting by Feb. 2025 -TNXP could file to extend Feb. 2025 >$1.00 delisting deadline to Aug. 2025 -FDA has until 12/16/2024 to proceed with the NDA submission and start the review process -if proceeded and non priority, FDA has until 10/16/2025 to approve the drug -if proceeded and granted priority review, FDA has until 6/16/2025 to approve the drug -TNXP can reverse split anytime for up to 1:100 -TNXP is meeting 10/30/2024 to propose a reverse split and an additional 1B shares -A new NASDAQ rule will be either approved or denied on 11/21/2024 to prevent TNXP from doing a reverse split up until 1 year from their last reverse split Best case scenario: TNXP does not reverse split in the next month and the new NASDAQ rule …...
Votes:
1
0
Yahoo Finance Community
10/16
Comment
My opinion to this: If DRUG can soar from $1 to $37 in just one day with their clinical studies in a phase 2 , how much more to a tnxp which already done with phase 2, done with phase 3 and positive result! Now a new press release about NDA. Just imagine that! This will go up! Expedite for a fast review! Just imagine that Got a government funding , just imagine that Fibromyalgia - the CEO was is medical practitioner for more or less 30 years of studying focusing more on fibromyalgia So i think this is a bullish!...
Votes:
3
1
Yahoo Finance Community
10/16
Comment
You only have to look at today's lackluster response to the NDA filing to know the upcoming vote for a reverse split is the direct result of a minimal upward response. Lots of newbie deniers, but not one of them can answer the question. First long awaited filing with odds for approval. Why are there no major institutional buyers today? The biggest news is a boutique 17 million dollar under management bought 1.7 million shares. They aren't Blackrock or State Street. Simple answer to the newbie deniers. Nobody on this planet trusts the CEO or BOD's for TNXP. They have a history of burning all and have shown their total disregard for stakeholders. Giddy Giddy newbies, a dog is a dog. IMO...
Votes:
3
0
Yahoo Finance News
10/17
Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department of Defense for Accelerated Development of Broad-Spectrum Antivirals with the Defense Threat Reduction Agency (DTRA)
Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department of Defense for Accelerated Development of Broad-Spectrum Antivirals with the Defense Threat Reduction Agency (DTRA) Tonix Pha...
Quantexa News
10/17
Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department of Defense for Accelerated Development of Broad-Spectrum Antivirals with the Defense Threat Reduction Agency (DTRA)
First payment received under Tonix’s contract with the Defense Threat Reduction Agency (DTRA), for up to $34 million over five years CHATHAM, N.J., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuti...
Quantexa News
10/17
Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department of Defense for Accelerated Development of Broad-Spectrum Antivirals with the Defense Threat Reduction Agency (DTRA)
CHATHAM, N.J., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. TNXP (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of...
Quantexa News
10/17
Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department of Defense for Accelerated Development of Broad-Spectrum Antivirals with the Defense Threat Reduction Agency (DTRA)
CHATHAM, N.J., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pi...
Quantexa News
10/17
Tonix Pharma (TNXP) Receives First Contract Payment from U.S. DoD for Accelerated Development of Broad-Spectrum Antivirals with the DTRA
October 17, 2024 8:03 AM EDT Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP ) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of developm...
Quantexa News
10/17
Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department
CHATHAM, N.J., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pi...
Reddit
10/17
TNXP News - Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department of Defense (DOD) for Accelerated Development of Broad-Spectrum Antivirals with the Defense Threat Reduction Agency (DTRA)
CHATHAM, N.J., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pi...
Reddit
10/17
TNXP News - Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department of Defense (DOD) for Accelerated Development of Broad-Spectrum Antivirals with the Defense Threat Reduction Agency (DTRA)
CHATHAM, N.J., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pi...
Yahoo Finance Community
10/17
Comment
Good timing. Next 50 days it will move in positive direction, hopefully! So, looks like they don't have to sell the plant, they took 50 mil write off. Maybe it is still on the table and they would get a better deal and still rent it for long term lease terms. Which gives them additional cash and less operations costs. Their challenge is to get this one above $1 without RS....
Yahoo Finance Community
10/17
Comment
Looks like Seth caught wind of me talking about their DOD contract last night and decided to capitalize on it. lol.Congrats on today's bounce. Yep, I had a feeling you were going to get another Pr this morning. Seth's frequency of PR's are quite predictable seeing how he still needs to sell a ton of new shares. Up to $300m dollars worth of new shares. It's all about selling shares folks. Speaking of which, I wonder how many shares Sethan sold yesterday during the run up? I'm gonna guess about 10 million shares. Caveat EmptorAs always, treat it as a trade.Cheers! GLTA...
Quantexa News
10/17
Tonix Pharmaceuticals Receives First Contract Payment From U.S. Department Of Defense For Accelerated Development Of Broad-Spectrum Antivirals With The Defense Threat Reduction Agency (DTRA)
MENAFN - GlobeNewsWire - Nasdaq) First payment received under Tonix's contract with the Defense Threat Reduction Agency (DTRA), for up to $34 million over five years CHATHAM, N.J., Oct. 17, 2024 (GLO...
Yahoo Finance Community
10/17
Comment
Here’s something to think about: it seems Sethan is in a pickle. Can’t get institutions to buy because of lack of trust, which resorts to tnxp RS and dilution.. but that’s what caused the lack of trust! Does he continue to dilute and lose trust or stomach less money and gain trust 🧐...
Votes:
2
0
Yahoo Finance News
10/17
Tonix Pharmaceuticals Shares Surge After 1st Payment From Defense Department
Read full article Premium MT Newswires Tonix Pharmaceuticals Shares Surge After 1st Payment From Defense Department MT Newswires Thu, Oct 17, 2024, 11:12 AM Link Copied In this article: Tonix Pharmace...
Quantexa News
10/17
Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department of Defense for Accelerated Development of Broad-Spectrum Antivirals with the Defense Threat Reduction Agency
Tonix Pharmaceuticals Holding Corp. received its first payment from the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense (DoD), to develop small molecule broad-s...
Yahoo Finance Community
10/17
Comment
FDA has 60 days to review the application and see if it has all requirements for the approval review which could take at least another 90 days. If approved the drug would receive its final approval by March 2025. If initial NDA review or the approval review is not approved then it gets shut down to 5 cents. So let’s hope they don’t do another RS any time soon otherwise we longs are yet to experience the worst toasting of this corrupt management. GLTA...
Votes:
2
0
Quantexa News
10/18
Noble Capital Markets Issues Outperform Rating for Tonix Pharmaceuticals Holding Corp (TNXP) Stock
Noble Capital Markets has recently initiated Tonix Pharmaceuticals Holding Corp (TNXP) stock to Outperform rating, as announced on April 18, 2022, according to Finviz . Earlier, on April 18, 2019, ROT...
Yahoo Finance Community
10/18
Comment
Check out how these recent reverse splitters are being played by the momo and fomo crowd....PEGY and the one I mentioned yesterday, SOBR. Both stocks are now low floaters due in part to their respective splits and is the reason why they are able to leap so high so quickly. Another stock that has gone parabolic is that other stock I mentioned last week...drug. from a low of 93 cents just a few weeks ago to a high of over $59 in the after hours a few days ago. Don't worry folks, thanks to Sethan's insatiable appetite for banana splits, he will make sure this will be a low floater soon, too. Just be careful walking around all those banana peels. As always, treat'em as a trade....
Yahoo Finance Community
10/18
Comment
BEWARE...The next share holder meeting is on October 30th and what they offer is terrible (at least for the next yr or so) 1- a reverse split between 1 to 2 all the way to 1 to 100 (imagine having a 2nd stock split just a few month after) 2- increasing the # of shares up to 1 billion That would be terrible for small investors like us. Do they have other hidden agenda...? Is it to avoid an hostile take over? In my opinion they want to avoid a hostile take over but I thing for TNXP small.owner, it's our best avenue. So I voted: NO (and do the directors want to load up for cheap...who knows)...
Votes:
1
0
Yahoo Finance Community
10/21
Comment
the price predictions from all these analysts are crazy. the range is from $8 to I've seen $60 price targets. if you look at all the gaps that could get filled during a huge move up then it could make sense. but how many gaps will fill that's the question. I can see the low target a possibility...
Yahoo Finance Community
10/21
Comment
Maybe someone can point out the last time TNXP had a vote approved for a reverse split and share increase count and did NOT conduct both. They've had seven approved....please give the stakeholders this needed information. Maybe someone else can show a buyback that was announced and fully conducted by TNXP....
Votes:
2
1
Quantexa News
10/23
Stock Market Recap: Tonix Pharmaceuticals Holding Corp (TNXP) Concludes at 0.18, a -5.21 Surge/Decline
Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth. 3 Tiny Stocks Prim...
Yahoo Finance Community
10/24
Comment
The approval of a proposal to authorize the Company’s Board of Directors (the “Board”), in its discretion at any time within one year after shareholder approval is obtained, to effect a reverse stock split of then-outstanding shares of the Company’s common stock, at a ratio of not less than one-for-two (1:2) and not greater than one-for-hundred (1:100), with the exact ratio to be determined by the Company’s Board and included in a public announcement (the “Reverse Stock Split Proposal”);The approval of an amendment to the Company’s Articles of Incorporation, as amended, to increase the Company’s authorized shares of common stock to 1,000,000,000 in the event a reverse stock split of our common stock is effectuated prior to approval of the Reverse Stock Split Proposal (the “Proposal to Increase Authorized Shares”); and...
Yahoo Finance Community
10/24
Comment
As I was reading today's fluffy Pr, something caught my attention with Tonix's fluffy description of their products. Take note of the * after the heading. Tonix Pharmaceuticals Holding Corp.*Read what that * means. It's a mandatory disclaimer at the bottom of the description. "Tonix’s product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication."So in other words, all they have at the moment are a bunch of dangling carrots.Caveat EmptorAs always, treat these one trick ponies for what they are good for .... a quick trade.glta...
Votes:
1
0
Yahoo Finance Community
10/24
Comment
Look at how they manipulate this stock. A few minutes ago there was over 50k shares sitting on the bid @ .16 and just like yesterday, all of that support disappeared in a blink of an eye without even one share traded at that price. For those who may have been watching the trades the last couple of days the price magically goes up on the last trade of the day @ 4:00pm. It's called "painting the tape" and it's illegal. Watch it happen again today.Caveat EmptorAs always, treat this highly manipulated stock for what it is..... a quick trade.GLTA...
Votes:
2
0
Quantexa News
10/28
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP): One Stock To Trade As Economic Progress Advances
In today's recent session, 9.05 million shares of the Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) have been traded, and its beta is 2.09. Most recently the company's share price was $0.18, and it...
Quantexa News
10/28
Tonix Pharmaceuticals (NASDAQ:TNXP) Discloses Preliminary Financial Results for Quarter Ended September 30, 2024 Posted by on Oct 29th, 2024 For the quarter ended September 30, 2024, Tonix Pharmaceuticals reported a net cash usage in operating activities
Tonix Pharmaceuticals Holding Corp. has released selected preliminary operating results for the quarter that concluded on September 30, 2024, along with specific preliminary financial condition detail...
Quantexa News
10/28
Short Interest in Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Declines By 34.1%
NASDAQ:TNXP – Get Free Report ) was the target of a significant drop in short interest in the month of October. As of October 15th, there was short interest totalling 5,460,000 shares, a drop of 34.1%...
Quantexa News
10/28
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Short Interest Down 34.1% in October
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) was the recipient of a large decrease in short interest during the month of October. As of October 15th, there was short interest to...
Quantexa News
10/28
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Short Interest Down 34.1% in October
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) was the recipient of a significant decline in short interest in October. As of October 15th, there was short interest totalling 5,...
Quantexa News
10/29
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Stock: Does It Have The Potential To Rise?
In the last trading session, 15.54 million shares of the Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) were traded, and its beta was 2.09. Most recently the company's share price was $0.18, and it...
Quantexa News
10/29
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Short Interest Down 34.1% in October
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) was the target of a significant decrease in short interest in the month of October. As of October 15th, there was short interest t...
Quantexa News
10/30
Tonix Pharmaceuticals (NASDAQ:TNXP) Discloses Preliminary Financial Results for Quarter Ended September 30, 2024 Posted by on Oct 30th, 2024 The net operating loss for the quarter ended September 30, 2024, was approximately $14.2 million, which shows an i
Tonix Pharmaceuticals Holding Corp. has released selected preliminary operating results for the quarter that concluded on September 30, 2024, along with specific preliminary financial condition detail...
Yahoo Finance News
11/01
Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024
Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024 Tonix Pharmaceuticals Holding Corp. Fri, Nov 1, 2024, 7:00 AM 9 min read In This Article: T...
Polygon News
11/01
Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024
Tonix Pharmaceuticals presented positive preclinical data on its potential mpox vaccine candidate TNX-801, which demonstrated tolerability and efficacy in protecting animals from lethal monkeypox chal...
Quantexa News
11/03
Tonix Pharmaceuticals Shareholders Approve Reverse Stock Split Proposal, Reject Amendment Increase –
Tonix Pharmaceuticals Holding Corp. disclosed on October 30, 2024, that at a special virtual meeting of shareholders held on the same day, shareholders voted on and approved one out of two proposals....
Quantexa News
11/04
Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announce...
Quantexa News
11/04
Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya
Tonix Pharmaceuticals Holding Corp. 9 min read In this article Proposed clinical study in Kenya intended to test the safety, tolerability, and immunogenicity of TNX-801, a vaccine being developed t...
Quantexa News
11/06
Tonix Pharmaceuticals Shareholders Approve Reverse Stock Split Proposal, Reject Amendment Increase –
Tonix Pharmaceuticals Holding Corp. disclosed on October 30, 2024, that at a special virtual meeting of shareholders held on the same day, shareholders voted on and approved one out of two proposals....
Quantexa News
11/06
Tonix Pharma enters research agreement with KEMRI to design, plan and seek regulatory approval for phase I study of TNX-801 for mpox in Kenya
Tonix Pharmaceuticals Holding Corp., a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, announced that it has entered into a sponsored resear...
Quantexa News
11/12
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Submits NDA for Fibromyalgia Treatment and Advances Mpox Vaccine Development
November 12, 2024 at 11:56 AM EST reported its third-quarter 2024 financial results, highlighting the submission of a New Drug Application (“NDA”) to the U.S. Food and Drug Administration (FDA) for T...
Quantexa News
11/13
Biomednewsbreaks - Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Submits NDA For Fibromyalgia Treatment And Advances Mpox Vaccine Development
MENAFN - Investor Brand Network) Tonix Pharmaceuticals (NASDAQ: TNXP) reported its third-quarter 2024 financial results, highlighting the submission of a New Drug Application (“NDA”) to the U.S. Food...
Yahoo Finance News
11/13
Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals
Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised A...
Yahoo Finance News
11/14
Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments
Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments Tonix Pharmaceuticals Holding Thu, Nov 14, 2024, 7:30 AM 9 min read In This Article: TNXP -6.95% This post was written and...
Quantexa News
11/14
Investornewsbreaks Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Launches Rapid-Relief Migraine Treatments For Urgent Needs
MENAFN - Investor Brand Network) Tonix Pharmaceuticals (NASDAQ: TNXP) through its subsidiary Tonix Medicines, has introduced two fast-acting migraine treatments, Zembrace® SymTouch® (sumatriptan autoi...
Quantexa News
11/16
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Sees Large Increase in Short Interest
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) was the target of a significant increase in short interest during the month of October. As of October 31st, there was short intere...
Yahoo Finance News
11/18
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting Tonix Pharmaceuticals Ho...
Quantexa News
11/18
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Highlights Phase 3 Success for TNX-102 SL in Fibromyalgia Treatment
November 18, 2024 at 10:37 AM EST presented data at the ACR Convergence 2024 Annual Meeting showcasing the success of its Phase 3 RESILIENT study for TNX-102 SL, a sublingual cyclobenzaprine treatmen...
Yahoo Finance News
11/18
Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual
Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual Tonix Pharmaceuticals Holding Corp. Mon, Nov 18, 2024, 4:05 PM 4 min read In This Article: TNXP -6.95% Tonix Pharmaceuticals...
Quantexa News
11/21
Tonix Pharmaceuticals Holding Corp (TNXP) 14-day ATR is 0.02: This Stock is Set to Soar Above its Peers
Witnessing the stock's movement on the chart, on Wednesday, Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) set off with pace as it heaved 16.78% to $0.19, before settling in for the price of $0.16...
Yahoo Finance Community
11/21
Comment
Pecunia, the trader bold and wise, With charts and graphs before his eyes. But TNXP did not go his way, And his investments began to fray. His heart filled with hate and rage, As he watched his money disengage. The stock tumbled, his wealth declined, Pecunia's troubles were intertwined....
Yahoo Finance Community
11/22
Comment
11/1/24 7,670,000 shares sold short… that’s a + 40.5 % increase in 2 weeks… dollar volume sold 1.11 Million… price on report date: .15 Itsy bitsy, itsy-bitsy itsy-bitsy itsy-bitsy itsy-bitsy itsy-bitsy itsy-bitsy itsy-bitsy little tiny squeeze...
Votes:
3
0
Yahoo Finance Community
11/22
Comment
On July 30, 2024, we entered into a Sales Agreement with AGP pursuant to which we may issue and sell, from time to time, shares of our common stock having an aggregate offering price of up to $150.0 million in the ATM. AGP will act as sales agent and will be paid a 3% commission on each sale under the Sales Agreement. Our common stock will be sold at prevailing market prices at the time of the sale, and, as a result, prices will vary. During the three months ended September 30, 2024, we sold approximately 134.5 million shares of common stock under the Sales Agreement, for net proceeds of approximately $41.8 million. Subsequent to September 30, 2024, we sold 31.3 million shares of common stock under the Sales Agreement, for net proceeds of approximately $5.1 million....
Yahoo Finance Community
11/22
Comment
Now I read something and let me state that I could not verify… but it’s someone I listen too which is no nonsense - stated … That BlackRock and vanguard Have increased their positions with Tonix… I dont have the “ dark pool ” access anymore so I couldn’t verify...
Yahoo Finance Community
11/22
Comment
I read the grievance letter filed with the SEC. Am I correct in saying that TNXP must file for 180 day extension in Feb 2025 and the earliest an RS can happen is May 2025? If this is correct, the SP could certainly be over $1 by mid December I.e. FDA judgement timeframe...
Votes:
3
0
Yahoo Finance Community
11/22
Comment
Oct 16 to Dec 16 = 61 Days. Will the juggernaut drug 102 be accepted by FDA for already designated fast track? We will see..we know they’ve had multiple discussions, it’s based on 2 trials per the PR/8k. Can’t do an RS. Looking good. Not advice but I’m going in heavier now. GL...
Yahoo Finance Community
11/22
Comment
These serious side effects are described below: Serious, even life-threatening, allergic reactions. Stop taking LYRICA and call your healthcare provider right away if you have any of these signs of a serious allergic reaction: swelling of your face, mouth, lips, gums, tongue, throat or neck trouble breathing rash, hives (raised bumps) or blisters Like other antiepileptic drugs, LYRICA may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Call a healthcare provider right away if you have any of these symptoms, especially if they are new, worse, or worry you:...
Yahoo Finance Community
11/23
Comment
all that pumping by 1 guy and nothing . . . shameful. Alliance Global Partners has it rigged to a sell algorithm and Bullsheeeeter is unaware of their agenda - reverse split, OTC filing, because the SEC is aware of 7 reverse splits ruining shareholders for good stealing their money for years with reverse split after reverse split...
Votes:
1
1
Yahoo Finance Community
11/24
Comment
Lassos, do you realize it is 100% Zero chance of an RS happening until May 25 and the 180 day extension will bring their $1 requirement to June 25? The most awesome part is FDA acceptance is being considered before that. If accepted, what do you think will happen between Jan and May 25. I think it’s highly unlikely the price will remain at .19. I still see an upward see saw action from here. IMO...
Votes:
5
0
Yahoo Finance Community
11/24
Comment
Enterprise value divided by outstanding shares. Tnxp is worth just about .08 per shares If I am not mistaken. One thing I am not mistaken and sure about is that lederman and the gang who takes advantage of small investors to pay themselves using our money without our permission is responsible for all of this. Hope they pay for it in their personal life since they are such c rim inals....
Yahoo Finance Community
11/25
Comment
As I said earlier today: It’s a trap. Have seen this a ten dozen times in the past 2 years. It’s all about selling shares and piling up money for the management to continue getting big fat checks. NeXT trap is the unannounced RS of 50 for 1 followed by another 50% drop...
Votes:
2
3
Yahoo Finance Community
11/25
Comment
Short action went from 100k to 1.9mil available, and interest % has skyrocketed to 111%. Could be seen as a very positive sign. Please note the word, could. Short DP was 37%, which compared to the last 30 days, quite low in volume. The tide may be shifting. NDA news may come sooner rather than later. IMO...
Votes:
5
0
Quantexa News
11/26
Tonix Pharmaceuticals Holding Corp (TNXP) Shares Rise Despite Market Challenges
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP)'s stock price has increased by 1.05 compared to its previous closing price of 0.19. However, the company has seen a 44.36% increase in its stock price...
Yahoo Finance News
11/26
Tonix Pharmaceuticals to Participate in the NobleCon20 Investor Conference
Tonix Pharmaceuticals to Participate in the NobleCon20 Investor Conference Tonix Pharmaceuticals Holding Corp. Tue, Nov 26, 2024, 7:00 AM 5 min read In This Article: TNXP -1.67% Tonix Pharmaceuticals...
Polygon News
11/26
Tonix Pharmaceuticals to Participate in the NobleCon20 Investor Conference
Tonix Pharmaceuticals, a biopharmaceutical company, announced that its Chief Operating Officer will present at the NobleCon20 conference. The company's pipeline includes drug candidates for fibromyalg...
Yahoo Finance Community
11/26
Comment
I have no idea why 8888 continuously says RS of 50:1. It's false info. Even if they were to RS, they can't until May of next year, and the number is way below 50:1. I wish people on here would get their facts straight and stop showing their ignorance...
Votes:
6
1
Yahoo Finance Community
11/26
Comment
Shorts continue to clear, this morning 3.5mil, this afternoon 2.1mil available. There's a 100% premium added, which even tells a better story. News has to be soon approaching on 102. Patience prevails, and it's either a yes or no. Stop/loss is the key. IMO...
Votes:
2
0
Yahoo Finance Community
11/26
Comment
the fees have come down 19% since yesterday. What I found odd was the close of over 2 million shares this PM, sent the price slightly south. I do think the decision to hand all those back is in anticipation of what could be some good news around the corner...
Votes:
4
1
Yahoo Finance Community
11/26
Comment
FDA decision will make december very interesting. If it will be approved i think we can expect bullish movement. Tnx-102 sl is a medication for FM, if approved it will be one of the few out there. It can be huge *not recommendation, just my opinion...
Votes:
6
0
Yahoo Finance Community
11/27
Comment
No news The more expectations, the less the outcome Some people have piled up on the shares of this junk in the hopes of becoming multimillionaire overnight. Sadly to say it’s not going to happen since thousands and thousands including myself tried believing in this scam but lost many many thousands. These guys don’t have the juice for anything real and are in the business of doing research and presentation and nothing more....
Votes:
1
6
Yahoo Finance Community
11/27
Comment
Looks like NASDAQ is not approving an automatic delisting if company is <$1 for 10 days and RS in past year. However, they are approving rule of only 1 RS in 1 year period and max 1.5 year (540 days) grace period from RS. T onic will have until Dec 2025 to reach >$1 and will not RS again. Good news...
Votes:
6
1
Yahoo Finance Community
11/27
Comment
As I thought shorts aren't to carry into the weekend - 3.4 mil available and 2.7 mil bought back today and they days not over. Percentage will most likely go below 2%. They missed an opportunity to drive it upwards. Close the ATM window and let stock develop naturally instead of giving them away. IMO...
Votes:
1
0
Yahoo Finance Community
11/27
Comment
Jessica gets $654,000.00 year salary to print out regurgitated press releases - so AGP can print out more shares and dilute shareholders, then SETH is caught in a bind after 7 reverse splits the SEC will tell SETH to shut the front door and leave Nasdaq soon to OTC...
Yahoo Finance Community
11/28
Comment
Jessica gets $654,000.00 year salary to print out regurgitated press releases - so AGP can print out more shares and dilute shareholders, then SETH is caught in a bind after 7 reverse splits the SEC will tell SETH to shut the front door and leave Nasdaq soon to OTC...
Yahoo Finance Community
11/29
Comment
Jessica $654,000.00 salary for sitting at home - reprinting old news like it was new news - over and over while Alliance Global Partners - dilutes shareholders with a rolling ATM every single time a "press release" comes out and SETH junky worst CEO on the planet...
Quantexa News
11/29
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Short Interest Down 31.9% in November
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) was the recipient of a significant decline in short interest in November. As of November 15th, there was short interest totalling...
Quantexa News
11/30
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Sees Large Decline in Short Interest
NASDAQ:TNXP – Get Free Report ) was the target of a large decrease in short interest in the month of November. As of November 15th, there was short interest totalling 5,220,000 shares, a decrease of 3...
Quantexa News
11/30
Short Interest in Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Decreases By 31.9%
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) was the target of a large decrease in short interest during the month of November. As of November 15th, there was short interest t...
Quantexa News
12/01
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Short Interest Down 31.9% in November
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) was the target of a significant decline in short interest in November. As of November 15th, there was short interest totalling 5,2...
Quantexa News
12/01
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Sees Significant Decrease in Short Interest
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) was the target of a significant drop in short interest during the month of November. As of November 15th, there was short interest...
Yahoo Finance Community
12/01
Comment
Jessica $654,000.00 salary for sitting at home - reprinting old news like it was new news - over and over while Alliance Global Partners - dilutes shareholders with a rolling ATM every single time a "press release" comes out and SETH junky worst CEO on the planet...
Yahoo Finance Community
12/01
Comment
No news The more expectations, the less the outcome Some people have piled up on the shares of this junk in the hopes of becoming multimillionaire overnight. Sadly to say it’s not going to happen since thousands and thousands including myself tried believing in this scam but lost many many thousands. These guys don’t have the juice for anything real and are in the business of doing research and presentation and nothing more....
Votes:
1
6
Quantexa News
12/02
Tonix Pharmaceuticals Holding Corp (TNXP) Shares Soar Above 1-Year High
The stock of Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has increased by 0.74 when compared to last closing price of 0.19. Despite this, the company has experienced a -7.10% fall in its stock p...
Yahoo Finance Community
12/02
Comment
fyi the average cost for R&D on a new drug, including cost of failures, is around 879 million. The range being 314 million to 5 billion and that is for only ONE drug. Just imagine if a company has multiple drugs. The beauty of this is that most of them only one juggernaut to make through the red tape to compensate for all that R&D. 102 could potentially be that for Tnxp....
Votes:
7
0
Quantexa News
12/02
These Numbers Show Just How Powerful Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Stock Is
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) price closed higher on Friday, November 29, and jumping 0.74% above its previous close. A look at the daily price movement shows that the last close r...
Yahoo Finance News
12/03
TNXP: NDA Filed for TNX-102 SL in Fibromyalgia…
TNXP: NDA Filed for TNX-102 SL in Fibromyalgia… Zacks Small Cap Research Tue, Dec 3, 2024, 5:25 AM 7 min read In This Article: TNXP -0.96% By David Bautz, PhD NASDAQ:TNXP READ THE FULL TNXP RESEARCH R...
Yahoo Finance News
12/03
Tonix Pharmaceuticals Announces Expansion of Leadership Team with Two Strategic Hires
Tonix Pharmaceuticals Announces Expansion of Leadership Team with Two Strategic Hires Tonix Pharmaceuticals Holding Corp. Tue, Dec 3, 2024, 7:00 AM 11 min read In This Article: TNXP -0.96% Tonix Pharm...
Yahoo Finance Community
12/03
Comment
two strategic hires in the leadership team. product development and marketing specialist and for affairs for strategic partners. looking great except the decision as approved. buy as much as you can and fasten your seatbelts we are getting ready to fly....
Votes:
4
1
Yahoo Finance Community
12/03
Comment
I guess there are not much interest for this gimmicky 18 cents waste of time and money. Perhaps NDA decision is not going to be good or not going to make the stock move in any significant manner. The fact that most of the trades were on the bid side recently and that stock is stuck under 20 cents could be a clue to the NDA not going to be positive. There could be more tests needed before final approval. Otherwise this junk should have been at least near a $1 territory. GLTA and hope NDA gives a thumbs 👍....
Votes:
1
3
Yahoo Finance Community
12/03
Comment
As of 11:22am, according to the stats at I-Hub, the buying has outnumbered the selling. Shares sold ..... 5,522,513Shares bought..... 6,291,654Neutral shares traded.....1,169,337 For those keeping score, the buying outnumbered the selling at around this time yesterday then the selling ramped up for the remainder of the day. The selling outnumbered the buying by a margin of nearly 2 to 1 by the end of the day. We shall see how today plays out. GLTA...
Yahoo Finance Community
12/03
Comment
Look at their LinkedIn Bio. Tonix is hiring for specialist in product launch. Posted a position three days ago. New hires have a whole lot of experience in building strategic patronships and product launch. There are tons of signs that they are ready for a product launch in 2025.Best of Luck everyone...
Votes:
2
0
Yahoo Finance Community
12/03
Comment
FDA most likely will ask for more information and testing before accepting the NDA. These guys never have gotten any drug accepted before and don’t quite know the success process. They may have to try a few times before getting anything approved. Just the fact that the stock have dropped from $275000 to 18 cents is one clue that their management team is not an experienced. Other indicators are that big buyers are absent and price is stuck at its lowest point so far. Knowing this company for nearly 5 years I can tell that this time is not any different. Most likely before the holidays they will reveal the non acceptance news causing the stock to go to the RS zone of 10 cents. I will be very surprised and also happy if otherwise happens and they get positive answers from the FDA for the first time in their …...
Yahoo Finance Community
12/03
Comment
Tale of the Tape.Here is a breakdown on all of today's trades, courtesy of I-Hub's trading platform.As of 4:00pm:Shares bought...... 10,390,796Shares sold....... 14,077,212Neutral shares traded....1,829,088 As was the case yesterday, the selling quickly resumed shortly after this morning's pump. I suspect Seth has another fluffy PR all set for tomorrow morning followed by more selling in the afternoon. Wash, rinse, repeat.Caveat EmptorAs always, treat it as a trade.GLTA...
Votes:
1
1
Yahoo Finance Community
12/03
Comment
Have they achieved the listing requirements besides SP? So if there is no possible RS until May 25 and $1 requirement is in Feb 25 (for now). Then what are the company’s options to get over $1 knowing they have over $20 million COH? Will the NDA get accepted and TNXP will let the SP fly post announcement (no ATMing) or will they suppress the run up, not allowing the gargantuan short squeeze to take place? Or will it all be a big nothing burger. Lot to unpack. GL…fyi, I am trading a portion with a tight stop loss but also have a long just in case. Not advice! GL...
Votes:
1
0
Yahoo Finance Community
12/03
Comment
the fact that they're this many pessimistic bears trying to Short the stock means they know they've already lost. look at OPTT, everyone knew it would crash and all the noise was positive. either they're few individuals are shorting the stock, they have shares in a rival company, or are just butt hurt from a bad trade...
Votes:
4
2
Yahoo Finance Community
12/03
Comment
January 1st 2023 was the date when the last buyback happened/ started …buyback was announced May 2022… And that’s all the Bears would say from May 2022 to January 1st is not going to happen … not enough money… it’s a scam… Seth’s a liar… he would never buyback shares cause it’s a fake company… Then January 1st came and stock went from .29 cents to just under 2 bucks a share …so save your nonsense, your words are falling on def ears 💰💎💰...
Votes:
1
0
Yahoo Finance Community
12/04
Comment
Tale of the Tape, as of 10:09am.Shares bought ....... 2,062,464Shares sold....... 4,646,511Neutral shares.... 388,367As you can see, the trading pattern has flipped from the last couple of days. Are the MM's simply mixing it up as to not look too obvious with their ATM selling? Perhaps we will see some buying in the PM. We shall see. ps...I was too tempted not to buy some of these cheap shares this morning. Stuck my little toe in at .1821. We shall see if I got in too soon. GLTA...
Yahoo Finance Community
12/04
Comment
Maybe someone knows if an insider buys cheap at the ATM window, does it have to be reported as such? Also, doesn't seem strange that with an NDA approaching first stage approval that there have been zero insider purchases. Nada none zilch. They sell cheap shares but don't buy some. Maybe telling a story. IMO...
Yahoo Finance Community
12/04
Comment
You should buy Tonix because of the risk vs. reward created by the $20 million market cap vs. potential sales for a non-opioid painkiller that can potentially be the only drug in its class. Insurance companies will have less leverage in negotiating prices because there is no equivalent alternative drug in the same class. The risk that the drug will not be approved is reduced because it has already been approved for fast-track phase 3 trials, meaning the FDA considers this a promising and important drug. View this as betting on a game with a 1/5 chance of winning 20x your money....
Votes:
6
0
Yahoo Finance Community
12/04
Comment
If approved, TNX-102 will go to market. Tonix does everything in-house and already markets 2 drugs. They have minimal debt and the experience to market drugs. Also, the investors post-approval will give them plenty $$. New drugs on market earn an average of $18B their first year in revenue....
Votes:
3
0
Yahoo Finance Community
12/04
Comment
Pfizer‘s Lyrica drug in 2018 alone 3 to 4,000,000,000… BILLION WITH A B …Tonmya data when compared to Lyrica doesn’t compare anywhere close… ( Tonmya ) superior in every aspect… with a 7 year rights and international licensing …you could be looking at well over 30 Billion… scary numbers I know shorts but - FACT...
Yahoo Finance Community
12/05
Comment
So much fake news being pumped here so allow me to clear the area with the truth: NDA decision next week, drug approval vote in April with priority and August without priority. Delisting in Feb if <$1 HOWEVER they can extend that deadline to August. They are fine as long as they stop. Selling. ATM. Please. Lol. GLTA...
Votes:
2
0
Yahoo Finance Community
12/05
Comment
Seeing how this is trending very similar to yesterday's action, my guess is the close will be painted (sudden jump in price) again on another wash sale at exactly 4pm. If you have been watching L2 or 3, you know what I am talking about. Once we enter the after hours session, we should see a few early leader buys in the post market with the purpose of luring in some unsuspecting newbies. Happens all the time. Just look at the pre-market trading this morning. They ran it up to .1988 at the opening of the pre-market...4am. Caveat EmptorAs always, treat it as a trade.GLTA...
Votes:
3
0
Yahoo Finance Community
12/06
Comment
Tale of the Manipulated Tape.As of 4:15pm.Shares bought..... 7,757,692Shares sold.......... 11,239,416Neutral trades.....1,136,506Checking the tape on the trades at precisely 4:00:00pm shows someone or some group washed 87,417 shares to close the day at .1725. I would copy the info and paste it, but the Yahoo police will immediately delete it. If you are interested in seeing this info first hand, go to I-Hub and look under the trades tab for this info.The trade just before that illegal trade at 4pm, was on the bid for 2,419 shares @ .1662.As always, treat it as a trade.GLTA...
Votes:
2
0
Yahoo Finance Community
12/06
Comment
Seth has been milking us investors ever since Covid hit making millions of dollars with no accountability and accomplishments so he could run his presentation empire while traveling lavishly. It’s time for SEC to stop this nonsense of RS and offerings....
Votes:
1
1
Yahoo Finance Community
12/06
Comment
The attempt earlier to pump and energize the stock failed because the management keeps selling shares silently. Any 2 cents gain is a 10% profit that day traders loving it. Staying long so far has been painful for most of us. With the end of the year, it’s best to realize the loss and help your taxes....
Votes:
1
1
Yahoo Finance Community
12/06
Comment
finally after 12 years of raising money, RS and repeating that process several times over…an NDA for a billion $ drug is being considered for acceptance. The FDA could send the ruling next week although the 60 day rule falls exactly on the 16th. Certainly an historical moment IMHO....
Votes:
4
0
Yahoo Finance Community
12/06
Comment
This company is known as 2 cents gimmick. Never climbed more than 2 cents and kept it. I think it will remain the same due to the bad history of not getting close to the end point. It keeps jumping from one thing to another wasting shareholder values. It will be a huge miracle if they don’t do the same this time around....
Yahoo Finance Community
12/06
Comment
Tale of the Smiling Tape.As of 4:00pm.Shares bought........ 9,741,114Shares sold.......7,976,116Neutral shares....1,831,153How about that folks, we finally finished a day with more buys than sells. Congrats! Who knows, maybe that is a sign of what is to come? You never know.GLTA...
Votes:
4
0
Yahoo Finance Community
12/07
Comment
What I think if things are so tight , instead of diluting the stock they should be delisted on the dreams shareholders have to be snuffed out by greed..c'mon startups blew past tonic and with tonic having awaiting approval on there products as well as established ties with bigger pharmaceuticals, either get with the game or find something else to squeeze the life out of shareholders..cheap doesn't justify the length of time wall st I'm sure is part to blame for this inconsistent holding a minimum standard. if shareholders were smarter they'd all bail on tonic and put there hard earned sweat n tears into a stock that moves at least, and not 2-3 cents forward and backwards, shame on you tonic...
Yahoo Finance Community
12/07
Comment
Uncle Seth loves to milk investors for all their money with his pump and dump schemes. Expert in hyping up the smallest news. It doesn't matter if any of the drugs succeed - what's most important is that he can use any news to pump up the share price so that he can fund his mansion. Insiders hold 0.17% of the shares of the company and if they don't believe in their own products, then why should you?...
Votes:
1
0
Yahoo Finance News
12/09
Tonix's TNX 102-SL Could Offer New Hope of Pain Relief Without Narcotics for Fibromyalgia Sufferers
Tonix's TNX 102-SL Could Offer New Hope of Pain Relief Without Narcotics for Fibromyalgia Sufferers Tonix Pharmaceuticals Holding Mon, Dec 9, 2024, 6:30 AM 4 min read In This Article: TNXP +2.13% Fibr...
Quantexa News
12/09
Tonix Pharmaceuticals Holding Corp (TNXP) Stock: A Study of the Market Performance
The stock of Tonix Pharmaceuticals Holding Corp (TNXP) has gone down by -3.27% for the week, with a 31.07% rise in the past month and a 11.14% rise in the past quarter. The volatility ratio for the we...
Quantexa News
12/09
Investornewsbreaks Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Awaits FDA Decision On New Fibromyalgia Treatment
Investornewsbreaks Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Awaits FDA Decision On New Fibromyalgia Treatment To view the full press release, visit About Tonix Pharmaceuticals Holding Cor...
Yahoo Finance Community
12/10
Comment
Short interest .83% - less than 1% DP / Naked shorts today 30% down from average of 55% Shorts have cleared TNXP is still selling cheap shares into the market.14 - $.15 - Fintel They need to pause selling, and shares will rise via market forces. Maybe tomorrow....
Votes:
4
0
Yahoo Finance Community
12/11
Comment
what is wrong with this generation - this company is a scam, it has basically done 7 reverse splits completely devastating shareholders equity to half a penny then - they authorized 1 billion shares and an ATM - diluting shareholders with every jessica Morris pump press release...
Yahoo Finance Community
12/11
Comment
Here’s what it comes down to: the company is pump and dumping their own stock to raise money to market 102. The question is when will they stop, will they stop, will they lessen, will they let the price rise at all? That’s why no one’s buying. When will it end?...
Votes:
1
1
Yahoo Finance Community
12/11
Comment
people are naive, when does "acceptance" news drop lol - The FDA rejects applications for BLA and NDA - if you do not understand this, then you are naive, ill experienced and ill equipped to understand what is going on - there are risks for shareholders trading penny stocks being diluted by an "authorized" 1 billion shares while Alliance Global services the ATM...
Quantexa News
12/12
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Sees Significant Decrease in Short Interest
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) was the recipient of a large decline in short interest in the month of November. As of November 30th, there was short interest tot...
Quantexa News
12/12
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Short Interest Down 69.5% in November
Tonix Pharmaceuticals Holding Corp. ( – ) saw a significant decrease in short interest in the month of November. As of November 30th, there was short interest totalling 1,590,000 shares, a decrease of...
Yahoo Finance Community
12/13
Comment
Before the submission to the FDA TNXP book value was as follows, .53 only days prior to submitting data. According to available data, the current book value per share for TNXP (Tonix Pharmaceuticals Holding Corp) is around $0.53. Now that we submitted the data to the FDA to analyze clearly that pushed the per shares value to 2.75 considering past history of the company, but if it was another company in the same situation as the Tonix the book value per shares would be something like 3.25. so under a dollar tnxp is a steal. The closer we get to the FDA announcement the higher the price of TNXP will go. You don't have to take my word for it. Please do your own research....
Votes:
5
1
Yahoo Finance Community
12/13
Comment
Tale of the Happy (After) Hour Tape.As of 7:59:10pm.Shares bought....21,897,465Shares sold .......23,866,351Neutral shares....3,232,968Geez, I go away for a few hours and an after hours party breaks out. Looks like you guys had one helll of a happy hour!Congrats! And they say Friday the 13th is bad luck? Maybe for the shorts it is. lol. Congrats again to everyone, especially to those who had the patience to hang in there. Hopefully, the momentum will continue in Monday's pre-market. GLTA...
Votes:
4
0
Quantexa News
12/13
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Short Interest Update
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) was the target of a large decrease in short interest during the month of November. As of November 30th, there was short interest t...
Yahoo Finance Community
12/13
Comment
One might consider the manipulation of the stock. In reality it has nothing to do with the FDA decision.Should there be a rejection by the FDA or a Complete Response Letter CRL - most of you Yahoos have the faintest clue what a CRL is btw, but more importantly is the ticking time line for the OTC and of course my new Christian friend Bill in California who has been watching the stock price go up and down for months but has no clue what's going on. Gotta chuckle - all of you wishing me well!...
Yahoo Finance Community
12/13
Comment
$TNXP Tonix will be boosted by about $100million in cash through pre-sold warrants C and D which they can ONLY draw down after ten working days….This should give a good base at $0.55 and $0.89 the two respective prices of the warrants…Thats not new shares being issued…that means of the 180million current float probably more with ATM…around 140million shares or a little more will transfer into the hands of the institution…leaving only 40 million shares or a little on market! 💰💎💰squidgy...
Votes:
4
2
Yahoo Finance Community
12/14
Comment
Lasso just go short when it hit $4. Save yourself agony and frustration. I am short PLTR, and many other nasdog stocks now . Let’s all make money . Trust me I am down on this stock many thousands of dollars . Maybe this time is really different and we can all make money including more for Seth!!...
Votes:
1
0
Yahoo Finance Community
12/14
Comment
Good morning you all. I am wondering why some of us here already have plans and assume that the NDA is a done deal next week. There is still a very high chance that FDA will ask for more information and delay it by at least another 6 months in which case Seth will start the next RS process. Pharmaceuticals are very tricky when it comes to win or lose. We should remember that things normally happen when you least expect them. Having too much hope for next week approval could backfire. Just be cool and let it come to you....
Votes:
3
7
Yahoo Finance Community
12/14
Comment
In the world of stocks and shares, he reigned supreme… A scorn investor named Lassy…with a heart so mean He threw his money around with reckless abandon But when things didn't go his way, he wasn't one to abandon His trades were risky…his decisions bold But he always seemed to end up in the cold His contempt for others…his greed so vast Left a trail of broken dreams in his past Lassy's eyes gleamed with a cruel delight As he watched others suffer…their futures not so bright He reveled in their despair, their losses his gain A heart so cold, it was hard to explain But deep down inside, beneath the scorn Lay a man broken and forlorn For all his wealth and power, he was truly alone A soul lost in the darkness…with no way home So beware of Lassy, the scorn investor For his actions will come back …...
Votes:
3
0
Yahoo Finance Community
12/14
Comment
they haven't even accepted the NDA application lol, oh my hoofs, you guys are a riotBill says $40 sharePecunia will take $1.20Bullsheeeter has so many guesses and estimates the stuff is flowing out of his mouth like a chocolate soft serve ice creamI just have 1 question for Y'all...
Yahoo Finance Community
12/14
Comment
no one has a grasp that this could get denied by the FDA in multiple forms - with or without a CRLand then the price would be .04 cents and everyone and his mother will be trying to get out for penniesbut listen carefully to Bill the Christian from California, he knows a lot of Crucifixion...
Yahoo Finance Community
12/14
Comment
I’m just going to say it … 10 million dollar buyback is in motion but very different than the last buyback… this time around AGP has been giving the green light to set short traps and execute very strategic buys this time around… enjoy the ride Shorts 💰💎💰...
Votes:
2
1
Yahoo Finance Community
12/14
Comment
Lyn is in charge of the 3 day pump: they will drive it up premarket Monday morning - the board will lit up with FOMO and the suckers will buy in "big time" on screams of $40 from Bill, $1.20 from Pecunia, Bull will give multiple price targets and you fools will get suckered into a 1 billion shares authorized ATM by Alliance Global Partners and by 2 pm you will see .21 cents, then probably .19 cents - but yeah sure go ahead block me and "trust" Lyn lol...
Votes:
2
5
Yahoo Finance Community
12/14
Comment
What do you guys think of an idea of not checking SP for a month or two? If I check it numerous times every day, like what happened many times to me before, I may get a temptation to sell for a small gain and miss a big gain opportunity, like a big run after a dip or a buyout....
Votes:
1
3
Yahoo Finance Community
12/15
Comment
Lyn is in charge of the 3 day pump: they will drive it up premarket Monday morning - the board will lit up with FOMO and the suckers will buy in "big time" on screams of $40 from Bill, $1.20 from Pecunia, Bull will give multiple price targets and you fools will get suckered into a 1 billion shares authorized ATM by Alliance Global Partners and by 2 pm you will see .21 cents, then probably .19 cents - but yeah sure go ahead block me and "trust" Lyn lol...
Votes:
1
2
Yahoo Finance Community
12/15
Comment
Hello. What do you think about Friday's after-hours price increase? What could have caused that strong rise and could it rise even more in Monday's pre market? Thanks to most of the positive and constructive comments in this thread. I'm a Bull myself, but criticism is also part of a good conversation. I personally think that if the FDA's decision is positive, the course can be over a dollar within a month. GLTA...
Yahoo Finance Community
12/15
Comment
I remembered 2 situations that reminds me this moment with tnxp. Nvax was a few bucks, I want to say but I don't remember exactly. Anyway it was very low. A few months later nvax went up, I sold it for 4, then was hanging around five right about the time they submitted NDA. The other one was Insm. I don't know if they are still in business. I must have had 35000 s at .71. Novavax went from a few dollars to like 400 per a. a few years later came back to 10 a share & Insm, went from .71 to like 40 per s? Looking back, honestly I really don't know what to do. Buy more? Stick with the tnxp that I currently own. Get more. Totally confused not sure what's the next step....
Votes:
2
0
Yahoo Finance Community
12/15
Comment
Lyn is in charge of the 3 day pump: they will drive it up premarket Monday morning - the board will lit up with FOMO and the suckers will buy in "big time" on screams of $40 from Bill, $1.20 from Pecunia, Bull will give multiple price targets and you fools will get trapped into a 1 billion shares authorized ATM by Alliance Global Partners and by 2 pm you will see .21 cents, then probably .19 cents - but yeah sure go ahead block me and "trust" Lyn lol...
Yahoo Finance Community
12/15
Comment
they haven't even accepted the NDA application lol, oh my hoofs, you guys are a riotBill says $40 sharePecunia will take $1.20Bullsheeeter has so many guesses and estimates the stuff is flowing out of his mouth like a chocolate soft serve ice creamI just have 1 question for Y'all...
Yahoo Finance Community
12/15
Comment
no one has a grasp that this could get denied by the FDA in multiple forms - with or without a CRLand then the price would be .04 cents and everyone and his mother will be trying to get out for penniesbut listen carefully to Bill the Christian from California, he knows a lot of Crucifixion...
Yahoo Finance Community
12/15
Comment
Lyn is in charge of the 3 day pump: they will drive it up premarket Monday morning - the board will lit up with FOMO and the suckers will buy in "big time" on screams of $40 from Bill, $1.20 from Pecunia, Bull will give multiple price targets and you fools will get trapped into a 1 billion shares authorized ATM by Alliance Global Partners and by 2 pm you will see .21 cents, then probably .19 cents - but yeah sure go ahead block me and "trust" Lyn lol...
Yahoo Finance Community
12/15
Comment
Lyn is in charge of the 3 day pump: they will drive it up premarket Monday morning - the board will lit up with FOMO and the suckers will buy in "big time" on screams of $40 from Bill, $1.20 from Pecunia, Bull will give multiple price targets and you fools will get trapped into a 1 billion shares authorized ATM by Alliance Global Partners and by 2 pm you will see .21 cents, then probably .19 cents - but yeah sure go ahead block me and "trust" Lyn lol...
Yahoo Finance Community
12/15
Comment
Dang there is a bunch of haters on here. Yes it will go up tremendously and yes it will get a RS. What do you expect? They been making this for YEARS and need running money. It's a AMAZING drug and will do fantastic in the future but for short term it will go up this week and then back down before it finally goes up and stays up. Just make your money on a predictable pump and dump, get out, wait till mid year next year and get in again. What is all the negativity for? Make some money this week. but it actually has from Monday to around the first of the year for the nda acceptance so it might not even be this week....
Votes:
5
2
Yahoo Finance Community
12/15
Comment
Lyn is in charge of the 3 day pump: they will drive it up premarket Monday morning - the board will lit up with FOMO and the suckers will buy in "big time" on screams of $40 from Bill, $1.20 from Pecunia, Bull will give multiple price targets and you fools will get trapped into a 1 billion shares authorized ATM by Alliance Global Partners and by 2 pm you will see .21 cents, then probably .19 cents - but yeah sure go ahead block me and "trust" Lyn lol...
Votes:
1
4
Yahoo Finance Community
12/15
Comment
Lyn is in charge of the 3 day pump: they will drive it up premarket Monday morning - the board will lit up with FOMO and the suckers will buy in "big time" on screams of $40 from Bill, $1.20 from Pecunia, Bull will give multiple price targets and you fools will get trapped into a 1 billion shares authorized ATM by Alliance Global Partners and by 2 pm you will see .21 cents, then probably .19 cents - but yeah sure go ahead block me and "trust" Lyn lol...
Yahoo Finance Community
12/15
Comment
Companies will know within 60 days of submitting their NDA to FDA whether it has been accepted for filing (or conversely, if FDA refuses to file your application due to lack of information or studies). This information is just a search away. Next week is the week. Get ready for a wild week imo and good luck, it’s going to be a tug of war with all this short volume accumulation....
Votes:
4
0
Quantexa News
12/16
Why Should We Buy Tonix Pharmaceuticals Holding Corp (TNXP) Stock?
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) has a beta value of 2.21 and has seen 41.68 million shares traded in the last trading session. The company, currently valued at $47.23M, closed the las...
Quantexa News
12/16
Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights
Tonix Pharmaceuticals Holding Corp. Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studies Granted Fast Track Designation...
Quantexa News
12/16
Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights
Tonix Pharmaceuticals Holding Corp. 17 min read In this article Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studies...
Yahoo Finance News
12/17
Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia
Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia Tonix Pharmaceuticals Holding Corp. Tue, Dec 17, 2024, 5:00 AM 14 min read In This Arti...
Reddit
12/17
Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia
>CHATHAM, N.J., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), today announced that the U.S. Food and Drug Administration (FDA) has acc...
Reddit
12/17
Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia
>CHATHAM, N.J., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), today announced that the U.S. Food and Drug Administration (FDA) has acc...
Quantexa News
12/17
Tonix Pharma (TNXP) Announces FDA Acceptance of the NDA for TNX-102
December 17, 2024 8:02 AM EST Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP ) (Tonix or the Company), today announced that the U.S. Food and Drug Administration ( FDA ) has accepted the filing of...
Yahoo Finance News
12/17
Tonix Pharmaceuticals Shares Jump After FDA Accepts NDA for Fibromyalgia Drug
PREMIUM Tonix Pharmaceuticals Shares Jump After FDA Accepts NDA for Fibromyalgia Drug MT Newswires Tue, Dec 17, 2024, 7:49 AM 1 min read In This Article: TNXP -37.00% Tonix Pharmaceuticals (TNXP) shar...
Quantexa News
12/17
Tonix Pharmaceuticals Announces FDA Acceptance of New Drug Application for Fibromyalgia Treatment
Tonix Pharmaceuticals Holding Corp. recently disclosed in an 8-K filing a significant development regarding its New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA). The NDA per...
Quantexa News
12/18
Tonix Pharmaceuticals Holding Corp. Announces Fda Acceptance of the New Drug Application for Tnx-102 Sl for Fibromyalgia
Tonix Pharmaceuticals Holding Corp. announced that the U.S. Food and Drug Administration (FDA) has accepted the filing of its New Drug Application (NDA) for TNX-102 SL (cyclobenzaprine HCl sublingual...
Quantexa News
12/18
Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application for TNX-102 SL for Fibromyalgia
December 18, 2024 at 10:33 am EST CHATHAM - Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), today announced that the U.S. Food and Drug Administration (FDA) has accepted th...
Quantexa News
12/19
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 3.7% – Here's Why
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) shares traded down 3.7% on Thursday . The company traded as low as $0.32 and last traded at $0.35. 51,497,243 shares traded hands du...
Quantexa News
12/19
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 3.7% – Should You Sell?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) dropped 3.7% on Thursday . The company traded as low as $0.32 and last traded at $0.35. Approximately 51,497,243 shares changed ha...
Quantexa News
12/20
Tonix Pharmaceuticals Holding Corp (TNXP) volume hits 713.05 million: A New Opening for Investors
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) started the day on Thursday, with a price increase of 56.25% at $0.57, before settling in for the price of $0.36 at the close. Taking a more long-term...
Yahoo Finance Community
12/20
Comment
Tale of the High Noon Tape.As of 12:00pm.Shares bought...92,877,753Shares sold....76,756,920Neutral shares...16,832,213As I was saying in last night's (after hours) tale of the tape post, it would be nice to see this great action carry over into today's trading and as you can see, it most certainly has continued. Cheers !!Best of luck to all....
Votes:
6
0
Yahoo Finance Community
12/20
Comment
Do you think this company will go down?. who just made a medical breakthrough?. NO... right.. So, relax...chill...shorties are just trying to scare you.. They are just hiring for a new VP with annual salary of more than 250-350k.. If they have a bleak future, their not gonna be hiring.....This is a HUGE COMPANY and now trading in pennies..get in while it's not yet late....
Votes:
4
0
Yahoo Finance Community
12/20
Comment
Guess it’s going to close around 65 cents today with 5 cents advance after the close and then we see what happens next week. Too much positive expectations here and some talk nonsense with no rational thinking saying it will be a $50 stock. It would be nice to see a humongous miracle like that but rational says NO....
Votes:
3
0
Yahoo Finance Community
12/20
Comment
Great overview presentation on yt titled “Tonix CEO Seth Lederman, MD Describes New Drug Candidate For Fibromyalgia” They also did some analysis of current drugs on the market. Conclusion: great drug with high market share potential. Check it out!...
Votes:
2
0
Yahoo Finance Community
12/20
Comment
This is a good company and progressed well relative to their competitors. It should be over 1. Ppl taking small profits and shorts are key reason this is not flying.. be smart… believe in the company. It will get FDA fast tracked and approved....
Votes:
4
0
Yahoo Finance Community
12/20
Comment
This is great news they are introducing shares beforehand so once approved the market cap explodes upwards making them more money than having less shares. would you make more of something if you knew the value of said something would increase exponentially? then add up all catalysts what do you get?...
Votes:
5
0
Yahoo Finance Community
12/20
Comment
I am new to TNXP, like what I read recently and bought a few thousand shares. But I am nervous, seems like many people are thinking this will take off in 2025 and hit 10$ plus and I just don't see that happening maybe 3-4 $is possible but double digits by next year seems like a reach to me...
Votes:
3
3
Yahoo Finance Community
12/20
Comment
FUTURE VALUE lesson. So Seth increases shares by $100 million bucks, like 200MM shares. But with that dough we bring approved drug to market. And in 2-5 years said drug is bringing in a billion a year in sales. Company worth, $5 to 10 billion. Investors buy Future Cash Flow. Period. Combined with risk assessment. So, if the drug hits then a 10-15 cent temporary drop in SP will be laughable when your investment is 10-30X today's price. So...what is the potential value of the company? Give me your thought out guesses. BTW, they sell for 4-7X sales if good margins....
Votes:
2
0
Yahoo Finance Community
12/20
Comment
Remember last December when Tonix announced in a PR their second positive phase 3? Then literally to the second 10 minutes later ANOTHER PR came stating the offering of X amount of shares for a price of .54 cents ( complete disappointment bty) Just imagine that .54 cent price they announced last December and replace it with 2.50 a share… Best I can do to get my point across...
Votes:
4
0
Yahoo Finance Community
12/20
Comment
ELTP repeating for the less informed and potential new investors... Generic Vyvanse, a $4.3 Billion market is anticipated to be launched within 2 weeks to early January after which generic Percocet, a $500 Million market in 6-8 weeks to be followed by Methadone in the next 6-8 weeks. FDA decision on generic Oxycontin, a $720 Million market - could be anytime A BE study result of another needle mover, perceived to be generic Concerta, a $1.2 Billion market is in queue before eoy....
Votes:
2
0
Quantexa News
12/20
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Up 11.3% – What's Next?
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report)’s stock price rose 11.3% during trading on Friday . The stock traded as high as $0.70 and last traded at $0.63. Approximately 151,23...
Yahoo Finance Community
12/20
Comment
ask Microsoft Copilot yourself what day 74 letter is and means.Question:in regards to the recent news related to TNPX, The FDA is expected to assign the NDA a Prescription Drug User Fee Act (PDUFA) target action date in a Day 74 Letter. On what date do we expect Day 74 letter?...
Yahoo Finance Community
12/20
Comment
Why do you care what people do with their money?? You've been saying the same thing for over an hour. I don't care what stocks anyone is in... long or short. I don't try to persuade people by repeating myself over and over and over. If you think that company's going belly up....cool. If it does, I still sleep just fine....
Votes:
1
1
Yahoo Finance Community
12/20
Comment
$250,000,000.00 million dollars , anyone who owns stock should be hyper concerned, they just did a reverse split after 7 reverse splits and Death is funner than shareholder dilution x 7 reverse splits, 1 billion shares authorized then $250,000,000.00 million offering!!...
Yahoo Finance Community
12/20
Comment
$250,000,000.00 million dollars lol after 7 reverse splits and literally hundreds of millions of dollars disappears, but, yeah ok trust Lyn, Pecunis and Billy lol cuz it's going to $22 dollars lol how many reverse splits? shareholders need $789 dollars share to break even...
Yahoo Finance Community
12/21
Comment
Guys.The issue is already happened. Thats why we saw so much pressure this couple of weeks. They needed money for the preparation of the medicine. Fda give us soon decision aprroval of the drug so plz chill now. Now we are going fast up. Monday will be exiting....
Votes:
8
1
Yahoo Finance Community
12/21
Comment
Key Points from the Filing 1. Increase in Aggregate Offering Price (Dilution Risk) Tonix raised the maximum aggregate offering price of shares issuable under its Sales Agreement with Alliance Global Partners from $150M to $250M. Impact: This signals that Tonix may issue more shares to raise additional capital. While raising funds is necessary for ongoing operations, especially pre-commercialization, it dilutes existing shareholders, potentially pressuring the stock price in the short term. 2. Legal Opinion on Issuance Validity The company filed an opinion confirming the legality of shares issuable under the updated Sales Agreement. Impact: This ensures the offering is compliant but doesn’t change the fundamental dilution concerns. 3. Cash Burn and Need for Funding Tonix's decision to increase the offering price suggests that it anticipates higher-than-expected expenses, likely related to preparing for the potential commercialization of TNX-102 SL. Impact: This is a neutral-to-slightly-negative development in the short term but indicates …...
Votes:
4
0
Yahoo Finance Community
12/21
Comment
Key Technical Levels Support Levels to Watch 1. $0.50 (Psychological Support) Strong psychological level where buyers often step in. The stock has shown support here previously, and it aligns with a common round-number threshold. 2. $0.44-$0.46 (Recent Trading Support) This range has served as a short-term floor during periods of heavy selling pressure. Buying volume has historically increased near these levels. 3. $0.40 (Strong Historical Support) Significant historical support and likely to hold if the stock faces additional dilution pressure. Represents a ~30% drop from your purchase price of $0.59, which is manageable if you’re confident in the long-term potential. --- Likely Scenario if Price Falls Given the news of potential dilution: Initial Pullback: Likely to test $0.50 if selling pressure increases due to investor concerns. Deeper Pullback: If $0.50 fails, the stock could test the $0.44-$0.46 range. Absolute Low: $0.40 appears to be the strongest support under current conditions …...
Votes:
1
0
Yahoo Finance Community
12/21
Comment
To anyone asking when they will do offering/dilution… they have already Done it, they did it in tuesday/wednesday.So basiclly they have enough cash now to produce and finance their growth. A K-8 Filling is filled within 3-4 days after a dilution/offering. So IT HAVE ALREADY HAPPENED!...
Votes:
8
0
Yahoo Finance Community
12/21
Comment
Key Takeaways for TNXP Investors Support Levels and Probabilities $0.50 (50% Probability): Psychological and technical support level; likely to hold in the short term if dilution fears stabilize and speculative buyers re-enter. $0.44-$0.46 (30% Probability): Short-term trading support where prior buying activity has been strong. This level may be tested if dilution concerns persist without immediate catalysts. $0.40 (15% Probability): Strong historical support. Likely the floor unless further dilution or delays in FDA progress occur. Below $0.40 (5% Probability): Only likely in the case of significant negative news, such as unexpected FDA setbacks or aggressive dilution. --- Catalysts to Watch Positive Catalysts: FDA updates on PDUFA Target Action Date (likely by March 2025). Priority Review status could drive strong momentum. Potential partnerships or licensing agreements for commercialization. Insider or institutional buying as confidence builds in TNX-102 SL approval. Negative Catalysts: Details of share issuance under the increased $250M offering—aggressive dilution …...
Votes:
7
0
Quantexa News
12/21
Tonix Pharmaceuticals Increases Maximum Offering Price Under Sales Agreement with A.G.P./Alliance Global Partners
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) announced in a recent 8-K filing with the Securities and Exchange Commission that the company has raised the maximum aggregate offering price of shar...
Yahoo Finance Community
12/21
Comment
People on this board keep talking and arguing about the amount of shelf offering. What difference does it make? If a drug is approved and is supposed to be a blockbuster, then regardless its stock will go up or the opposite could happen. The important thing is not to have another RS in which case we the retail investors will be burned. So far there is high chance the management is staging another RS. This is how they have survived all these years. Issuing shares and then taking them away from us free of charge by doing RS. A total robbery in modern ways....
Votes:
2
0
Yahoo Finance Community
12/21
Comment
My opinion only: We aren’t getting an FDA approval for at least a couple months. Quicker if we get the Fast Track. What IS short at hand is an approval or rejection for Fast Track status, and THAT is what we’re hoping for in a matter of days. We get a yes, and we have a potentially nice upswing resulting in over a $1 and possible market compliance recovery. That gets rejected, and we have many more months to drug approval, a price that remains below $1 and a higher probability for an RS. This is so fragile! ANY more bad news and this is in big trouble. Crazy!!!!...
Votes:
4
1
Quantexa News
12/21
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 3.7% – Time to Sell?
Shares of Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) dropped 3.7% on Thursday . The company traded as low as $0.32 and last traded at $0.35. Approximately 51,497,243 shares...
Yahoo Finance Community
12/21
Comment
Don’t get discouraged with baseless negative claims here. Think twice why some users here spend remarkable time to post message to discourage investors like me and you. Their only task is to discourage you by spreading lies and baseless claims. Trust what you have and go until you hear great news....
Votes:
6
0
Yahoo Finance Community
12/21
Comment
I think people don't realize the volatility in bio tech stocks. If it was super bad news on Friday it would have went to zero. Yes it was knocked down but it rebounded. Where it opens who cares. It didn't go to zero. And if we get news good news next week all this will be behind us. I bought in just under .64 and I am not worried one bit with the "potential" of what this might become. So the nay s ay e r s can b lo w me...
Votes:
11
1
Yahoo Finance Community
12/21
Comment
ALERT! This could move up very High Monday in Pre-Market (probably not high enough to hit my Sell point) then drop like a rock when the market opens....and I will scoop up your cheap shares. Thanks for your cooperation. ( Those hips don't lie )...
Votes:
3
0
Yahoo Finance Community
12/21
Comment
This 8k form was already filed with the SEC on 9/20, this was merely posted on Friday to shake or scare retail investors. If it was filed yesterday, the stock would have tanked to .15 plus the news didn’t come out of Tonix directly. Lots of questions marks. It could be the hedge funds wants to cover at a low price before this takes off before the dec 30th. It’s going to be an interesting week. Hold the lines longs, if you agree with me , please like this post so everyone can see it and know the truth....
Votes:
12
4
Yahoo Finance Community
12/21
Comment
I’m retired and I have a lot stocks,not trying to brag just wanted to get my point across,this is the only one that I have been watching for some time now and I got in at 21 and out of all my holdings this is the one I have been following more than the rest is because I truly believe this one is going to be my best asset.good luck to everyone....
Votes:
11
0
Yahoo Finance Community
12/21
Comment
This is a volatile stock and this is messing peoples mind easily. If u buy this stock, make ur plan before buy. Dont go with the feeling or flow. Find out about the company for u self before getting in. Anyway I believe this stock and going to earn some money with it. GLTA especially all BULLS!...
Votes:
10
0
Quantexa News
12/22
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 11.3% – Time to Buy?
Tonix Pharmaceuticals Holding Corp. ( – )'s share price shot up 11.3% during mid-day trading on Friday . The company traded as high as $0.70 and last traded at $0.63. 151,239,068 shares traded hands d...
Quantexa News
12/22
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 11.3% – Time to Buy?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) shot up 11.3% during trading on Friday . The company traded as high as $0.70 and last traded at $0.63. 151,239,068 shares changed...
Yahoo Finance Community
12/22
Comment
You don’t need to be a fortune teller to see that this stock won’t stay below $1 for long. There is high demand for this medication on the market, and its development is partially supported by the FDA. It’s just a matter of time before it gets released. So, thinking outside of the trading bubble, it’s clear that this drug is much needed, and sooner or later, it will be brought to market. You can fantasize about the stock price and bitterly regret not buying it for pennies....
Votes:
3
1
Yahoo Finance Community
12/22
Comment
The people who are happy to see others lose their life savings truly need to reevaluate themselves. I just want to say I'm sorry to anyone who panicked and sold. To those who are still holding, don't lose hope and keep holding. It will bounce back. NDA approval is a huge step....
Votes:
4
2
Yahoo Finance Community
12/22
Comment
You don’t need to be a fortune teller to see that this stock won’t stay below $1 for long. There is high demand for this medication on the market, and its development is partially supported by the FDA. It’s just a matter of time before it gets released. So, thinking outside of the trading bubble, it’s clear that this drug is much needed, and sooner or later, it will be brought to market. You can fantasize about the stock price and bitterly regret not buying it for pennies....
Votes:
7
1
Yahoo Finance Community
12/22
Comment
I have never posted anything on this board or the others I use to be on saying … buy the dips or just buy… personally , i don’t care what you do… but i will say , regardless what the stock does Monday I’m buying 1800.00 more Tuesday … sprinkling a little more on top of my already juicy position… been waiting years to collect and I will collect as much as possible… # 1 priority is still COMPLIANCE 💰💎💰...
Votes:
4
1
Yahoo Finance News
12/23
Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for Fibromyalgia
Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for Fibromyalgia Tonix Pharmaceuticals Holding Corp. Mon, Dec 23, 2024, 7...
Quantexa News
12/23
Tonix Pharma (TNXP) Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102
December 23, 2024 8:01 AM EST Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP ) (Tonix or the Company) today announced that the U.S. Food and Drug Administration ( FDA ) assigned a Prescription Dru...
Yahoo Finance News
12/23
Tonix Pharmaceuticals Says FDA Set Target Action Date for Potential Fibromyalgia Drug
PREMIUM Tonix Pharmaceuticals Says FDA Set Target Action Date for Potential Fibromyalgia Drug MT Newswires Mon, Dec 23, 2024, 8:59 AM In This Article: TNXP -34.09% Tonix Pharmaceuticals (TNXP) said Mo...
Quantexa News
12/23
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Awaits FDA Decision on TNX-102 SL for Fibromyalgia
December 23, 2024 at 10:27 AM EST announced that the FDA has set a Prescription Drug User Fee Act (“PDUFA”) goal date of Aug. 15, 2025, for a decision on TNX-102 SL (cyclobenzaprine HCl sublingual ta...
Yahoo Finance Community
12/23
Comment
EXEC will get the money via BONUSES and money from Dilution AKA administrative expenses, next year they do Reverse Split and use the so called " personal Money " yes money that they grand themselves from dilution via bonuses to buy shares in the Company haha...
Yahoo Finance Community
12/23
Comment
I have no problem waiting until August. I've got patience regardless of the outcome which I feel ultimately will be extremely positive. This stuff happens and you can't expect every penny stock to pull a NUKK lol. (that was awesome lol) Patience...I bought SOUN in February at $1.67....its looking pretty sweet right now. Sold off a small portion, covered my position and some play money....
Votes:
8
0
Yahoo Finance Community
12/23
Comment
Just curious the final date of decision is in August and that's a pretty long time but could that be enough time to buy at $0.30 - $0.55 and sell at above $1 as it continues to fluctuate for the next several months or is it better to buy now and hold until post day of approval? I want to play this stock as a trade until we get closer to August or should it be a longer term investment? I can see this stock falling back down based on any broader news in the stock market that seems negative like inflation spiking for e.g....
Votes:
2
0
Yahoo Finance Community
12/23
Comment
What am i missing?.....The new drug is cyclobenzaprine. Only in a sublingual form. I was prescribed this in the mid 80's for a pulled muscle in my back. The drug is 40 years old and available in generic form for 30 cents a pill or less. Are they able to repackage it, give it a new name, jack the price and get insurance to pay big bucks for it?...
Votes:
1
1
Yahoo Finance Community
12/23
Comment
If this symbol wasn't named Tonix, my confidence for this one would be 100% on getting approved. 70% confidence in approval as of now. That being said, I hope all that have been through the ringer with this one through the years, gets rewarded nicely!...
Votes:
5
1
Yahoo Finance Community
12/23
Comment
In the world of pharmaceuticals…Merck reigns supreme…With medications and treatments that fulfill every dream. But a small company called Tonix arose… With a drug called Tonmya, its reputation grows. Merck saw the potential in Tonix's tiny pill, Containing cyclobenzaprine, it could cure many ills. So Merck made a deal to buy Tonix for all it's worth, Promising investors a golden future with mirth. The drug was reformulated, made even better, And soon it was flying off the shelves with a clamor. Investors rejoiced as the profits rolled in, Their faith in the merger was truly a win. And so Merck and Tonix, giants and small, Worked together to answer the pharmaceutical call. Cyclobenzaprine, the drug that MERCK CREATED started it all, Had now become a success story, standing tall. 💰💎💰...
Votes:
6
0
Quantexa News
12/24
Tonix Pharmaceuticals Holding Corp. Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for Fibromyalgia
December 23, 2024 at 08:00 am EST Tonix Pharmaceuticals Holding Corp. announced that the U.S. Food and Drug Administration (FDA) assigned a Prescription Drug User Fee Act (PDUFA) goal date of August...
Yahoo Finance Community
12/24
Comment
I bought in because fibromyalgia represents a serious challenge for medical professionals and their patients and families. Because the condition is still very poorly understood, there are no single breakthrough treatments for it. So any new treatment that proves helpful should be more than welcome by the community and have some success in this large market, particularly since current fda approved drugs for fibromyalgia still leave much to be desired. The sublingual route is important since it bypasses 1st pass liver metabolism potentially making it more effective at a lower dose and can limit systemic adverse effects....
Votes:
5
2
Yahoo Finance Community
12/24
Comment
Can anyone tell me how many stock splits tnxp had? How many times they issued new shares, how much the CEO get paid for issuing new shares. How much tonix paid the PR firms and news organizations. Can someone tell me how many useless presentations did tonix have? Come on. Be honest to yourself and others....
Yahoo Finance Community
12/24
Comment
Bill & Matt make you believe Lederman had a gun to their heads when they pressed the buy button numerous times. They both need to go look in the mirror and see who who's actually responsible for their losses. IMO //BeAgrownUpandAcceptresponsibilty...
Votes:
2
0
Yahoo Finance Community
12/24
Comment
To Bill: looks like I was spot on Bill; you might want to read the 10Q - all the answers were right there, and then they filed the 8K only supporting their intentions - it was clearly documented in SEC Filings, after they did a 1:32 reverse split - these guys are basically white collar criminals, "Dr" Lederman never practiced medicine because he realized it wasn't for him, how ironical...
Yahoo Finance Community
12/24
Comment
this piece shi stock is killing loosing ppls hard working money trying make little better living in this country that mess up by this hedge fund billionaire by making a living by stealing and manipulating the market and living free no harm done if I would president the fir thing I would do the this ppl end this corruptions...
Yahoo Finance Community
12/24
Comment
Tonix is doing this every month..they krep price under 1 and troll some fake news and get some fish dividens ,they have some troll güys working here for cheating people and get cash until another fake news...i said from the beginning..this iş really bad company...
Yahoo Finance Community
12/24
Comment
The matter of fact is that RS is for sure. The question and important part is that When & what ratio? Mr CEO loves to maximize the share price so after the split, he can continue selling shares on the Nasdaq avoiding delisting. As it’s normal, he also likes the share price to go as high as it can, so he himself and the company makes millions. Wether or not that’ll happen is a bit puzzling right now. Perhaps by first week of the new year, we can have some clues. GLTA & HAVE A MERRIEST XMAS YOU ALL...
Votes:
3
2
Yahoo Finance Community
12/24
Comment
Marry Christmas and Happy new year to all of you, Once you come back from the break take a resolution to not to lie, not to spread fake news, do not misrepresent. Enjoy holidays, stay safe, stay blessed and be happy always, No matter what happens always smile....
Votes:
2
2
Yahoo Finance Community
12/24
Comment
lol the comments on this board are comical. Anyone in a long position does not lose unless they sell at a lose. My shares are parked and waiting for more good news. I would not have a short position on a stock waiting to get FDA approval. Stop talking about August 2025 date.. it’s going to happen way before. Good luck to all… be kind to one another. Merry Christmas to those celebrating and happy new year to everyone!...
Votes:
18
1
Quantexa News
12/24
Tonix Pharmaceuticals (NASDAQ:TNXP) Announces PDUFA Goal Date for TNX-102 SL for Fibromyalgia
Tonix Pharmaceuticals Holding Corp. recently revealed in an 8-K filing with the U.S. Securities and Exchange Commission that the U.S. Food and Drug Administration (FDA) has set a Prescription Drug Use...
Quantexa News
12/25
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 3.2% – Should You Sell?
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report)’s stock price traded down 3.2% on Tuesday . The stock traded as low as $0.37 and last traded at $0.39. 45,372,542 shares changed han...
Quantexa News
12/25
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 26.8% – Here's Why
Shares of Tonix Pharmaceuticals Holding Corp. ( – ) traded down 26.8% during trading on Monday . The company traded as low as $0.42 and last traded at $0.45. 86,930,683 shares traded hands during trad...
Quantexa News
12/25
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 26.8% – What's Next?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) shares fell 26.8% during trading on Monday . The stock traded as low as $0.42 and last traded at $0.45. 86,930,683 shares were tra...
Yahoo Finance Community
12/25
Comment
I’m confused. Cyclobenzaprine is an approved drug (since 1977) currently in use for various pain syndromes. It is sold as “flexeril”; there are generic formulations. TNXP has a sublingual formulation OF THE SAME DRUG that it is seeking approval for use in Fibromyalgia. Assuming it is approved, why would the treating physician not simply prescribe the oral generic formulation to his/her fibromyalgia patients? Has the sublingual drug demonstrated greater efficacy versus the oral formulation? This is my first time hearing about TNXP. I normally avoid penny stocks but if they have a promising compound, I am willing to speculate. On the surface, the “data” the CEO presented in the recent video suggests this is a slam dunk. But repackaging an old drug and offering it as “new” is gimmicky. Am I missing something?...
Quantexa News
12/25
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 4.4% – Time to Sell?
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) shares dropped 4.4% during trading on Wednesday . The company traded as low as $0.37 and last traded at $0.39. Approximately 78,251,...
Quantexa News
12/25
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 4.4% – Here's What Happened
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report )'s stock price traded down 4.4% during mid-day trading on Wednesday . The company traded as low as $0.37 and last traded at $0.39....
Yahoo Finance Community
12/25
Comment
I don't understand why FDA gave a PDUFA deadline fo 15 Aug, even if FDA itself gave few time a go a fast track designation (6 months instead of 10 months from the application). The application is dated mid Oct so I was expecting mid Apr. ..... simeone has any clue for that?...
Votes:
2
0
Quantexa News
12/26
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 3.2% – Should You Sell?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report )'s share price was down 3.2% during trading on Tuesday . The company traded as low as $0.37 and last traded at $0.39. Approximately...
Quantexa News
12/26
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 3.2% – Here’s Why
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report)’s stock price traded down 3.2% on Tuesday . The company traded as low as $0.37 and last traded at $0.39. 45,372,542 shares traded ha...
Quantexa News
12/26
After Sinking 15.27% During Past Week, Is Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Still A Buy?
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)'s traded shares stood at 78.22 million during the last session, with the company's beta value hitting 2.06. At the close of trading, the stock's price...
Yahoo Finance Community
12/26
Comment
I must have been off in dream land and became Delusional to think Tnxp would turn there stock into a winner SMH it's too bad not just for there stock but my heart goes out for all the broken dreams again. I want to know who's going to invent a cure for broken hearts there's well over 200 million people who have been waiting for tonix , I'm out while I still have enough left of my investment to put into another company with more promise than hype...good luck with this uptalk and you will see I am not far from right is why I left....going south of .20 and then a reverse, I would bet the farm on it......
Votes:
3
4
Yahoo Finance Community
12/26
Comment
taking advice from pumpers on this board without reading the 10 Q and the 8 K filing will be financial suicide for many pumpers - Lyn, Pecunia, Bill, and of course the lying con artist Bullsheeeeeeeeeeeter who claims to have been here through multiple reverse splits and excessive dilution from AGP...
Votes:
1
4
Yahoo Finance Community
12/26
Comment
Some times I get so surprised that all junk companies who’s shares price was 10 cents and within month now trading more than 5 dollars without no any fundamentals and some real good companies are just struggling to way go up !!! What a US market !!!...
Votes:
2
0
Yahoo Finance Community
12/26
Comment
Interesting how only a few people on here see the potential of a possible merger or buy out that could come about any day now, which would cause this stock to fly. If you have funds to spare, invest, and be patient, even if it's not until next year, this new drug will make many of us significant financial gains 🚀💰...
Votes:
6
0
Yahoo Finance Community
12/26
Comment
Dec 28th marks the 6 month of this stock staying below a dollar. RS is imminent folks, meaning this will crash to a sub penny. With the massive naked shorting here and only 4% actual short interest, any spike in the price would be an orchestrated pump and dump ......
Votes:
1
6
Quantexa News
12/26
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 2.6% – Should You Sell?
Shares of Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) fell 2.6% on Thursday . The stock traded as low as $0.35 and last traded at $0.38. 36,840,297 shares were traded during...
Quantexa News
12/26
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 2.6% – Time to Sell?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) shares traded down 2.6% during mid-day trading on Thursday . The stock traded as low as $0.35 and last traded at $0.38. 36,840,297...
Yahoo Finance Community
12/26
Comment
Closing in RED, possible green after the close. Not much is expected till after the new year break. Lots of people selling to take advantage of tax write offs. However if they try to get in within 30 days their losses will not be deductible. Sell it only if you no longer interested in this miserable stock and have no patience to wait for the final result. I personally prefer day trading it rather than waiting for the end. Good luck to you and your decision....
Votes:
1
1
Yahoo Finance Community
12/26
Comment
Tale of the Painted Tape.As of 4:00:43pm.Shares bought.....30,273,690Shares sold....40,065,181Neutral shares...4,505,159Washed shares(painted) at 4:00:00.......72,787 .... these washed shares 'painted the tape' which gave the stock the appearance of a higher closing price .37.For those watching this on L2, you saw how they painted the close. Apparently, the MM's are back to their old tricks.Caveat Emptor.Anyone not familiar with the term" Painting the Tape", I'd suggest google searching it....
Votes:
3
0
Yahoo Finance Community
12/26
Comment
Shorts will send this back to 20 and lower ,it took 6 months to cross a buck and was there for a nanosecond .They dropped it back to 35 cents in a week .They rule this stock and one has to evaluate both the newest ,the trend and the ride alongs on other names at early breakout stage ....
Votes:
2
1
Quantexa News
12/27
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 4.4% – Should You Sell?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) fell 4.4% during mid-day trading on Wednesday . The company traded as low as $0.37 and last traded at $0.39. 78,251,078 shares wer...
Yahoo Finance Community
12/27
Comment
Noticing several people invest with their emotions and hope rather than with facts and patience. The reality of this company is that it could merge or be acquired by another company at any moment and the value will skyrocket. I understand there are some who are not financially equipped or are too impatient to wait, but for those who can hold, we will be so very thankful we held on to our shares. Good luck to all and God bless...
Votes:
5
0
Yahoo Finance Community
12/27
Comment
My advice - this is a multi billion dollar drug trading at 0.35. Use this time to train your emotional trading skills. observe how manipulation works. 😉 you will likely be in this position again in the future but if you do your DD then trust it....
Votes:
4
4
Yahoo Finance Community
12/27
Comment
What happen to the 988 new TNXP patrons to the Y board two weeks ago. Oh where oh where did they all go. Disillusioned by not becoming over night millionaires on the risky gamble in town. This is a long play for only strong stomaches. Trade it, don't love it. IMO...
Votes:
1
1
Yahoo Finance Community
12/27
Comment
The only certainty to this stock is daily chaos and manipulation. It's takes place from MM's and worst yet, world headquarters. I've stated it for years. if they bagged the CEO today, the stock would rise to $1.50 on Monday. The manipulators would leave because large institutional money would flow back. Fire the CEO, reward the stakeholders. IMO...
Votes:
7
0
Yahoo Finance Community
12/27
Comment
Don’t doubt about this junk to be a gimmick. I have been saying it ever since Covid hit and these guys jumped in to claim they are making vaccines for it. After 2 years when Covid settled down, Seth decided to drop pursing Covid vaccines and moved to monkey pox. This how this management has been operating by falsifying accomplishments by over 100 bogus presentations that had no interest nor gain whatsoever. I have no doubt that FDA will not approve their drug and will ask for 2 more sets of testing which will take about a year to complete. At the end it will most likely be rejected all together....
Yahoo Finance Community
12/27
Comment
It’s FUD mania when on a down swing and Pumptastic on an up swing. 102 NDA was submitted, accepted and established approval timeline which could happen before Aug 15. Either sit back and watch, go long buy on dips or trade it. COH will be reported soon which I believe will be massive and sustainable through Aug. GL...
Votes:
2
2
Yahoo Finance Community
12/27
Comment
The US market is very much down today and the volatility index increases. This is an expected behaviour as we're almost finalising the year of 2024. I will still hold my shares until the end of second week of Jan, 2025. If it drops below 0.25, I might sell, to minimise my loss. But at this point I will not sell, as it doesn't make sense to me....
Votes:
2
0
Yahoo Finance Community
12/27
Comment
Tale of the early morning (face) Tape.As of 10:30am.Shares bought......13,163,970Shares sold.....21,899,696Neutral shares....2,771,729It would appear it is trying to rebound off of today's low of .3134. Currently trading at .339. We shall see how we look at the noon tape reading. GLTA...
Votes:
4
1
Yahoo Finance Community
12/27
Comment
Tale of the Tape.As of 12PM.Shares bought.....22,537,438Shares sold....27,272,716Neutral shares.....4,644,032The selling has slowed and the buying has increased, compared to the tape from earlier today...10:30am. That is a good sign. Hopefully, that trend will continue through the afternoon. I seem to be having trouble again with the AI police as they are not too happy with this post. Who the helll knows why?...
Votes:
3
0
Yahoo Finance Community
12/27
Comment
Short term bear, long term bull. Scott, Meeksy, Penicula would love your thoughts here: T on will implement their $140M offering soon. This will provide them with more than enough money to make it to drug approval in August. This will also max out their outstanding shares to 1B; they cannot issue more shares after this without a notice/vote to increase their authorized share count. Then, in February, they will extend their delist date to August ‘25. I believe they absolutely will get the delist extension approved; what better reason for NASDAQ to approve than waiting on an FDA decision? Finally, they will reverse split in May to reduce the 1B share count. This can be seen as a good thing, as they reducing the number of outstanding shares, causing the share price to rise higher. Keep an eye on any filings/notices of offering increases. I don’t think they will …...
Votes:
3
0
Quantexa News
12/27
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 8.7% – Should You Sell?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report )'s stock price traded down 8.7% during mid-day trading on Friday . The stock traded as low as $0.31 and last traded at $0.34. 46,07...
Yahoo Finance Community
12/27
Comment
It's trying to get back above 35 cents. That would be great if it can close above 35 cents. We shall see. I'm heading out for the afternoon, so I won't be around to post the tale of the tape post at 4pm. Perhaps someone can posts those numbers, if they feel inclined to do so. IHub is where I get those numbers, under the trades tab. GLTA....
Votes:
2
0
Quantexa News
12/27
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Short Interest Up 151.6% in December
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) was the recipient of a large increase in short interest in the month of December. As of December 15th, there was short interest to...
Quantexa News
12/27
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Short Interest Up 151.6% in December
NASDAQ:TNXP – Get Free Report ) was the target of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 4,000,000 shares, a growth of 151.6...
Yahoo Finance Community
12/27
Comment
The patent application made by Tonix Pharma was appealed by a company which sells medicines in treating fibromyalgia However, it was ruled out by the European Patent Office. I think we can better understand to what extent the new drug will be successful by looking at how much that company earns via its medicines in treating fibromyalgia....
Votes:
1
1
Yahoo Finance Community
12/27
Comment
For those holding, hang tight for probable merger or acquisition coming soon. Like Tyler said, this company is ran by doctors, not business men and women, and you can place your bets that there are some big pharmas looking into acquiring TNXP and making big money 🙏🚀💰...
Votes:
9
2
Quantexa News
12/28
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 2.6% – What's Next?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report )'s stock price was down 2.6% on Thursday . The company traded as low as $0.35 and last traded at $0.38. Approximately 36,840,297 sh...
Yahoo Finance Community
12/28
Comment
I’m thinking aloud. The facts:- RS is not possible - Issuing more shares is not possible.- The accepted drug needs to be approved by the FDA anytime before Aug, 2025, before it’s marketed.Potential solutions: - Financing: borrowing money from certain places- Merging: merging to another company Observations:- Stock price almost doubled, from 0.18 level.- Manipulations happened immediately before the announcement of NDA acceptance. - Day traders helped fluctuations.- All these things scared long term investors.I expect that once the new year starts (second week of Jan), we’ll have to hear some news from Tonix Pharma.Any ideas, please share here. Please be constructive, and not spread false information....
Quantexa News
12/28
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Short Interest Update
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) was the recipient of a significant growth in short interest in December. As of December 15th, there was short interest totalling 4...
Quantexa News
12/28
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Short Interest Update
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) was the target of a large growth in short interest during the month of December. As of December 15th, there was short interest total...
Quantexa News
12/29
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 8.7% – Here’s What Happened
Shares of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) were down 8.7% during trading on Friday . The company traded as low as $0.31 and last traded at $0.34. Approximately 46,07...
Quantexa News
12/29
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 8.7% – Here’s Why
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report)’s share price fell 8.7% during trading on Friday . The stock traded as low as $0.31 and last traded at $0.34. 46,071,262 shares were...
Quantexa News
12/29
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Short Interest Up 151.6% in December
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) saw a significant increase in short interest in the month of December. As of December 15th, there was short interest totalling 4,0...
Quantexa News
12/30
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 5.3% – What’s Next?
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report)’s stock price traded down 5.3% on Monday . The stock traded as low as $0.31 and last traded at $0.32. 28,828,476 shares changed hand...
Yahoo Finance Community
12/31
Comment
I am saddened because I sold my AI stock in a hope to buy it back. I did it three times and made good money but not good enough and now it sky rocketed. I lost big, If I held on to it. I would have retired early today that is why I will not buy and sell tnxp. I will keep my tnxp until I get the money I need to buy my house cash!...
Votes:
3
1
Yahoo Finance Community
12/31
Comment
there is a lot of people still holding from .15 so the ones that are selling are the newbies with paper hands and no bolls for this volatility. one push past $2 will keep us at $1 after pullback. we just need a few big players to step in and buy huge...
Votes:
4
0
Yahoo Finance Community
12/31
Comment
Tale of the early morning Tape.As of 10:31am.Shares bought...12,543,849Shares sold...19,815,544Neutral shares.....1,924,916The MM's tipped their hand yesterday with that painted finish at the closing bell. Painted finishes, which btw are illegal, usually is a sell indication. Hopefully, this sell off is short lived. We shall see. GLTA...
Votes:
5
1
Yahoo Finance Community
12/31
Comment
Gotta be honest I’ve been burnt many times by companies doing reverse splits because I held on and their stock value was too low. I’ve learned my lesson so if this doesn’t take off by March, I’m either cutting my losses or taking the small profit and never looking back....
Votes:
3
0
Quantexa News
12/31
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 7.8% – Should You Sell?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report )'s stock price dropped 7.8% during trading on Tuesday . The company traded as low as $0.33 and last traded at $0.33. Approximately...
Quantexa News
12/31
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 7.8% – Here’s What Happened
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report )'s stock price fell 7.8% on Tuesday . The stock traded as low as $0.33 and last traded at $0.33. 39,393,920 shares were traded duri...
Yahoo Finance Community
12/31
Comment
Tale of the last tape of the Year.As of 4:09pm.Shares bought.....33,128,183Shares sold.....41,283,846Neutral shares..5,586,257If there is any silver lining with today's action, at least the buying picked up later in the day. We'll have our day again. Best wishes and Happy New Year everyone!...
Votes:
7
0
Yahoo Finance Community
12/31
Comment
As long as no filings come to increase authorized shares, you WILL make money in this stock if the drug is approved. Max authorized shares of 1B will make market cap $1B at $1. The drug is a $4B market on top of their pipeline and growth. Correct me if I’m wrong, but if they don’t increased authorized shares, this WILL rise....
Votes:
4
1
Yahoo Finance Community
01/01
Comment
After the FDA accepts an NDA under the Fast Track designation, the review process typically aims to be completed within a shorter timeframe than a standard review, with the FDA aiming to make a decision within 6 months due to the expedited nature of the Fast Track pathway; however, the exact time can vary depending on the complexity of the drug and the quality of the data submitted. Since tnxp had two successful phase 3 tests. Plus the time that has already lapsed, One can safely assume that at least 95 percent chance of getting FDA approval. When that happens we can fairly expect tnxp in the 10 to 15 range....
Votes:
12
1
Quantexa News
01/01
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 5.3% – Should You Sell?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) traded down 5.3% on Monday . The company traded as low as $0.31 and last traded at $0.32. 28,828,476 shares were traded during tra...
Quantexa News
01/01
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 5.3% – Time to Sell?
Tonix Pharmaceuticals Holding Corp. ( – )'s share price fell 5.3% during trading on Monday . The stock traded as low as $0.31 and last traded at $0.32. 28,828,476 shares traded hands during mid-day tr...
Quantexa News
01/01
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 8.4% – Time to Sell?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) fell 8.4% during mid-day trading on Wednesday . The company traded as low as $0.32 and last traded at $0.33. 80,811,016 shares wer...
Yahoo Finance Community
01/01
Comment
Serious question what do yall think the market cap will be if drug approved and 1B shares out? Im thinking $2.50 ($2.5B), for anticipating 200-400M in 102 revenue first year, their pipeline, growth potential and P/B and P/S ratio going to 3-6. They also currently have a PE ratio of 0 lol so that going to ~30 will certainly rise the stock. Thoughts?...
Votes:
2
0
Quantexa News
01/02
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 7.8% – Should You Sell?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report )'s stock price was down 7.8% on Tuesday . The company traded as low as $0.33 and last traded at $0.33. Approximately 39,393,920 sha...
Quantexa News
01/02
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 7.8% – Here’s Why
Shares of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) dropped 7.8% during mid-day trading on Tuesday . The company traded as low as $0.33 and last traded at $0.33. Approximatel...
Quantexa News
01/02
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 4.5% – What's Next?
Shares of Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) dropped 4.5% on Thursday . The stock traded as low as $0.31 and last traded at $0.32. Approximately 28,860,322 shares ch...
Quantexa News
01/03
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 8.4% – Here's What Happened
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) shares fell 8.4% during mid-day trading on Wednesday . The stock traded as low as $0.32 and last traded at $0.33. 80,811,016 share...
Quantexa News
01/03
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 8.4% – Should You Sell?
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) fell 8.4% on Wednesday . The stock traded as low as $0.32 and last traded at $0.33. 80,811,016 shares traded hands during trading, a...
Quantexa News
01/03
A Bullish 2025 Outlook For Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Shares
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares, rose in value on Thursday, January 02, with the stock price down by -4.79% to the previous day's close as strong demand from buyers drove the s...
Yahoo Finance Community
01/03
Comment
It looks like as usual there is lots of resistance due to sneak sales and offerings. It appears to be non ending and it’s very obvious since most of the trades are on the bid side blocking price increase. Most likely nothing going to happen today and need to wait for next week...
Votes:
1
0
Yahoo Finance Community
01/03
Comment
Very simple meth. If you buy at 30 cents and invest $5000 and wait for one year and even if it goes to at least 60 cents then you made 100% profit. Now theirs is million dollar question is that if they do another reverse split then whole game will change !!!...
Votes:
1
0
Quantexa News
01/03
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 3.5% – Here's Why
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) shares traded down 3.5% during trading on Friday . The company traded as low as $0.29 and last traded at $0.30. 25,356,621 shares...
Quantexa News
01/03
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 3.5% – What’s Next?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report )'s stock price dropped 3.5% during mid-day trading on Friday . The company traded as low as $0.29 and last traded at $0.30. Approxi...
Yahoo Finance Community
01/03
Comment
They see their stock bleeding 5% every day after they just received FDA acceptance and a 34 million dollar grant from the govt. Yesterday was a day with prodimently more stock bought then sold yet price was still down. The company is still quiet as a mouse. What’s really going on here?...
Votes:
1
0
Yahoo Finance Community
01/03
Comment
Are people even aware of how many people on our planet suffer from Fibromyalgia? Tonix is the only one on the planet that has 100% something that every country will want, every health institution, and that is TNX-102 SL.How many similar diseases are there with some of the symptoms of Fibromyalgia where TNX-102 SL will also be sought after?People, these shares are worth hundreds of times more than the current price.Don't be NAIVE, you have diamonds in your hands, guard them and WAIT.Very soon, you will scream with happiness.That's it....
Votes:
6
0
Yahoo Finance Community
01/03
Comment
I have a 30 years of good experience trading stocks. When stocks behave as tnxp is behaving right now. It's best not to distracted If it goes up or down. Aim should be to buy tnxp and hold because at this point any day vast majority of investors will sell with a hope to buy cheaper, They may succeed a few times but eventually they will not be able to buy back the same stock again because they they don't want to buy fraction of the original shares they held before....
Votes:
7
0
Yahoo Finance Community
01/03
Comment
This smells fishy and looks more like a trap. All day in negative territory and all of a sudden 5 cents green? Come on crooks, you can do better than that. I have a feeling that it was a major dump attempt cause there could be a bad news after hours. Remember most bad news come Friday after the market closes. Let’s hope that’s not the case....
Votes:
2
2
Yahoo Finance Community
01/03
Comment
Tonix has been releasing news every week for the past 6 months or so. Whether it’s appearing at a conference or making a presentation at investor meetings. It’s been about 2 weeks with no official news. I suspect next week something big is coming. But like everyone else, this is pure speculation. GLTA...
Votes:
4
0
Yahoo Finance Community
01/04
Comment
Delisting and reverse split intoCompany has until Feb 5 to meet $1 requirement. If not, upon request it will get another 180 days.. extension which is Aug 2025.So I would not worry about RS right now. I am sure it will reach $3 range before FDA makes it decision....
Votes:
14
0
Yahoo Finance Community
01/04
Comment
People like throwing around extension like it’s a sure thing ( very well might happen) but considering under the new rule if RS is performed and within a years time fall under that dollar threshold, well… not even 1 extension is permitted and keep in mind Tonix will be asking for their second… NOT saying they won’t be granted, just saying it’s a HARD ASK…...
Votes:
1
1
Yahoo Finance Community
01/04
Comment
Advice to TNXP, if you end up doing a 7:1 RS in May 25, consider splitting your Outstanding as well as your Authorized shares so your retail shareholders are truly kept whole. Chances of your SP going up would dramatically increases if you do this. This will lower your float as well....
Votes:
2
0
Quantexa News
01/05
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 3.5% – What's Next?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report )'s share price dropped 3.5% during trading on Friday . The stock traded as low as $0.29 and last traded at $0.30. Approximately 25,...
Quantexa News
01/05
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 3.5% – Time to Sell?
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report)’s stock price dropped 3.5% during trading on Friday . The company traded as low as $0.29 and last traded at $0.30. Approximately 25,...
Yahoo Finance Community
01/05
Comment
The stock price is going to fluctuate and yes the company has a history of reverse splits etc BUT they have made the drug, done the clinical trials, had great results and got FDA fast tracking. Drugs that get fast tracked are more likely to be approved by the FDA plus this drug is the first new one for fibromyalgia with minimal side effects. It's going to be a great summer! Good luck to all!...
Votes:
9
1
Yahoo Finance Community
01/05
Comment
Copied from the FDA website. I can't post the entire page so I suggest anyone interested or holding this stock check the FDA website.Once a drug receives Fast Track designation, early and frequent communication between the FDA and a drug company is encouraged throughout the entire drug development and review process. The frequency of communication assures that questions and issues are resolved quickly, often leading to earlier drug approval and access by patients....
Votes:
8
1
Yahoo Finance Community
01/05
Comment
This company is a dilution machine. According to filing on 12/20, they sold 363M shares between July and 12/20 and have now filed to sell an additional $140M worth (about 420M shares in the near future). So they will soon have about 1 Billion share and the current market cap will soon be about $300M. So if you think this is undervalued, think again....
Votes:
2
3
Quantexa News
01/06
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 2.5% – Here's Why
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) shot up 2.5% during trading on Monday . The company traded as high as $0.34 and last traded at $0.32. 48,039,653 shares changed hand...
Yahoo Finance Community
01/06
Comment
This company and its management have never ever produced anything whatsoever for the shareholders. This would be the first time and a miracle if they succeed to the end having their drug approved and the shareholders rewarded after enduring so much losses. They score ZERO so far and their future grade to be determined in a couple of months. GLTA...
Votes:
2
3
Yahoo Finance Community
01/07
Comment
A common comment - No one trusts this company. Well, for starters, see the volume traded every day. up or down, some is buying, and someone is selling. I guess, whoever is buying is looking for that silver lining or the end of tunnel where they might find gold. Whoever is selling is taking their money and moving on to a different stock. As far as me, I feel sad this is going down every day, but recent activity with the company I see light close by and I don't want to miss out....
Votes:
5
0
Yahoo Finance Community
01/07
Comment
So what’s making it go down this time around? Such a big enthusiastic long crowd are we. As been saying it all this time for the past 4 years, this management isn’t trustworthy and this company is all about gimmicks. Otherwise there is hardly any reason this should keep going down. In reality it should be above $5 by now if any. It’s not and the reason is again that it’s all gimmicks. We going to learn that the hard way. The only way to make money here is to short it like many of us or day trade to your best ability....
Votes:
2
1
Yahoo Finance Community
01/07
Comment
I salute the many longs hanging in there. It's apparent that many are in for the quick pennies while the rest of us are in for retirement checks, which are coming. Patience is key, this will fly so high, especially in light of investors convention days away 🚀💰...
Votes:
5
0
Yahoo Finance Community
01/07
Comment
Tale of the Tape.As of 12pm.Shares bought....14,298,134Shares sold.....20,514,505Neutral shares.....2,343,819As to where might all these shares be coming from day after day? The short interest has been drying up lately, as of 8 minutes ago, there are 7.1m shares available to short. My guess is Seth is the reason for the continued selling... selling from his ATM....
Votes:
1
0
Yahoo Finance Community
01/07
Comment
ok so share count was 4m june 30 and cash of $4m. raised $4m in july wth 7m shares . they sold 363m shares from July 30 to dec 20 and raised $112m. so that is total cash of 120m with 374m shares as of dec 20 ( when prospectus was filed).burning around 17m /q so burned around 35m from june 30 to dec 31 so cash now $85m and this is before any more ATM selling from Seth since Dec 20. so mkt cap is 112M and cash around $85m not factoring in any ATM selling since Dec 20.cash / share is $0.22 and stock is not much higher at 0.29. This is a huge buy here in 0.20s !! from 0.3 all way down to 0.22 ( cash / share) , not saying it gets there, just if it does , time to load more core shares. If …...
Votes:
3
0
Yahoo Finance Community
01/07
Comment
Anything is possible I could be wrong but I think I am right, not based on feelings but based on facts. I am totally relaxed I don't know why some folks panic. At this stage we need to add more shares it's an opportunity of a life time if you can't see it then you will always remain poor if you don't have the money or guts then go work your 9 to 5 job....
Votes:
6
1
Quantexa News
01/07
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 7.2% – Should You Sell?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) fell 7.2% on Tuesday . The company traded as low as $0.28 and last traded at $0.29. 30,458,623 shares traded hands during trading,...
Quantexa News
01/07
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 7.2% – Time to Sell?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) dropped 7.2% during mid-day trading on Tuesday . The company traded as low as $0.28 and last traded at $0.29. Approximately 30,458...
Yahoo Finance Community
01/07
Comment
assuming no more ATM and with current burn , cash will be be around 50m in august with 375m shares and if price is still 0.3 , that is mkt cap 112m less cash so enterprise value 62m and with a drug that can do 300-600m in annual sales, Big pharma salivating here to be able to buy , more like steal tnxp at $1 for EV of around $300m or under 1x Tonyma sales. they can then shut down or sell off rest of pipeline that is a cash drain and milk those high margin tonyma sales until the cowns come home. I actually dont want this to be the case as I feel it will hit 2s on approval but just saying how I can see this happening , that is a pharma company coming in and buyng this around $1...
Yahoo Finance Community
01/07
Comment
just an opinion I think strong investment money is cautious based on companies past. Sabby dropped 300K Friday for one reason, hedge If mid -big pharma with buying or merging interests exist they have been talking and performing due diligence since last year. folks the money is in the patent with FDA approval, not manufacturing and distribution with an override one more point to keep in mind for Seth and friends this is their swan song lot of moving parts trying to become together Be patient...
Quantexa News
01/08
Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Gary Ainsworth as Vice President of Market Access
Mr. Ainsworth brings over two decades of industry and market access experience to Tonix U.S. Food and Drug Administration ( FDA) recently assigned a Prescription Drug User Fee Act (PDUFA) goal date o...
Quantexa News
01/08
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 6.7% – Time to Sell?
Tonix Pharmaceuticals Holding Corp. ( – )'s share price traded down 6.7% during trading on Wednesday . The company traded as low as $0.26 and last traded at $0.27. 32,941,376 shares changed hands duri...
Quantexa News
01/08
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 6.7% – Here's Why
Shares of Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) were down 6.7% during mid-day trading on Wednesday . The company traded as low as $0.26 and last traded at $0.27. Approx...
Quantexa News
01/08
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading 2.5% Higher – What's Next?
Shares of Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) were up 2.5% during mid-day trading on Monday . The company traded as high as $0.34 and last traded at $0.32. Approximat...
Quantexa News
01/08
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 2.5% – Time to Buy?
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report)’s share price traded up 2.5% during trading on Monday . The company traded as high as $0.34 and last traded at $0.32. 48,039,653 sha...
Yahoo Finance Community
01/09
Comment
Well.the only thing Seth knows anything about is RsThere is nothing else in his skill set. So am out w a small profit until he's done with that and feeding shorts another needless windfall. What can you say? Likely approval but no Sr management chops at all...
Votes:
3
1
Yahoo Finance Community
01/09
Comment
Since the market is closed, we can brainstorm some ideas about this company and what's expected for 2025. Honestly, I think we'll have some surprises at the conferences next week (just a hunch), but I don't know if they'll be positive or negative. What I've already decided is that I won't sell for less than $20. I have time to wait, even if it takes 5 years. I hope they stay on the NASDAQ and don't dilute any further....
Votes:
2
0
Quantexa News
01/09
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 11.1% – Time to Sell?
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) shares traded down 11.1% during mid-day trading on Thursday . The stock traded as low as $0.26 and last traded at $0.26. 72,709,392...
Quantexa News
01/09
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 7.2% – Here’s Why
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) shares fell 7.2% during trading on Tuesday . The stock traded as low as $0.28 and last traded at $0.29. 30,458,623 shares were tra...
Quantexa News
01/09
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 7.2% – Time to Sell?
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) was down 7.2% during trading on Tuesday . The company traded as low as $0.28 and last traded at $0.29. Approximately 30,458,623 shar...
Yahoo Finance Community
01/09
Comment
Tale of the Tape.As of 12:12pm.Shares bought.... 0Shares sold..... 0Neutral shares....0Good news longs, the selling has completely dried up, not a single share was sold today. Hurray! And for the shorters out there, good news for you as well, not a single share was bought today. As for our Swedish friends, neutral shares were also on holiday today. The weather was perfect today for a day trip to the Alps. See ya all tomorrow.Rest in Peace #39. You were a great humanitarian. Hebrews 6:10...
Votes:
5
0
Yahoo Finance Community
01/09
Comment
If/when they issue all of their authorized shares (1B), they will have 1B outstanding shares. Fibromyalgia market is $2.7B; they will make at least $500M in revenue their first year if drug is approved (the drug’s chemical makeup is not new, but it is the first new Fibro drug in 15 years). Based on a market wide average of 3x P/S ratio, current P/E ratio of 0, their pipeline and shift on market sentiment, if drug approved and authorized shares remain 1B, the share price will be $1.50 - $2.50 per share by EOY 2025. Thoughts? Meeksy? Scott? Penicula?...
Yahoo Finance Community
01/09
Comment
Ok I just read the Jan 8 nasdaq response. Nasdaq is asking the SEC to approve the new RS proposal without delay. This means no RS in Feb, making way for a request for an extension. Whether an extension will be granted is up to the powers that be. Scott Pecunia is my assessment correct? In other words, this is good news taking into account Tnxps current condition...
Votes:
4
0
Yahoo Finance Community
01/09
Comment
I finally read the letter its a reply from Sherry R. Haywood Assistant Secretary United States Securities and Exchange Commission regarding NASDAQ "propsed " amendments to the below a dollar listing regulations.What everyone here need appreciate is Tonix submitted a comment on the proposal to the SEC explaining although naked shorts are NOT illegal and can help in some case, Naked Shorts can cause harm to companies .Tonix as I read it is in favor of the amendment which would change the $1.00 requirement to 360 days Until the amendment is approved nothing will change The Take-away for investor is Tonix ( Seth ?) is not happy with the constant games.Hopefully this pdf will stay attached...
Votes:
1
1
Yahoo Finance Community
01/10
Comment
Wow. This new rule is cut throat but I love it. It says companies will have 360 days to stay <$1 before delisting, ALSO if they reverse split, there will be no 360 day grace period and they will be delisted ASAP once <$1 after reverse splitting. nasdaq actually stepped up to prevent RS and I hope this is approved quickly...
Votes:
2
0
Yahoo Finance Community
01/10
Comment
They have Dod contracts with potential funding of 34M over the next 5 years. This company is not going anywhere but up and will have cash on hand for awhile. Of course there will be ups and downs in funding but they have plenty of hands in various cookie jars to keep things going....
Votes:
6
1
Yahoo Finance Community
01/10
Comment
If I had the chance I would go to the Investors meeting in S.F this weekend to hear what TNXP has going on with its current testing and the results. JMO if news is positive, it could be more news for the FDA to possibly ease restrictions on TNXP and changing the August time frame....
Yahoo Finance Community
01/10
Comment
I googled chances of TNXP stock increasing. The results are below.The stock is expected to rise 64.50% during the next 3 months.The average analyst price target is $3130.23, representing a +1001574.53% increase from the current price of $0.3125.The average target predicts an increase of 19,736.86% from the current stock price of $0.27.The Wall Street analyst predicted a share price of $11.00 by Jul 22, 2025.The range of stock forecasts is 4.04 - 50.40 USD, with a consensus recommendation of BUY....
Votes:
7
2
Yahoo Finance Community
01/10
Comment
Just did some research and 1/12 is their biggest meeting by far. 30+ investment firms will be there. And this is the only time they have an NDA approved. Maybe this weekend S eth will finally publicly state that they will no longer RS- which will be the millionaire dollar question. Big weekend for sure...
Votes:
6
1
Yahoo Finance Community
01/10
Comment
Tale of the Smiling Tape.As of 4pm.Shares bought.....27,361,637Shares sold....20,484,250Neutral shares....6,171,387How about that folks, we closed in the green. We needed to see some green for a change. Hopefully, this will be the start of a new trend. We picked up nearly 7m shares on the + side today. Sweet! Enjoy your weekend....
Votes:
12
0
Yahoo Finance Community
01/10
Comment
To be brutally honest, I think the key to success is to diversify. I know we have a fear of reverse split and possible rejection of FDA but tnxp also have some potential as well. Have some tnxp if tnxp have FDA approval it's great we make money but if it doesn't it's good to have some shares in AI , some shares of industrial and for defensive stock against market drop, it's good to have some shares of consumer staples, food, oil etc, basically good to have tnxp but we need other stocks too in order to survive in case tnxp does reverse split and number of shares go down..since we don't know the direction of the market and political uncertainty plus the damage that is caused to our international standing in the past 20 years, diversity of a portfolio is a must. Peace! ✌️...
Votes:
5
1
Yahoo Finance Community
01/10
Comment
I know I’m preaching to the choir but RS then share issuing is absolutely crazy. I finally fully understand it. If they 10:1 RS and you have 100 shares @ $1 you now have 10 shares and price is $10. But then they issue all those shares back until you’re stuck with 10 shares @ $1 and they just took 90% of your money. Wild. If there’s no more RS this thing will fly...
Quantexa News
01/11
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 11.1% – What's Next?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report )'s stock price fell 11.1% during trading on Thursday . The stock traded as low as $0.26 and last traded at $0.26. 72,709,392 shares...
Quantexa News
01/11
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 11.1% – Should You Sell?
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report)’s share price dropped 11.1% during trading on Thursday . The company traded as low as $0.26 and last traded at $0.26. Approximately...
Yahoo Finance Community
01/11
Comment
this company torments me, has me thinking about it on a Saturday evening I hate it, I'm kinda sure it has a future however I'm torn between selling and taking a loss now and just buying back after the impending rs that's 100 percent sure to happen again now, or what, I dunno it's sad, I just can't believe still that I didn't sell on the news 3 or 4 weeks ago now, when it was reaching 2 dollars, my life would be in a little bit better off scenario right now, and could've bought back in with 100x the amount of shares after the rs ahead of August, man, that is to say that if the fda outcome turns in their favor, I would've been able to consider myself a well to do person, but that isn't going to be instead I'm just pondering to cut my losses before …...
Votes:
3
0
Quantexa News
01/12
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 3.5% – What's Next?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) shot up 3.5% during mid-day trading on Friday . The stock traded as high as $0.28 and last traded at $0.26. 29,962,066 shares were...
Yahoo Finance Community
01/12
Comment
Why TNXP Faces Imminent Delisting Risks? Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP), currently trading at $0.26, is at high risk of delisting due to non-compliance with Nasdaq’s minimum bid price requirements. Here’s a detailed analysis based on available data: Key Compliance Issues 1. Nasdaq Compliance Notice • August 9, 2024: TNXP was notified of non-compliance with Nasdaq’s $1.00 minimum bid price rule after closing below $1.00 for 30 consecutive business days. • Deadline: TNXP must achieve a $1.00 bid price for ten consecutive business days by February 5, 2025. 2. Current Trading Price • As of January 8, 2025, TNXP trades at $0.26—well below the $1.00 threshold. (Source: Yahoo Finance) 3. Reverse Stock Split Not an Option • TNXP executed a reverse split in June 2024, regaining compliance temporarily. • Nasdaq Rule: Companies cannot perform a second reverse split within 12 months if their stock price falls below $1.00 again. …...
Votes:
3
7
Yahoo Finance Community
01/12
Comment
As long as it's true that the earliest they can RS is in May, then they will not RS. On 1/8, nasdaq denied theirs and other companies' appeal to the new rule. They also promptly approved and urged SEC to approve ASAP. that being said, it's fair to assume the SEC will approve the rule by May and they won't be able to RS again. extremely bullish because that's really the only risk here, alongside drug approval which has high chances of being approved. In other words, if they don't RS, you will make money with this stock if tnx102 approved which is highly likely. thoughts?...
Votes:
12
0
Yahoo Finance Community
01/13
Comment
adding to core shares 0.22-0.25s range. added 0.25s and more bids down to 0.22. Oh cash / share is $0.22 and we have good odds firbo drug ( 300-600m annual sales) will be approved , the drug and rest of pipeline is essentially being valued at zero ( enterprise value that is) , pure insaniteeee...
Votes:
1
0
Yahoo Finance Community
01/14
Comment
This doesn't matter at all what Tonix's stock price is before August. After that, it will either rise above $5 or lose its value entirely. The current situation is just a drift. Of course, a big pharmaceutical company could always buy them out, but that's unlikely to happen....
Votes:
4
2
Yahoo Finance Community
01/14
Comment
Pipeline of new products supports future stock pricing estimates. 2025 should see stock pricing in the range of 50.56 per share. Short term valuations should allow for stock pricing to achieve the + 5.00 share value and there place this company back on the big board....
Votes:
9
1
Quantexa News
01/14
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Short Interest Up 94.5% in December
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) saw a large increase in short interest in December. As of December 31st, there was short interest totalling 7,780,000 shares, an inc...
Quantexa News
01/14
Short Interest in Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Expands By 94.5%
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) saw a large increase in short interest in December. As of December 31st, there was short interest totalling 7,780,000 shares, an i...
Quantexa News
01/14
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 7.1% – Time to Sell?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) shares dropped 7.1% during mid-day trading on Tuesday . The company traded as low as $0.24 and last traded at $0.24. Approximately...
Yahoo Finance Community
01/14
Comment
These next couple weeks are make or break for dilutiom (misspelled so yahoo police doesn't get me). Nasdaq approved RS rule so sec will approve soon. And with the 2/5 deadline, they really only have a few weeks to announce RS. 1 of 2 announcements will come soon and will be either very bullish or very bearish: 1. RS 2. Extension. GLTA next week going to be crazy...
Votes:
3
2
Quantexa News
01/15
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading 1.8% Higher – Still a Buy?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report )'s share price was up 1.8% during trading on Wednesday . The stock traded as high as $0.24 and last traded at $0.23. Approximately...
Quantexa News
01/15
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Short Interest Update
NASDAQ:TNXP – Get Free Report ) was the recipient of a significant growth in short interest in December. As of December 31st, there was short interest totalling 7,780,000 shares, a growth of 94.5% fro...
Quantexa News
01/15
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Sees Significant Growth in Short Interest
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) saw a large increase in short interest in the month of December. As of December 31st, there was short interest totalling 7,780,000...
Quantexa News
01/16
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 7.5% – Here’s Why
Shares of Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) rose 7.5% during mid-day trading on Thursday . The stock traded as high as $0.26 and last traded at $0.25. Approximately...
Quantexa News
01/16
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 7.5% – What's Next?
Shares of Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) rose 7.5% during mid-day trading on Thursday . The stock traded as high as $0.26 and last traded at $0.25. Approximately...
Quantexa News
01/16
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Sees Large Increase in Short Interest
NASDAQ:TNXP – Get Free Report ) was the target of a large increase in short interest in December. As of December 31st, there was short interest totalling 7,780,000 shares, an increase of 94.5% from th...
Quantexa News
01/16
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Short Interest Up 94.5% in December
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) was the recipient of a large growth in short interest during the month of December. As of December 31st, there was short interest...
Quantexa News
01/17
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 7.1% – Here's What Happened
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) shares traded down 7.1% during mid-day trading on Tuesday . The stock traded as low as $0.24 and last traded at $0.24. 19,377,092 sh...
Yahoo Finance Community
01/17
Comment
I don't think they will RS again however that $140M ATM increase last month put a bad taste in institution's mouth. They pretty much stated they will exhaust close to all of their 1B authorized shares. Institutions don't want to buy into companies that do that. Extension is the only solution next week...
Votes:
2
2
Quantexa News
01/17
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 2.6% – What’s Next?
Shares of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) traded down 2.6% during mid-day trading on Friday . The stock traded as low as $0.22 and last traded at $0.23. 16,568,814...
Quantexa News
01/17
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 1.8% – Here’s Why
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) shares shot up 1.8% during trading on Wednesday . The company traded as high as $0.24 and last traded at $0.23. 22,176,383 shares ch...
Yahoo Finance Community
01/17
Comment
Tale of the Tape.As of 4pm.Shares bought....14,665,011Shares sold...20,813,498Neutral shares...2,428,719As predicted, from 4 hours earlier, they made sure to close this in the green even though the selling clearly outnumbered the buying by a wide margin. In fact, the selling intensified (nearly doubled) from my tale of tape post at noon. Oh well, if this is how they want to play it, so be it. Pay no attention to that man behind the curtain.As always, treat it as a trade.GLTAHave a good weekend! Tale of the Tape.As of 12pm.Shares bought .....7,883,458Shares sold....10,400,711Neutral shares....1,383,157...
Votes:
8
0
Quantexa News
01/18
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Up 7.5% – Time to Buy?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) shot up 7.5% during mid-day trading on Thursday . The company traded as high as $0.26 and last traded at $0.25. 33,566,019 shares...
Quantexa News
01/18
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Up 7.5% – Still a Buy?
Shares of Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) shot up 7.5% on Thursday . The company traded as high as $0.26 and last traded at $0.25. 33,566,019 shares changed hands...
Quantexa News
01/20
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 0.2% – Still a Buy?
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) shares were up 0.2% on Monday . The company traded as high as $0.25 and last traded at $0.24. Approximately 39,010,846 shares change...
Quantexa News
01/20
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 0.2% – Should You Buy?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report )'s share price rose 0.2% on Monday . The company traded as high as $0.25 and last traded at $0.24. Approximately 39,010,846 shares...
Yahoo Finance Community
01/20
Comment
New SEC rule states "If a company effected a RS over the prior one year period, then company will get no compliance periods". I can't imagine this rule being retroactive, that's like moving the goal mid game. They can't RS until June 10 2025. It's either delist, extension, or >$1. GLTA. Feb 5 (delist date) seems to be the 3rd to last hurdle for us shareholders, following June (RS potential) and August (drug approval). GLTA....
Votes:
4
1
Quantexa News
01/21
Should You Invest in Tonix Pharmaceuticals Holding Corp (TNXP) Now?
The 36-month beta value for TNXP is at 2.05. Analysts have varying views on the stock, with 2 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.” The public floa...
Quantexa News
01/22
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 7.6% – Here’s What Happened
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report)’s share price rose 7.6% during trading on Wednesday . The stock traded as high as $0.26 and last traded at $0.26. Approximately 17,8...
Yahoo Finance Community
01/22
Comment
$1 Steady growth is often the most reliable path to significant gains. Building a strong foundation takes time and consistent effort. Focusing on long-term value creation can lead to sustainable appreciation. Impulsive decisions based on short-term market fluctuations can be detrimental. Patience and a well-defined strategy are key to achieving financial goals....
Votes:
3
1
Yahoo Finance Community
01/22
Comment
Tale of the Happy Tape.As of 4pm.Shares bought...98,865,837Shares sold...87,870,751Neutral shares...15,014,107What a sweet finish. We closed near the high of the day. After hours could get very interesting. I see we already hit .35 in the A/H's. Congrats to all....
Votes:
7
0
Yahoo Finance Community
01/22
Comment
just thoughts from a newbie. I don't have much invested but it's invested at a low price. I know this company has issues with Nasdaq, but if it can overcome that (without RS) and meet it's August goal with a fantastic treatment, this will be legendary....
Votes:
7
0
Yahoo Finance Community
01/22
Comment
I sold my 143,964 shares after hours today. We have a long time to wait on the FDA decision. I will buy back in below 0.25. Good luck to all who are long! I do think that eventually this will cross $1 on any good news regarding no plans for a reverse split & no delisting. It's obviously still a gamble, but I think it's a good gamble!...
Votes:
7
6
Quantexa News
01/23
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading 13.2% Higher – Here's Why
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) rose 13.2% during mid-day trading on Thursday . The stock traded as high as $0.37 and last traded at $0.36. Approximately 85,764,5...
Quantexa News
01/23
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 3.6% – Here's Why
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) traded down 3.6% during trading on Tuesday . The stock traded as low as $0.22 and last traded at $0.23. 15,196,699 shares traded h...
Quantexa News
01/24
Is Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) A Suitable Stock For New Investors Today?
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares, rose in value on Thursday, January 23, with the stock price up by 2.66% to the previous day's close as strong demand from buyers drove the stoc...
Yahoo Finance Community
01/24
Comment
140 M shares traded in the first 2 hours, only 20 M in the last 3/5 hours. A total slowdown I say. Don’t expect any news either unless sneaky Seth shows up with some sort of gimmicks regarding new offerings or RS. Longs need to keep it up and strong above 40, otherwise we might close in RED...
Votes:
2
1
Quantexa News
01/24
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Up 22.4% – Still a Buy?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) shares were up 22.4% during trading on Friday . The company traded as high as $0.41 and last traded at $0.40. Approximately 60,477...
Quantexa News
01/24
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Up 22.4% – Still a Buy?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) shares rose 22.4% during mid-day trading on Friday . The company traded as high as $0.41 and last traded at $0.40. Approximately 6...
Yahoo Finance Community
01/24
Comment
Been holding long, and plan to hold for awhile yet....only question is whether I add a bit more. I honestly thought this was going to pull back a bit today. Thanks to this little heart-stopper, my gains for the week are quite nice, even though I had one of my minor holdings declare a RS this week- fortunately, I treated that one with caution and didn't invest much........
Votes:
2
0
Yahoo Finance Community
01/24
Comment
Tale of the Steady Tape.As of 4pm.Shares bought...84,116,222Shares sold...83,200,372Neutral shares....10,900,403Another excellent finish( 16.98% for the day) and an outstanding finish for the week(59% for the week). Now that is what I'm talking about!! Congrats to all.Enjoy the weekend!...
Votes:
25
0
Quantexa News
01/24
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 7.6% – Should You Buy?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report )'s share price shot up 7.6% during trading on Wednesday . The company traded as high as $0.26 and last traded at $0.26. 17,897,355...
Quantexa News
01/24
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading 7.6% Higher – What's Next?
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) was up 7.6% during mid-day trading on Wednesday . The stock traded as high as $0.26 and last traded at $0.26. Approximately 17,897,3...
Yahoo Finance Community
01/24
Comment
Some newsA hedge fund recently bought a new stake in Tonix Pharmaceuticals stock. PFG Investments LLC acquired a new stake in shares of Tonix Pharmaceuticals Holding Corp in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 218,003 shares of the company's stock, valued at approximately $72,000. PFG Investments LLC owned approximately 0.12% of Tonix Pharmaceuticals at the end of the most recent quarter. 82.26% of the stock is currently owned by institutional investors and hedge funds....
Votes:
17
0
Quantexa News
01/25
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Up 13.2% – Here's What Happened
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report )'s stock price rose 13.2% during trading on Thursday . The company traded as high as $0.37 and last traded at $0.36. Approximately...
Yahoo Finance Community
01/25
Comment
Everyone giving takes here's mine extension needs to be filed, so we'll know when they do. S eth fears a sel the news event and is prolonging it as much as possible to keep the organic rise coming. If we see big drops, they may file the extension, if not, then I think they'll file on 2 / 5...
Votes:
2
0
Yahoo Finance Community
01/25
Comment
I was talking with someone on Facebook and they work in a hospital. They said the doctors are all talking about this and it is going to get approved and could be as early as June. Has anyone else heard anything to that affect? Earlier approval would be better. 🙂...
Votes:
25
1
Quantexa News
01/26
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 22.4% – Should You Buy?
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report)’s share price rose 22.4% during trading on Friday . The stock traded as high as $0.41 and last traded at $0.40. Approximately 60,477...
Yahoo Finance Community
01/26
Comment
Short availability went down a day ago now back up to 10 mill as of 12 hours ago via Fintel, borrow rate is still super low. Why none of these funds are shorting? Wonder what the 4am bid price will be tomorrow. May be the beginning of TNXP breaking $1 for good. 🤷♂️...
Votes:
9
0
Yahoo Finance Community
01/26
Comment
whats everyones thoughts on the chances of the extension being a 'sell the news' event? I have two holdings of this; 1 in roth that I'm holding for years, and another I swing trade. I'm wondering if I should sell some after extension is announced. Ideally I'd like my swing trade holdings to be lifer holdings as well haha. Thanks : )...
Yahoo Finance Community
01/26
Comment
up 60 percent last week !! 0.24 to 0.38 , nicestill worth $2-3 on approval ( so lots of upside left) and I still have 70-90 percent odds of approval based on strong efficacy ( p value 0.00002 ) and solid safety data and fact that FDA fast tracked it due to large unmet medical need and no FM drug in over 15 years...
Votes:
11
0
Yahoo Finance Community
01/26
Comment
Whatever the revenue estimate for this Fibro drug and then discount a bunch for the execution risk/approval risk etc and then some multiple of what is left should be your valuation target. 3-4 dollar stock imo. The rest of the pipeline no one cares about at this point...
Votes:
2
5
Yahoo Finance Community
01/27
Comment
Interesting enough that DWTX is up nearly $13 in 2 days just because of dozing phase 2 studies while this junk has successfully completed all phases and waiting for approval is still a 40 cents stock. Definitely something not right. It just makes no sense. I can only say that there is no trust in this company and its management....
Votes:
3
5
Quantexa News
01/27
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Up 11.5% – Here's What Happened
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) shares traded up 11.5% during mid-day trading on Monday . The stock traded as high as $0.45 and last traded at $0.43. 54,448,846 s...
Yahoo Finance Community
01/27
Comment
$TNXP climb by 76.63% in just a few days is honestly inspiring! It’s a reminder that the market can surprise us in the best ways when we stay patient and focused. Watching it grow from $0.24 to over $0.42 feels like a win not just for investors, but for everyone who believes in persistence and potential. Whether you’re already holding or just cheering from the sidelines, moments like this make the journey worth it. Let’s keep riding this wave....
Votes:
6
0
Yahoo Finance Community
01/27
Comment
It is hope, but we aren't invested on hope, we are invested based on the significant potential of where this stock is headed in the very near future. I know a lot of people read what Maurizio predicts and laugh, but in reality, he sees the potential of this company like I do, with an opioid free pain relief, this thing will be in high demand as soon as it hits the market 🚀💰...
Votes:
12
0
Yahoo Finance Community
01/27
Comment
For those who are on the fence on whether or not to invest, I don't think you gonna get in at a lower price. TNXP is on the map now to continuous growth. Invest wisely, but buy now or pay higher later, or worse, sit and watch and regret the opportunity that passed you by...
Votes:
10
0
Yahoo Finance Community
01/27
Comment
According to the last 10Q dated on 11/12/2024. The Company believes that its cash resources at September 30, 2024 and the net proceeds of $5.1 million that it raised from an equity offering in the fourth quarter of 2024 (See Note 19), will not meet its operating and capital expenditure requirements through the first quarter of 2025....
Votes:
1
9
Yahoo Finance Community
01/28
Comment
Didn't I tell you guys, you should have listened to me. I shorted this at 0.57 and will cover at 0.35. I am fine with small profit from shorting but I did make money on buying at 0.2 and selling at 0.57. Learn how to invest not every stock is longterm hold....
Votes:
1
10
Yahoo Finance Community
01/28
Comment
Tale of the dipsy doodle Tape.As of 4pm.Shares bought..172,632,339Shares sold....165,338,759Neutral shares......30,959,669Any body still queasy from that roller coaster ride? Good grief!Fortunately, it bounced back rather quickly which is a good sign. I say it's time to bring back steady Eddie to the race. I had a feeling ole Freddy wasn't going to last very long....
Votes:
12
0
Yahoo Finance Community
01/28
Comment
As somebody stated so eloquently on X"Short sellers built this day with their long positions on purpose to scare people. Thanks for revealing we have built an INCREDIBLE base! What a mistake this was on short sellers their part. Digesting this I am more thankful than anything!"...
Votes:
9
0
Yahoo Finance Community
01/28
Comment
Insiders own measly .17%Institutional own paltry .23%That is less than 1% combined from those who know a lot more about this loser than any daytrading pump and dumpers here.These crooks have stolen billions of dollars from both institutional and retail investors.They're doing it again by luring in more bunny fools with dangling carrot....
Votes:
6
2
Yahoo Finance Community
01/28
Comment
I don’t think the same to happen tomorrow due to mistrust. What happened today was a brutal shortening. I consider it as always a gimmick with this stock and the management is helping it by not addressing the shareholders. Also, the floor didn’t lock it up when it crashed from 58 to 34 so suddenly. They should have froze it....
Votes:
3
1
Quantexa News
01/28
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Up 21.8% – What's Next?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report )'s share price shot up 21.8% during mid-day trading on Tuesday . The company traded as high as $0.49 and last traded at $0.50. 48,6...
Quantexa News
01/28
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 21.8% – Here's What Happened
Shares of Tonix Pharmaceuticals Holding Corp. ( – ) rose 21.8% during mid-day trading on Tuesday . The company traded as high as $0.49 and last traded at $0.50. Approximately 48,603,004 shares were tr...
Yahoo Finance Community
01/28
Comment
big players can sell enough shares on a day like today to initiate a mini panic, and then buy more shares back at lower prices. rinse, repeat. that is all that's happening. a bunch of Johnny come latelies took the L today and some sharks increased their stake. fundamentals haven't changed, FDA still accepted their drug application it's still moving forward...
Votes:
7
0
Yahoo Finance Community
01/29
Comment
I could have bought in the .20's but waited and my average is .48 thereabouts. Wanted to see if serious with this organic climb and to me it appears so. So I loaded up a bunch....everyone has different strategies. But I wasn't scared, just should have jumped in earlier. And for sure not scared now...let it do it's thing now. Best of luck everyone....
Votes:
9
0
Quantexa News
01/29
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Up 6.7% – Here's Why
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report )'s stock price shot up 6.7% on Wednesday . The company traded as high as $0.55 and last traded at $0.49. 59,902,238 shares were tra...
Yahoo Finance Community
01/29
Comment
manipulated turd stock had a massive manipulated range yesterday 0.36 to 0.58 and then today another one .55 to 0.38. stock is an absolute joke , always has been for 10 years. now that doesnt negate the fact 80% odds fibro drug gets approved and this hits $2-3 and that is why I am here with my core shares with 0.28 avg...
Votes:
2
2
Yahoo Finance Community
01/29
Comment
tell me where u see a green stock today? nowhere... all of the stock in the medicin sector is red, many are down 10%... but this is just down 6 and rebounded great before close. tomorrow is going to be a 20% day. mark my words. 1 dollar soon. sit in the boat and relax....
Votes:
12
0
Yahoo Finance Community
01/29
Comment
well now I know to wait tomorrow for the little boys to play their little shorty game in the afternoon and I can buy some more cheap shares. They really are children aren't they? You can tell by the way they talk they can't be over 22 or 23., there's just no way...
Votes:
5
0
Yahoo Finance Community
01/29
Comment
the ones that are trying to bring a co.that is involved in making drugs to help the sick people are sick more then then people that are sick.they are the lowest of the low and we can all hope someday if they need a drug to help them and the cos.they brought down that could have help them are not around and now they will die.it would serve them right....
Votes:
2
0
Quantexa News
01/29
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 11.5% – Should You Buy?
Shares of Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) rose 11.5% on Monday . The company traded as high as $0.45 and last traded at $0.43. Approximately 54,448,846 shares tra...
Quantexa News
01/29
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Up 11.5% – Here's What Happened
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) shares rose 11.5% on Monday . The company traded as high as $0.45 and last traded at $0.43. Approximately 54,448,846 shares were t...
Yahoo Finance Community
01/29
Comment
, I guess some here wondered what happened today The drop was so sharp and fast that it wasn’t a natural price movement at all. Instead, it had all the characteristics of a stop-loss hunt (also called “raid”) or liquidity grab by market makers or large institutions. The speed of the drop was extreme, likely triggering stop-loss orders placed by retail traders. When a stock falls rapidly through key support levels, automatic sell orders get executed, leading to a cascade effect. Once those stop-losses were triggered, the price rebounded, which is a common sign of a liquidity grab. Also, there was a clear volume spike exactly at the moment of the crash..This suggests that either a large institution was offloading shares, or algorithmic trading programs amplified the move. In both cases, this kind of volatility is often exploited by those with deep liquidity to shake out weak hands before pushing …...
Votes:
12
0
Quantexa News
01/29
Short Interest in Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Rises By 94.5%
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) was the recipient of a significant increase in short interest in the month of January. As of January 15th, there was short interes...
Yahoo Finance Community
01/30
Comment
Mgmt. & Board are in the business of collecting a salary. There’s never been a sense of urgency to produce. Their greatest opportunity was Covid and absolutely nothing was brought to market. Just Poster Presentation after poster presentations. Sounds like little school science fair projects. But no real medical breakthroughs. Very disappointing. Be careful and good luck. Yes I’m biased because I let this investment get away from me without protecting my principal. Don’t make the same mistake use some stops....
Votes:
1
2
Yahoo Finance Community
01/30
Comment
average twelve-month stock price forecast for Tonix Pharmaceuticals is $53.50, with a high forecast of $96.00 and a low forecast of $11.00 am, laughing all the way to the bank if this comes through he'll even if it gets to $4 it's life changing with what I got...
Votes:
3
0
Yahoo Finance Community
01/30
Comment
No offense intended for the people who are actually telling the truth BUT in all honesty if you want answers to your questions about the company there is TONS of information on the website of the company as well as the SEC and lots of articles on the internet. Do your own due diligence and don't be misled by people who don't have your best interests at heart. Good luck to all....
Votes:
16
0
Yahoo Finance Community
01/30
Comment
Like I said this morning.. its not going to hold the .44 price for long. The possibility of a RS or delisting being a near future before the fda approval is the issue. That and the average is .15 - .20.. at .40 the fda approval is priced in. so it will need to RS to get above a $1. Then they need to distribute and profits to become a serious company. The plans this company has are good, but its overvalued right now. just my 2 cents...
Votes:
1
3
Yahoo Finance Community
01/30
Comment
For panny stock like this one TXNP, in other words(TOXIC) to go down 6 CENTS, it's a huge deal, people..! this stock has been R/S zillion times. It's made to get bought around .20 CENTS to .26 CENTS a share (larg quantity) and should be sold around .36 CENTS to .46 CENTS a share. Then you will be making SEREIOUS PROFIT. That's what I've been doing with this (TOXIC STOCK) numerous times. Waiting for .26 CENTS(It will come down to .26 CENTS. soon or later. But it will..!!...
Yahoo Finance Community
01/30
Comment
Those guys that are disagreeing with me are the ones who have nowhere to go now. They stocked with this junk. They probably bought the stock at a high price. They are keeping the stock so they don't feel guilty. Not being aware that this is their hard earning money. WHY LOSING IT?...
Votes:
1
4
Quantexa News
01/30
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 7.7% – Should You Sell?
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) fell 7.7% during mid-day trading on Thursday . The stock traded as low as $0.38 and last traded at $0.40. 34,984,174 shares changed...
Yahoo Finance Community
01/30
Comment
There are several longs on here of which the list is too long to name that provide accurate info and opinions that help us all, even those of us who been doing this for awhile. I have managed to profit many times in different stocks through sharing like this, and you guys will be no different. So, to all the longs, thank you so much. Teamwork 💰💰...
Votes:
12
1
Yahoo Finance Community
01/30
Comment
Im just pointing at it again. Every analyst set the price target of this stock at 2.5 dollars… that is 6x. In addition this company have a deadline… and then have to get it to show how good of a compny this really is. Im just saying that longs ar going strong on this stock. Look at how longs are eating up the shorts in after hours. I’m sold on this and I’m all in on this stock…...
Votes:
6
0
Quantexa News
01/30
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 21.8% – Should You Buy?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) traded up 21.8% during trading on Tuesday . The company traded as high as $0.49 and last traded at $0.50. 48,603,004 shares were t...
Quantexa News
01/31
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 6.7% – Time to Buy?
Shares of Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) were up 6.7% on Wednesday . The stock traded as high as $0.55 and last traded at $0.49. Approximately 59,902,238 shares...
Quantexa News
01/31
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading 6.7% Higher – Time to Buy?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report )'s stock price shot up 6.7% during mid-day trading on Wednesday . The stock traded as high as $0.55 and last traded at $0.49. 59,90...
Quantexa News
02/02
PFG Investments LLC Invests $72,000 in Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)
PFG Investments LLC purchased a new stake in Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Free Report ) during the fourth quarter, according to its most recent filing with the SEC. The firm pur...
Quantexa News
02/02
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading 11.5% Higher – Here's What Happened
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report )'s share price rose 11.5% during mid-day trading on Friday . The stock traded as high as $0.45 and last traded at $0.42. Approximat...
Quantexa News
02/02
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Up 11.5% – Time to Buy?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report )'s stock price rose 11.5% on Friday . The company traded as high as $0.45 and last traded at $0.42. Approximately 34,499,859 shares...
Yahoo Finance News
02/03
Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock Split
Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock Split Tonix Pharmaceuticals Holding Corp. Mon, Feb 3, 2025, 8:05 AM 9 min read In This Article: TNXP -54.47% Tonix Pharmaceuticals Holding Corp....
Quantexa News
02/03
Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock Split
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announce...
Quantexa News
02/03
Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock Split
CHATHAM, N.J., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pi...
Quantexa News
02/03
Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock Split
GlobeNewswire | Tonix Pharmaceuticals Holding Corp. Today at 2:05pm GMT+1 CHATHAM, N.J., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a...
Quantexa News
02/03
Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock Split
CHATHAM, N.J., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pi...
Quantexa News
02/03
Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock Split GlobeNewswire | Tonix Pharmaceuticals Holding Corp. Today at 2:05pm GMT+1
CHATHAM, N.J., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pi...
Quantexa News
02/03
Tonix Pharmaceuticals Implements 1-for-100 Stock Split Strategy
Overview of the Reverse Stock Split by Tonix Pharmaceuticals Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a renowned biopharmaceutical company, has made a significant announcement regarding a...
Quantexa News
02/03
Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock Split
CHATHAM, N.J., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pi...
Quantexa News
02/03
Tonix To Implement 1-for-100 Reverse Stock Split For Nasdaq Compliance
Tonix Pharmaceuticals Holding Corp. ( TNXP ), a fully-integrated biopharmaceutical company, on Monday announced that its Board of Directors has approved a 1-for-100 reverse stock split of its outstand...
Yahoo Finance Community
02/03
Comment
They just ruined all hopes for existing investors to make any money, even with a FDA approval. The management for this company is obviously not concerned about investor relations & he's very likely corrupt as heck with this move. Why not file for an extension before you ruin the stock price? I just don't get it......
Votes:
6
1
Quantexa News
02/03
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 48.6% – What’s Next?
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report)’s share price traded down 48.6% on Monday . The company traded as low as $0.18 and last traded at $0.22. Approximately 191,793,903 s...
Yahoo Finance Community
02/03
Comment
Call me crazy but I bought thousands of shares today. Am I nuts or just coco pops? By the way any crypto coins are now deep diving and will have a long haul ahead to get back to those inflated levels expect 30-49.99999999% more drop Pausing tariffs ain't gonna butter any parsley -that's my hallucination...
Votes:
1
0
Yahoo Finance Community
02/03
Comment
everyone seriously, I took a loss this morning and Im alright that I did, it will rs way to high and then continue to drop probably back to the 3 to 4 range, then it will probably be worth taking a chance on it again, it definitely has good news coming maybe even before August, but from my little 2 years of experience, every stock that does the 100 to 1 comes way back down because it's no way even close to being woth 20 to 30 dollars for the next 7 months, that's crazy, 100 to 1, nutz, I was sur it was coming and 10 or 12 or maybe even 20 to 1 I was gonna ride it out, but 100, they skrwd us...
Votes:
3
0
Quantexa News
02/03
Tonix Pharmaceuticals Announces Termination of Loan Agreement and Preliminary Financial Results; Plans for Reverse Stock Split
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) recently disclosed several significant updates in a Form 8-K filing with the Securities and Exchange Commission. On February 3, 2025, the company ter...
Yahoo Finance Community
02/03
Comment
A holes are like opinions everyone has one.. this is a viable company that’s smart to keep bringing money in.. park what you can afford and move on. The FDA will approve this. And yes historically this company has done MANY r/s and is still around today. It takes LOTS of money to build up a small cap bio company. They already have drugs in the market and will continue to produce. EVERY single analyst has this at over 1 … read up on it. Stop crying .. #longstrong shorts beware after reverse splits.. it’s tempting but news could come out and your not dealing with a penny stock anymore it could hurt!...
Votes:
5
1
Yahoo Finance Community
02/03
Comment
They never had a plan for another extension. They rode the ATM market and retail buyers to the last viable day to file for a reverse split. Smart business moves but horrible way to treat stakeholders. Sethan knew after his SEC letter that they would never be granted an extension. All legal, approved by stakeholders but evil in every form. IMO...
Votes:
8
2
Yahoo Finance Community
02/03
Comment
If the CEO did in fact release the rest of the shares while the price was tanking after a run up before a reverse split it sounds to me like there needs to be an SEC investigation The sec needs to verify that it wasn't an artificial run Up orchestrated by the CEO...
Votes:
1
0
Yahoo Finance Community
02/03
Comment
RS does not reduces the value of your holdings. 40 shares @ $0.40each = $40 Holding 10 shares at $4 = $40 holding The maths is really as simple as that. The reason they are doing a RS Is to regain compliance for minimum listing price. The RS will not impact the value of your share portfolio....
Votes:
1
9
Quantexa News
02/04
Tonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical Officer
Ms. Fogarty has served at Tonix since 2016, most recently as Executive Vice President, Product Development Tonix is Preparing for Potential Launch of TNX-102 SL for the management of fibromyalgia wit...
Quantexa News
02/04
Tonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical Officer
Ms. Fogarty has served at Tonix since 2016, most recently as Executive Vice President, Product Development Tonix is Preparing for Potential Launch of TNX-102 SL for the management of fibromyalgia wit...
Quantexa News
02/04
Tonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical Officer
Ms. Fogarty has served at Tonix since 2016, most recently as Executive Vice President, Product Development Tonix is Preparing for Potential Launch of TNX-102 SL for the management of fibromyalgia wit...
Quantexa News
02/04
Tonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical Officer
Ms. Fogarty has served at Tonix since 2016, most recently as Executive Vice President, Product Development Tonix is Preparing for Potential Launch of TNX-102 SL for the management of fibromyalgia with...
Quantexa News
02/04
Tonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical Officer
Ms. Fogarty has served at Tonix since 2016, most recently as Executive Vice President, Product Development Tonix is Preparing for Potential Launch of TNX-102 SL for the management of fibromyalgia wit...
Quantexa News
02/04
Tonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical Officer
Tonix Pharmaceuticals Holding Corp. Ms. Fogarty has served at Tonix since 2016, most recently as Executive Vice President, Product Development Tonix is Preparing for Potential Launch of TNX-102 SL f...
Quantexa News
02/04
Tonix Pharmaceuticals Appoints Siobhan Fogarty As Chief Technical Officer, Stock Down
Tonix Pharmaceuticals Holding Corp. ( TNXP ) Tuesday announced that it has promoted Siobhan Fogarty to Chief Technical Officer, effective immediately. Fogarty, who joined the company in 2016, previou...
Yahoo Finance Community
02/04
Comment
I think if you’re buying stocks that you know full well (or should know) are on the Nasdaq noncompliance list in the (probably realistic) hopes that it’s worth a lot more later…class action suits are a little much. And the stock is not worth nothing unless people freak out and make it worth nothing, it will recover, because the drug is just a different formulation of flexeril to bypass the stomach since most people with fibromyalgia diagnoses also have IBS.They had to do the RS before mid Feb or take their chances with delisting. As long as they didn’t violate some other rule in how they went about this it will be fine eventually.People who have it at too high a cost basis are stuck anyway so lying about the drug being a hoax or fda approval odds when it’s got a better chance than most at approval is just …...
Votes:
3
1
Yahoo Finance Community
02/04
Comment
This is a gross dereliction of fiduciary responsibility and a class action suit is to be expected. While it might be a civil matter, the lack of respect to shareholders is criminal and rises to an ethical disregard of the public. We all need to write to the FCC and moreover, the FDA. If this is how they treat their shareholders who knows what chicanery their research and ultimate roll out of their product will contain. Yes it is a speculative stock, but it is a public company and to throw the investors under the bus with these machinations is cruel....
Votes:
5
0
Quantexa News
02/04
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 13.8% – Time to Sell?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report )'s stock price was down 13.8% during mid-day trading on Tuesday . The company traded as low as $0.15 and last traded at $0.17. Appr...
Yahoo Finance Community
02/04
Comment
This is why you never buy & hold penny biotech companies who aren't generating any revenue. They will reverse split you to death & then raise more money after the reverse split via share offerings, diluting the shareholders even more. These kinds of actions should be criminal, but they aren't, unfortunately. This turd will continue to sink after the reverse split tomorrow. Management knows it too, which is why they decided to do a 100:1 reverse split. Anything less & they would be right back in the same boat within days!...
Votes:
9
0
Quantexa News
02/04
Tonix Pharmaceuticals (NASDAQ: TNXP) Promotes Siobhan Fogarty to Chief Technology Officer
Tonix Pharmaceuticals Holding Corp. recently announced the appointment of Siobhan Fogarty as the Chief Technology Officer of the company. The decision, effective from February 3, 2025, reflects the Bo...
Quantexa News
02/04
Tonix Pharmaceuticals Announces Termination of Loan Agreement and Preliminary Financial Results; Plans for Reverse Stock Split
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) recently disclosed several significant updates in a Form 8-K filing with the Securities and Exchange Commission. On February 3, 2025, the company ter...
Quantexa News
02/04
Investornewsbreaks Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Promotes Siobhan Fogarty To Chief Technical Officer
MENAFN - Investor Brand Network) Tonix Pharmaceuticals (NASDAQ: TNXP) announced the Promotion of Siobhan Fogarty to chief technical officer. Fogarty, who joined Tonix in 2016, previously served as exe...
Polygon News
02/05
Tonix Pharmaceuticals to Participate in the 2025 BIO CEO & Investor Conference
Tonix Pharmaceuticals, a biopharmaceutical company, announced that its CEO will present at the BIO CEO & Investor Conference. The company is focused on transforming therapies for pain management and v...
Yahoo Finance Community
02/05
Comment
Why don’t u like bashers aka shorts.. let them short it .. even tomorrow jump right in. Easy money for them.. until they get burned when news drops… plenty of small cap bios with nothing in the pipeline that are trading higher then this… #longstrong...
Votes:
2
1
Yahoo Finance Community
02/05
Comment
sometimes you just have to work out what the market cap of the co. at each RS was and see if it is now fair value. I'm a newbie and see the mkt as fair value compared to companies like UNCY so building a sizeable chunk with more to add if any placing comes about....
Yahoo Finance Community
02/05
Comment
well scrub that, u can't even buy a put contract at the moment, have to wait a few days maybe weeks it says, but I seriously think I'm going to buy my first put soon as I can, this will continue to drop to the 5 dollar range thru till July, then ,maybe then it would be worth buying a couple of calls in anticipation of the August decision , for smarter more experienced traders, does that not make sense...
Yahoo Finance Community
02/05
Comment
they currently have 6M outstanding shares and 1B authorized. They have $100M in cash and claim to be fine until Q1 2026. But does that include commercializing TNX102 if approved? I don't think it does, and they need more $$. Operating expenses in 2023 were $130M and $60M in 2024. They need more $$ for commercializing 102. Fortunately for crooked S eth, he still has $100M of his ATM available. And 995M authorized shares!! Come on, you don't think another public offering is coming? Don't be silly. They won't dilute until late Feb, that'll be when they are back in Nasdaq compliance (10 trading days above $1). In March, they will issue another offering, to the tune of $100M - $300M. That, with their $100M ATM will give them plenty of money for 2025, 2026 and commercializing TNX-102. My point? I would buy after they issue another public offering, as …...
Votes:
6
0
Yahoo Finance Community
02/05
Comment
I was a bag holder too , and knew this was coming but I though just maybe all the , "they won't rs because the sec changed the rules and they want to get back compliance the organic way" talk was perhaps coming from more experienced people, and that maybe just maybe there was some validity to that talk, but nope, I guess I should've listened to my gut, and maybe , just maybe I do know what I'm doing, not much but a little more than some.No worries, it's my own fault. and I know that how, because if anyone held after a 100 to 1 reverse split and thought that they wouldn't continue to lose the rest, is beyond crazy. beyond nutz. I took a good loss monday,but wasn't willing to just give them the rest, and the rest of the market hasn't been too bad yesterday and …...
Votes:
1
0
Quantexa News
02/05
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 3.7% – Time to Sell?
Shares of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) fell 3.7% during mid-day trading on Wednesday . The company traded as low as $13.71 and last traded at $14.65. 1,371,627 s...
Quantexa News
02/05
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 3.7% – What's Next?
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) was down 3.7% during trading on Wednesday . The company traded as low as $13.71 and last traded at $14.65. Approximately 1,371,627 s...
Quantexa News
02/05
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 48.6% – Here's Why
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) shares traded down 48.6% during trading on Monday . The company traded as low as $0.18 and last traded at $0.22. 191,793,903 share...
Quantexa News
02/05
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 48.6% – Here's What Happened
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) dropped 48.6% during mid-day trading on Monday . The stock traded as low as $0.18 and last traded at $0.22. Approximately 191,793,...
Yahoo Finance News
02/06
Tonix Pharmaceuticals Announces Positive Topline Results from Phase 1 Trial for TNX-1500, a Next Generation anti-CD40L mAb Candidate for Prevention of Kidney Transplant Rejection and Treatment of Autoimmune Diseases
Tonix Pharmaceuticals Announces Positive Topline Results from Phase 1 Trial for TNX-1500, a Next Generation anti-CD40L mAb Candidate for Prevention of Kidney Transplant Rejection and Treatment of Auto...
Quantexa News
02/06
Tonix Pharmaceuticals Announces Positive Topline Results from Phase 1 Trial for TNX-1500, a Next Generation anti-CD40L mAb Candidate for Prevention of Kidney Transplant Rejection and Treatment of Autoimmune Diseases
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announce...
Quantexa News
02/06
Tonix Pharmaceuticals Announces Positive Topline Results from Phase 1 Trial for TNX-1500, a Next Generation anti-CD40L mAb Candidate for Prevention of Kidney Transplant Rejection and Treatment of Autoimmune Diseases GlobeNewswire | Tonix Pharmaceuticals H
Results from the Phase 1 single ascending dose study support proceeding to develop a Phase 2 trial for the prevention of kidney transplant rejection TNX-1500 blocked the primary and secondary antibod...
Quantexa News
02/06
Stock Of Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Dropped By -51.68 Percent Over The Past Month, Is There Room For Downside?
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)'s traded shares stood at 2.04 million during the last session, with the company's beta value hitting 2.17. At the close of trading, the stock's price w...
Quantexa News
02/06
Tonix Pharmaceuticals Announces Positive Topline Results from Phase 1 Trial for TNX-1500, a Next Generation anti-CD40L mAb Candidate for Prevention of Kidney Transplant Rejection and Treatment of Autoimmune Diseases
Tonix Pharmaceuticals Announces Positive Topline Results from Phase 1 Trial for TNX-1500, a Next Generation anti-CD40L mAb Candidate for Prevention of Kidney Transplant Rejection and Treatment of Auto...
Quantexa News
02/06
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 12.6% – Time to Sell?
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) dropped 12.6% during trading on Thursday . The company traded as low as $12.53 and last traded at $13.10. Approximately 803,071 shar...
Yahoo Finance Community
02/06
Comment
While waiting for the Q4 ER, I think the issue with step SP drop are the financials. About $15M in quarterly expenses, $28M in cash, and low $9M debt. They may just won't have enough cash to sustain operations until August when FDA approval is due, plus a couple of quarters needed to start getting revenues. So they need to either further dilute or borrow....
Votes:
2
1
Yahoo Finance Community
02/06
Comment
What happened to the Sales Agreement with Alliance Global Partners. The offering capacity has been raised from $150 million to $250 million, representing a $100 million expansion from the original agreement dated July 30, 2024. What will happen to them and their valuation after RS? They would have already lost 70% valuation ! Is my understanding correct...
Yahoo Finance Community
02/06
Comment
Tonix CEO is the stu pidest CEO I have ever seen in my life. The stock was just getting the momentum, instead of paying debt he should have bought a million dollars day stock and take over a dollar for 10 days would have gotten the compliance so he could nicely put pressure on the research team and better communication with the FDA. It was going to be a home run, but this stupid CEO sat idle and waited for easy way out as usual reverse split. What a dumb mada phka...
Votes:
13
0
Yahoo Finance Community
02/06
Comment
They could have had an extension....but no, the RS allows them to raise $$$ ATM. Which is now 100 times richer except for the slide of a third in two days. When the shares go low single digits, and they will, I might drop back in. In the meantime Anavex remains my bio pick....
Votes:
6
0
Quantexa News
02/06
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 13.8% – Here's Why
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) fell 13.8% during trading on Tuesday . The stock traded as low as $0.15 and last traded at $0.17. 73,990,631 shares changed hands...
Yahoo Finance Community
02/06
Comment
Look at the bright side. You could have invested in MULN, FFIE, ACB, or one of the 100 other junk stocks out there. You picked the biggest loser of all of them, making you some of the most special type of amateur burger flippers. Remember, don't touch the grill. It's hot....
Votes:
3
3
Quantexa News
02/06
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 13.8% – Time to Sell?
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) shares dropped 13.8% during trading on Tuesday . The company traded as low as $0.15 and last traded at $0.17. Approximately 73,990,6...
Yahoo Finance News
02/07
Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash
Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash Tonix Pharmaceuticals Holding Corp. Fri, Feb 7, 2025, 8:30 AM 9 min read In This Article: TNXP +...
Quantexa News
02/07
Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash
February 07, 2025 at 08:31 am EST Company had $98.8 million in cash as of December 31, 2024 ; existing cash expected to fund planned operations into the first quarter of 2026 Company is debt-free af...
Quantexa News
02/07
Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash
Company had $98.8 million in cash as of December 31, 2024; existing cash expected to fund planned operations into the first quarter of 2026 Company is debt-free after repaying mortgage on facilities...
Quantexa News
02/07
Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash
Company had $98.8 million in cash as of December 31, 2024; existing cash expected to fund planned operations into the first quarter of 2026 Company is debt-free after repaying mortgage on facilities...
Quantexa News
02/07
Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash
Company had $98.8 million in cash as of December 31, 2024; existing cash expected to fund planned operations into the first quarter of 2026 Company is debt-free after repaying mortgage on facilities...
Quantexa News
02/07
Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash
Company had $98.8 million in cash as of December 31, 2024; existing cash expected to fund planned operations into the first quarter of 2026 Company is debt-free after repaying mortgage on facilities...
Quantexa News
02/07
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Gap Down – Here's Why
Shares of Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) gapped down prior to trading on Wednesday . The stock had previously closed at $15.21, but opened at $14.21. Tonix Pharm...
Quantexa News
02/07
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Gap Down – Time to Sell?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report )'s share price gapped down prior to trading on Wednesday . The stock had previously closed at $15.21, but opened at $14.21. Tonix P...
Yahoo Finance News
02/07
Tonix Pharmaceuticals reports positive topline trial outcomes of TNX-1500
Tonix Pharmaceuticals reports positive topline trial outcomes of TNX-1500 Across three cohorts · Clinical Trials Arena GlobalData Fri, Feb 7, 2025, 8:43 AM 2 min read In This Article: TNXP +10.23% Ton...
Yahoo Finance Community
02/07
Comment
Got people in here prior to RS who told others to push all in. going to $20. There's no RS they'll get an extension. They claimed they put their life savings into TNXP. Fast forward two weeks. Their now telling people not to buy now and wait till closer to August. Obviously clueless and agenda driven liars. Fact is they can't RS until next year, if even then. Fact is they have enough money till 1/2026. Fact is buying low vs. in June or July when price is elevated, which is smart investing. Still high risk, but be careful of these folks who disappeared, and they've resurfaced....
Votes:
2
0
Quantexa News
02/07
Tonix Pharmaceuticals Holding Corp. Releases Preliminary Year-End 2024 Financial Results
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) recently published selected preliminary operating results and financial condition information for the year ending December 31, 2024. The company disc...
Yahoo Finance Community
02/07
Comment
Hey everyone, I'm relatively new to the stock market, so apologies if this sounds naive. I recently experienced a 1:100 stock split—my holding went from 3,867.45768 shares to about 38.6745 shares, and the price adjusted from $0.15 to $15.00 accordingly. Here's where I'm at: I initially got in at $0.16. The stock sold as it hit $0.56 last week. I pulled out my original investment and reinvested the remaining profit at $0.13. My main questions are: 1. If the stock dips below $1 before August, does that mean I lose all my assets? 2. Given the current situation, should I sell now or ride it out until August? Any insights or advice would be greatly appreciated. Thanks in advance! Looking forward to hearing your thoughts....
Quantexa News
02/07
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Gap Up – Should You Buy?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) shares gapped up before the market opened on Friday . The stock had previously closed at $11.24, but opened at $13.71. Tonix Pharm...
Quantexa News
02/07
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Gap Up – Here's What Happened
Shares of Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) gapped up before the market opened on Friday . The stock had previously closed at $11.24, but opened at $13.71. Tonix Ph...
Yahoo Finance Community
02/07
Comment
Looks like ole Uncle Seth is starting to show signs of Dementia. He has repeated himself twice today. I guess he figured why not go back to the well. It worked great with this morning's (prelim numbers) Pr,which was posted 4 days ago, so why not try for another home run, right? Well, it looks like the folks here are starting to catch on to what ole Seth is trying to do.Congrats to those who flipped this at $18 this morning. Well played. Wash, rinse, repeat.As always, treat'em as a trade.GLTA...
Votes:
2
0
Quantexa News
02/07
Investornewsbreaks Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Preliminary 2024 Financial Results
MENAFN - Investor Brand Network) Tonix Pharmaceuticals (NASDAQ: TNXP) released selected preliminary financial results for 2024, reporting approximately $98.8 million in cash and cash equivalents as of...
Yahoo Finance News
02/07
Tonix Pharmaceuticals Rises After Preliminary 2024 Results
PREMIUM Tonix Pharmaceuticals Rises After Preliminary 2024 Results MT Newswires Fri, Feb 7, 2025, 3:22 PM 1 min read In This Article: TNXP +10.23% Tonix Pharmaceuticals (TNXP) was still 13% higher, af...
Yahoo Finance Community
02/07
Comment
as much volume today as day NDA acceptance when it soared to 130mkt cap was 400m that day at top, now just 78m yet nothng has chnaged except RS which doesnt affect the value of firm , on and cash now 130m vs 70 then so actually much better cash posiiton , crazy. worth $1B at a minimum on approval...
Votes:
3
2
Quantexa News
02/07
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Up 13.2% – Should You Buy?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) was up 13.2% during trading on Friday . The company traded as high as $18.40 and last traded at $12.72. Approximately 8,770,194 sh...
Quantexa News
02/07
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 13.2% – Should You Buy?
Shares of Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) rose 13.2% during trading on Friday . The company traded as high as $18.40 and last traded at $12.72. Approximately 8,77...
Yahoo Finance Community
02/07
Comment
Sal/HQ I’m not a paid pumper. I understand how micro bios run. Yes the company has done 8 R/S since 2007 with multiple offering. This is part of the process. This company is on the verge of breaking out. Longs are at the ground level. Shorts such as yourselfs are playing with fire. Go short another stock that is not awaiting FDA approval and has enough cash to make it through this year.. you should know better. I could easily short this stock looking at the number but I am fully committed to this company. Hope no one buys or sells this stock based on info they obtained from a chat forum. #longstrong all the way to the bank.. and FYI I said it would go up just keep watching…...
Votes:
1
2
Yahoo Finance Community
02/07
Comment
Sal/HQ I’m not a paid pumper. I understand how micro bios run. Yes the company has done i believe 8 since 2007 with multiple offering. This is part of the process. This company is on the verge of breaking out. Longs are at the ground level. Shorts such as yourselfs are playing with fire. Gl...
Votes:
1
1
Yahoo Finance Community
02/07
Comment
Go short another stock that is not awaiting FDA approval and has enough cash to make it through this year.. you should know better. I could easily short this stock looking at the number but I am fully committed to this company. Hope no one buys or sells this stock based on info they obtained from a chat forum. #longstrong all the way to the bank.. and FYI I said it would go up just keep watching…...
Votes:
1
1
Quantexa News
02/07
Tonix Pharmaceuticals Holding Corp (TNXP) last month volatility was 22.97%: Don't Ignore this Blaring Warning Signal
Witnessing the stock's movement on the chart, on Thursday, Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) had a quiet start as it plunged -24.97% to $11.24, before settling in for the price of $14....
Yahoo Finance Community
02/07
Comment
Just to let everyone know,tnxp stock in 2020 was $250K a share (5 RS)so only 4 shares back then would be a million dollars spent!Look at it now, you see 4 shares cost less than 50 bucks!That's right $1,000,000 to $50 in just 5 years.That's how billions of money were stolen by whoever is working behind for them.It all started from them touting covid vax trial in 2020 but yet there's not a sign of progress even after 5 years of studies They're not just incompetent!These are just skin-skinned outright liars!That's why all the major institutional investors ran and are never coming back.It'll likely be trading on OTC even with a drug approved by FDA this august....
Votes:
4
0
Yahoo Finance Community
02/07
Comment
People under estimate this stock NOW. It actually has potential to be a big player. People would be stupid to say this if it wasn't true. But what is truth? Philosophers thru the ages have tried to unravel this but I digress. Just believe me when I say Have you been to the BAH HA jessie? I say again " there ain't no gears in the bike Mike" let's all agree then okee dough kee...
Votes:
1
1
Yahoo Finance Community
02/07
Comment
re posting as yehooo removed for some odd reasonFibro market 3-3.5B - fact10 million in usa alone have FM - factand they are desperate for a drug that helps as no new drug in over 15 yearsand current 2 approved drugs only help 20 percent and are loaded with side effects...
Yahoo Finance Community
02/07
Comment
Turn off your hate meters and let's just do real world math 6 million outstanding shares 129 million in cash - cash Stage 3 NDA 1st stage approved - final in August No debt - other assets in play The CEO is the worst in the history of mankind, can't disagree Enterprise value $23 - without NDA figured in Big Pharma or PE vultures, if they aren't already figuring a plan to get their hands on the cash, they will if stock drops below $10. That 8th RS was the death nail for Sethan because he can't do math....
Votes:
1
0
Yahoo Finance Community
02/07
Comment
There’s only a handful of retail investors in this stock. Institutions only move stock. This is now almost completely in the hands of institutions. Low supply and then when the high demand comes in to play watch out! 100-200 a share. 60-70 this year with approval and then in 2 years they will sell it for 2-3 billion dollars....
Quantexa News
02/07
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 3.7% – Here's Why
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report )'s share price was down 3.7% during mid-day trading on Wednesday . The company traded as low as $13.71 and last traded at $14.65. A...
Quantexa News
02/07
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 3.7% – Here's Why
Shares of Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) were down 3.7% on Wednesday . The stock traded as low as $13.71 and last traded at $14.65. Approximately 1,371,627 share...
Yahoo Finance Community
02/07
Comment
Ignore all those fancy financial analyses! 😉 With a versatile stock like this and a savvy advisor like £Iìzäßēth £. Howard message her now on fãçēbōõk the sky's the limit. The diversity of revenue streams and profitability make this a solid long-term investment. If you’re a day trader and haven’t made money, that’s on you. Remember, long-term investors, especially those who have followed Elizabeth's advice, have reaped the rewards of their patience....
Votes:
1
2
Yahoo Finance Community
02/08
Comment
CEO has done 7 RS CEO has an approved 8th RS (which was voted and approved by stovkholders) CEO doesn't file 15 days before 2-5 for another extension CEO never going to the pinks. he would lose his status on Nasdaq Recap 7 previous, 8th already approved, didn't file for 180 day extension and we have a group of folks here who listen to all the future millionaires tell you they couldn't RS and the 2nd 180 day extension was going to be pencil whipped through. If that RS caught you off guard and you didn't turn into a millionaire. Go look in the mirror. That's the problem, not the 7 previous RS CEO who have never valued a stakeholder. There was lots of time prior to the 8th RS to sell. Most likely, you had already cashed the million dollar check. This stock has never been a long. on …...
Yahoo Finance Community
02/08
Comment
Fibro market 3-3.5B - fact10 million in usa alone have FM - factand they are desperate for a drug that helps as no new drug in over 15 yearsand current 2 approved drugs only help 20 percent and are loaded with side effectsjust getting 2% of those to use tomnya at 2k/ year ( $5/ day) is $400moh and $5 / pill / day for patented drug is very reasonablenote: silenor drug ( sleep med) back in the day cost around $5/ dayalso Lyrica ( currently apporved for FM) costs 1-2k / year and it is off patent...
Votes:
1
0
Yahoo Finance Community
02/08
Comment
Wow, so much good news lately. Seems like every day they have more and more positive things to write about the company. How miraculous! if the company is in such great shape then why did they need to do ANOTHER reverse split? So they did a reverse split again and now, magically, everything is perfect over in TONIXville? If reverse splits were the cure all then why didn't the price stay up after all of the other reverse splits?...
Votes:
4
0
Yahoo Finance Community
02/08
Comment
186541Adoption rates for cryptocurrencies are rising, and regulatory clarity is improving, thanks in part to Trump. The market is stabilizing, with around 15,000 businesses worldwide and 2,500 in the U.S. accepting Bitcoin. Early investment is key to success. For more information, reach out to {👉Låûrëñ.D.Pårkêr} 👈on ~FÅÇÊbook or via Whatsa.pp at 👉{+44. 7.3.0.7.3.8.0.9.3.2}...
Votes:
2
0
Yahoo Finance Community
02/08
Comment
How could you not see it coming? CEO has done 7 RS CEO has an approved 8th RS (which was voted and approved by stockholders) CEO doesn't file 15 days before 2-5 for another extension CEO writes an ugly whiny letter to Nasdaq and SEC sealing the no chance for extension CEO never going to the pinks. he would lose his status on Nasdaq Recap 7 previous, 8th already approved, didn't file for 180 day extension and we have a group of folks here who listen to all the future millionaires tell you they couldn't RS and the 2nd 180 day extension was going to be pencil whipped through. If that RS caught you off guard and you didn't turn into a millionaire. Go look in the mirror. That's the problem, not the 7 previous RS CEO who have never valued a stakeholder. There was lots of time prior to …...
Votes:
3
1
Yahoo Finance Community
02/10
Comment
How could you not see it coming? CEO has done 7 RS CEO has an approved 8th RS (which was voted and approved by stockholders) CEO doesn't file 15 days before 2-5 for another extension CEO writes an ugly whiny letter to Nasdaq and SEC sealing the no chance for extension CEO never going to the pinks. he would lose his status on Nasdaq Recap 7 previous, 8th already approved, didn't file for 180 day extension and we have a group of folks here who listen to all the future millionaires tell you they couldn't RS and the 2nd 180 day extension was going to be pencil whipped through. If that RS caught you off guard and you didn't turn into a millionaire. Go look in the mirror. That's the problem, not the 7 previous RS CEO who have never valued a stakeholder. There was lots of time prior to …...
Votes:
5
1
Yahoo Finance Community
02/10
Comment
tonix submitted 2 phase 3 studiesphase 3 data was stellar ( 2023 phase 3 Resilient study had p value 0.00005 for primary end pt). p value 0.05 is normally the cut off with the smaller number the more powerful the data. all secondary end pt data had p value 0.001 - again very strong1st phase 3 in 2020 - Relief - had P value 0.01 - not as strong as Resilent but still very strong as still way below 0.05 cut offsolid safety data as Flexeril been around since 1977 with no safety issues and both phase 3 studies were tolerated with no new safet issues.fda fast tracked tonmya as they deemed Fibromylgia an large unmet medical need market and no Fibro drug in over 15 yearsadd it all up and you get 80 percent approval odds...
Votes:
3
1
Yahoo Finance Community
02/10
Comment
Jaded long bagger who keeps up with the drug will never be approved. The chart below will give all some clarity and show that he's a c o w l n with an agenda. Lost some money and takes no responsibility for his actions. The success rate of each drug discovery stage in academia was 31.8% for preclinical, 75.1% for phase I, 50.0% for phase II, 58.6% for phase III, and 87.5% for NDA and BLA....
Yahoo Finance Community
02/11
Comment
Have you looked at insider ownership? It looks like the management only owns 0.17% of the stock!! What a joke! These scammers don't even believe in their own junk. Remember to always follow the insiders. If they won't invest, then you shouldn't invest....
Votes:
6
1
Quantexa News
02/11
Tonix Pharmaceuticals Holding Corp (TNXP) volume exceeds 1.49 million: A new investment opportunity for investors
A new trading day began on Monday, with Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) stock price down -3.63% from the previous day of trading, before settling in for the closing price of $12.39....
Yahoo Finance Community
02/11
Comment
The dark pool (naked) is still in control, along with 8% short interest. DP is averaging 62% of the daily trades. It's become all too obvious that this company needs a change in leadership. CEO has been ineffective in altering the course of this company as it relates to stakeholder value. The Board of Directors has been complicit in and derelict in their duties to represent stakeholders' value. Nothing will change unless the leadership is removed and a CEO is appointed who can guide the company through the shark invested waters of being a public company. The new CEO would also build confidence with institutional investors. The bottom line is CEO must go. Give him a quality position with a golden parachute when NDA is passed but fire him and allow stakeholders to flourish in growth. It's long overdue....
Votes:
2
0
Yahoo Finance Community
02/11
Comment
It’s paused at the record low (essentially 11 cents per share) which can only be due to the low volume movements as entire community no longer trusts Tonix. There is a really big crash coming as people unload these, from next week when we can short them again let’s hit this hard.Their despicable behaviour also tells me not to trust any results they declare and I’d certainly never put anything developed by Tonix in my body. Hugely confident there will be tens of thousands sharing the same thoughts....
Votes:
4
3
Quantexa News
02/11
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 1.7% – Time to Sell?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report )'s share price traded down 1.7% during trading on Tuesday . The company traded as low as $11.21 and last traded at $11.74. 367,725...
Yahoo Finance Community
02/11
Comment
Checked my etrade for the first time in quite a while. Looks like the last reverse split removed all of the 22 Tonix shares I had remaining. Now TNXP isn't even listed in my etrade portfolio. My entire Tonix investment from 2020 has evaporated.....
Votes:
6
0
Yahoo Finance Community
02/11
Comment
Guys and Gals and everything in between there will be no more dilution nor stock splits. I believe , and it's a strong belief , that the stage is now set for slow and gradual growth thru PR and community understanding that the products are viable , work and , more importantly, will alert institutionals to goggle up more and then, we hope, provoke buy out...
Votes:
3
4
Yahoo Finance Community
02/12
Comment
The dark pool (naked) is still in control, along with 8% short interest. DP is averaging 62% of the daily trades. It's become all too obvious that this company needs a change in leadership. CEO has been ineffective in altering the course of this company as it relates to stakeholder value. The Board of Directors has been complicit in and derelict in their duties to represent stakeholders' value. Nothing will change unless the leadership is removed and a CEO is appointed who can guide the company through the shark invested waters of being a public company. The new CEO would also build confidence with institutional investors. The bottom line is CEO must go. Give him a quality position with a golden parachute when NDA is passed but fire him and allow stakeholders to flourish in growth. It's long overdue....
Votes:
2
0
Yahoo Finance Community
02/12
Comment
Consider this a service to community: I owned this piece of trash of a stock for a few years until the most recent split. This is not a company and it shouldn't be on the stock market because it is a scam. Why?In the period I owned it, the pattern was: price wen to to almost zero, then every six months there was a reverse split which eventually turned thousands of dollars to zero and no shares left, they just disappeared. The crooks running this company get paid to have their fun but have no regard for shareholders. I truly believe after the last split, they will go to zero again. I wanted to short it but can't because I don't have that kind of account. Do whatever you want with this info, it's not financial advice, just my own experience....
Votes:
8
0
Quantexa News
02/12
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Sees Large Decrease in Short Interest
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) saw a significant decline in short interest in the month of January. As of January 31st, there was short interest totalling 97,300...
Quantexa News
02/12
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Short Interest Update
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) was the target of a large decrease in short interest during the month of January. As of January 31st, there was short interest tot...
Quantexa News
02/12
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 3.7% – Time to Sell?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) shares fell 3.7% during mid-day trading on Monday . The stock traded as low as $11.70 and last traded at $11.94. 788,735 shares ch...
Quantexa News
02/12
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 3.7% – Time to Sell?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) shares were down 3.7% during mid-day trading on Monday . The company traded as low as $11.70 and last traded at $11.94. Approximat...
Yahoo Finance Community
02/13
Comment
This stock is holding between $11 and $12. It's not dropping way down like everyone said it would do by this week. With big investors like Black Rock investing in this, then I believe it has a good chance...IF.... that FM drug is approved for market in August. At this point after the RS, it would be better for me to wait it out....
Votes:
2
2
Quantexa News
02/13
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Short Interest Down 99.4% in January
Tonix Pharmaceuticals Holding Corp. ( – ) was the recipient of a large drop in short interest during the month of January. As of January 31st, there was short interest totalling 97,300 shares, a drop...
Quantexa News
02/13
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Up 5.7% – Here's Why
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) shares were up 5.7% during mid-day trading on Thursday . The stock traded as high as $12.14 and last traded at $12.15. Approximate...
Yahoo Finance Community
02/13
Comment
The same guy have been doing the same thing for a long time, earning tons of money by buying tnxp at the closing of the market and selling at the market open the next day. Thus setting the trend for tnxp to go down and he repeats the same thing the next day and the next day and so on. Lederman is still staying in expensive hotels with a worry in the world....
Votes:
1
0
Yahoo Finance Community
02/13
Comment
After N number of RS, here is the IPO price $710,400Just imagine their survival with huge salaries in the past 12 years, These ppl r scamming people to run their business and personal lavish lifestyle. Stay away & don’t contribute a single penny. Let them pump, dump alone. Don’t buy any share....
Votes:
6
0
Yahoo Finance Community
02/15
Comment
I'm sniffing around on this junk pile. The positive I see is an extremely negative sentiment which is perfectly normal when a company completely washes out their prior stake holders with massive dilutions. A lot of burned stake holders enjoy kicking the C-suite in the groin to vent and feel a little bit better.Now that all the old believers have been completely fleeced and the company is well capitalized to get through a potential FDA approval and launch, is this a good time to start building a position?Admittedly I am just starting a little ancillary DD. Can anyone chime in on what their fibromylasia drug might be worth if it gains approval? Is this just another "me too" drug trying to penetrate this market? How does their drug compare in efficacy to cheap generic gabapentin?Those of you who have lost their shirts, socks and under wear need not respond as …...
Quantexa News
02/16
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 4% – What's Next?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report )'s share price rose 4% during trading on Friday . The company traded as high as $11.94 and last traded at $11.89. Approximately 147...
Quantexa News
02/17
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 4.5% – Time to Buy?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) rose 4.5% during trading on Monday . The stock traded as high as $12.01 and last traded at $11.95. Approximately 371,678 shares ch...
Quantexa News
02/18
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 8.5% – Here's What Happened
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) traded down 8.5% on Tuesday . The company traded as low as $10.91 and last traded at $10.94. 494,717 shares traded hands during mi...
Quantexa News
02/19
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 9.3% – What's Next?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report )'s share price was down 9.3% during trading on Wednesday . The stock traded as low as $9.72 and last traded at $9.94. Approximately...
Quantexa News
02/19
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 4.5% – Time to Buy?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) shares rose 4.5% during mid-day trading on Monday . The company traded as high as $12.01 and last traded at $11.95. Approximately...
Quantexa News
02/19
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 4.5% – Time to Buy?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) traded up 4.5% during trading on Monday . The company traded as high as $12.01 and last traded at $11.95. 371,678 shares traded ha...
Yahoo Finance Community
02/20
Comment
I remember everyone telling me for the last month before it happened that there would be no rs, I should've listened to myself but didn't, glad I got out at what would've been $27 though, still took a good loss but nowhere what it would've been if I held, I'm gonna get back in around mid July at 3 dollars though...
Yahoo Finance Community
02/20
Comment
Scott, I see you have been posting that the stock is still too expensive. What are you basing this on ? in 9s , that is mkt cap of $ 54m, and they have 125m of cash with a pdufa in hand ( which surely has value and quite a bit actually) not to mention rest of their pipeline , so the company is in fact undervalued currenlty not overvalued. Perhaps you are saying it is too high as you just feel the crooks will keep dropping it which is different than the company being overvalued...
Votes:
2
1
Yahoo Finance Community
02/20
Comment
Guys do not listen to meeksy-baby For as long as I known this Company It's just been trials after trials after no products no generated money The only money they have is when they take your money and do reverse split year after year after year...
Votes:
3
1
Yahoo Finance Community
02/20
Comment
Scott confirmed 365m share count on dec 20 around when NDA was approved by FDA , pre mkt on day of NDA accepance was $1.9 ( $190 post RS) so mt cap was 690m !! ( vs 54m now) and why my 500m - 1B range on actual approval in pre market is very reasonable and very likely and I would say closer to the high end of that range. with 6m share count, a 500m -1B mkt cap is stock of 83-166 for 700-1500% gains from current price....
Votes:
2
1
Yahoo Finance Community
02/20
Comment
If they have anything someone would swoop in and buy them. Think of it this drug they have blown millions on is supposedly ready for market in August, well if it was something real big another pharmaceutical would just scribble the check. You can buy the whole company for less than fifty million and no one is interested....
Yahoo Finance Community
02/20
Comment
I called the company this afternoon and had a chat asking if they can tell me when they will stop dumping shares on the ATM. They told me they can not tell me as this would be considered insider information and told me to look to the SEC filings if I want to obtain any further information.And that's all I got.Thank you sir may I have another!...
Votes:
2
1
Quantexa News
02/20
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 8.5% – Here's Why
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) shares fell 8.5% during trading on Tuesday . The company traded as low as $10.91 and last traded at $10.94. 494,717 shares traded...
Yahoo Finance Community
02/21
Comment
Holo Nowwww listen to me I'm the king ,not that orange man who belongs in an orange jumpsuitCall Trump ask him to get the 40 million back from Department of Defense , see if he's really for the working man or not , demand that 40 million get paid to tnxp bagholders before that sniveling Samaritan Lederman blows it on a monkeypox trial in Kenya....
Votes:
2
3
Quantexa News
02/21
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 1.1% – Should You Buy?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report )'s stock price was up 1.1% during mid-day trading on Friday . The stock traded as high as $10.40 and last traded at $9.78. Approxim...
Quantexa News
02/21
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 1.1% – What's Next?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) shares were up 1.1% during mid-day trading on Friday . The stock traded as high as $10.40 and last traded at $9.78. Approximately...
Yahoo Finance Community
02/21
Comment
Well, this stock has pretty much broken me, lol. Seriously, stocks should not be allowed to manipulate like this, and they need to tighten the laws on such stocks. I refuse to believe that this is an acceptable way to conduct a company by literally stealing from the investors and the sudden reverse split surely things like this should be announced in good time not sprang on people to just lose big time shame on them and a shame for me :[ 1 years worth of investment gone between this and Kulr Idk I've learnt a valuable lesson investing is for the whales to gain not the people who work hard trying to get ahead for a better future...
Votes:
3
0
Yahoo Finance Community
02/21
Comment
can only see manipulation here. The board have no obligation to manage the price action here as they are news driven. Mr Market clearly sees the past RS as way to manipulate the SP. For me I move more of my trading position to holding. Less to trade, more to hold until next news....
Votes:
1
0
Quantexa News
02/21
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 9.3% – Time to Sell?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report )'s share price dropped 9.3% on Wednesday . The stock traded as low as $9.72 and last traded at $9.94. Approximately 476,972 shares...
Yahoo Finance Community
02/22
Comment
Follow the money ,Buffett has big cash pile he's hoarding ,he knows the market is toppy and overbought , I've been shorting the mag 7 and buying Chinese " scam" stocks like holo, mlgo , wimi and exited Baba this week to free more dry powder .Interest rates are stubbornly high and Trump and Powell cannot lower them .China will just pare back US Treasury spending to ensure rates are high .The so called Mag 7 were holding up the market but cracks in the armor are showing .Automotive stocks , materials , and services will continue to fall .I'm only buying stocks with big cash , trading less than book value .These will be the mag stocks of the future ....
Votes:
1
0
Quantexa News
02/22
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 1.6% – Should You Sell?
Shares of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) traded down 1.6% on Thursday . The company traded as low as $9.41 and last traded at $9.84. 354,980 shares changed hands d...
Quantexa News
02/22
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 1.6% – Should You Sell?
Shares of Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) were down 1.6% on Thursday . The stock traded as low as $9.41 and last traded at $9.84. Approximately 354,980 shares cha...
Quantexa News
02/23
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading 1.1% Higher – Here's Why
Shares of Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) rose 1.1% during mid-day trading on Friday . The company traded as high as $10.40 and last traded at $9.78. Approximatel...
Quantexa News
02/24
TNXP: PDUFA Date for TNX-102 SL in Fibromyalgia of August 15, 2025…
PDUFA Date of August 15, 2025 for NDA TNX-102 SL in Fibromyalgia On December 23, 2024, Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) announced that the FDA assigned a Prescription Drug User Fee Ac...
Quantexa News
02/24
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 6.6% – Here's What Happened
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) was down 6.6% during mid-day trading on Monday . The stock traded as low as $8.26 and last traded at $8.57. Approximately 332,532...
Quantexa News
02/26
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 6.6% – What’s Next?
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) traded down 6.6% on Monday . The company traded as low as $8.26 and last traded at $8.57. 332,532 shares were traded during trading,...
Quantexa News
02/26
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 6.6% – Here's Why
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) fell 6.6% on Monday . The company traded as low as $8.26 and last traded at $8.57. 332,532 shares changed hands during trading, a...
Quantexa News
02/28
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Sees Significant Growth in Short Interest
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) was the recipient of a large increase in short interest during the month of February. As of February 15th, there was short interes...
Quantexa News
02/28
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Short Interest Up 243.1% in February
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) saw a large increase in short interest during the month of February. As of February 15th, there was short interest totalling 333,800...
Quantexa News
03/01
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Sees Large Growth in Short Interest
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) saw a large growth in short interest in the month of February. As of February 15th, there was short interest totalling 333,800 share...
Quantexa News
03/02
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 4.8% – Time to Sell?
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) fell 4.8% during trading on Friday . The stock traded as low as $7.54 and last traded at $7.79. 155,186 shares were traded during mi...
Quantexa News
03/02
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 4.8% – Time to Sell?
Shares of Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) dropped 4.8% during trading on Friday . The company traded as low as $7.54 and last traded at $7.79. Approximately 155,1...
Quantexa News
03/02
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Sees Large Growth in Short Interest
Tonix Pharmaceuticals Holding Corp. ( – ) was the target of a large growth in short interest during the month of February. As of February 15th, there was short interest totalling 333,800 shares, a gro...
Polygon News
03/03
Global Artificial Intelligence in Drug Commercialization Market to Observe Stupendous Growth at a CAGR of ~24% by 2032 | DelveInsight
The increasing prevalence of chronic diseases is driving the demand for advanced and effective treatments, highlighting the need for AI-powered drug commercialization. Pharmaceutical companies are lev...
Quantexa News
03/03
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 1.1% – Here's What Happened
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) traded down 1.1% during mid-day trading on Monday . The stock traded as low as $7.65 and last traded at $7.78. Approximately 81,72...
Quantexa News
03/03
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 1.1% – Here's What Happened
Shares of Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) fell 1.1% during trading on Monday . The company traded as low as $7.65 and last traded at $7.78. 81,724 shares changed...
Yahoo Finance News
03/04
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at 7th International Congress on Controversies in Fibromyalgia
Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at 7th Internation...
Quantexa News
03/04
TONIX PHARMACEUTICALS HOLDING CORP. Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at 7th International Congress on Controversies in Fibromyalgia
TNX-102 SL is a sublingual formulation of cyclobenzaprine designed for transmucosal delivery and durable activity in treating fibromyalgia TNX-102 SL demonstrated statistically significant improvemen...
Quantexa News
03/04
Investornewsbreaks Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Presents Positive Phase 3 Data On TNX-102 SL For Fibromyalgia
MENAFN - Investor Brand Network) Wheaton Precious Metals (NYSE: WPM) (TSX: WPM) announced ReThink Milling Inc. as the winner of its inaugural Future of mining Challenge, awarding the company $1 millio...
Yahoo Finance News
03/05
Tonix Pharmaceuticals to Present at the 2025 Virtual Investor Summit
Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Tonix Pharmaceuticals to Present at the 2025 Virtual Investor Summit Tonix Pharmaceuticals Holding Corp. Wed, Mar 5,...
Quantexa News
03/05
Tonix Pharmaceuticals Holding Corp (TNXP) Stock: Navigating the Market Volatility
The stock of Tonix Pharmaceuticals Holding Corp (TNXP) has seen a 12.10% increase in the past week, with a -51.51% drop in the past month, and a -50.18% decrease in the past quarter. The volatility ra...
Quantexa News
03/05
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 18.3% – Here's Why
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) shot up 18.3% during trading on Wednesday . The stock traded as high as $10.37 and last traded at $9.23. 897,286 shares changed ha...
Quantexa News
03/06
The key reasons why Tonix Pharmaceuticals Holding Corp (TNXP) is -99.10% away from 52-week high?
Witnessing the stock's movement on the chart, on Wednesday, Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) set off with pace as it heaved 40.51% to $10.96, before settling in for the price of $7.80...
Quantexa News
03/06
Tonix Pharmaceuticals (TNXP) Stock Is Up 115% This Week: What's Going On?
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares have surged 115% to $16.85 since Monday's open, driven by a series of key business updates this week. What To Know: Tonix this week announced d...
Yahoo Finance News
03/06
Tonix Surges 31% Following Positive Phase 3 Fibromyalgia Drug Trial Results
Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Tonix Surges 31% Following Positive Phase 3 Fibromyalgia Drug Trial Results Faizan Farooque Thu, Mar 6, 2025, 10:23...
Yahoo Finance News
03/06
A 41% Surge? This Small-Cap Pharma Stock Just Shook Up the Fibromyalgia Market
Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now A 41% Surge? This Small-Cap Pharma Stock Just Shook Up the Fibromyalgia Market Khac Phu Nguyen Thu, Mar 6, 2025, 10:...
Quantexa News
03/06
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 54.5% – Still a Buy?
Tonix Pharmaceuticals Holding Corp. ( – ) rose 54.5% on Thursday . The stock traded as high as $16.95 and last traded at $16.93. Approximately 6,687,768 shares traded hands during trading, an increase...
Quantexa News
03/06
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 54.5% – Here's Why
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) shares traded up 54.5% on Thursday . The stock traded as high as $16.95 and last traded at $16.93. 6,687,768 shares traded hands dur...
Quantexa News
03/06
Tonix Pharmaceuticals (TNXP) Stock Is Up 115% This Week: What's Going On?
Tonix Pharmaceuticals Holding Corp TNXP shares have surged 115% to $16.85 since Monday's open, driven by a series of key business updates this week. What To Know: Tonix this week announced data regar...
Yahoo Finance News
03/07
Why Tonix Pharmaceuticals Holding Corp. (TNXP) Soared on Thursday
Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Why Tonix Pharmaceuticals Holding Corp. (TNXP) Soared on Thursday Angelica Ballesteros Fri, Mar 7, 2025, 12:40 PM 2...
Quantexa News
03/07
Why Tonix Pharmaceuticals Holding Corp. (TNXP) Soared on Thursday
We recently published an article titled Micro-, Small-Cap Firms Dominate Market Rally In this article, we are going to take a look at where Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) stands aga...
Quantexa News
03/07
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 18.3% – Here's What Happened
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report )'s share price was up 18.3% during trading on Wednesday . The stock traded as high as $10.37 and last traded at $9.23. Approximatel...
Quantexa News
03/07
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 18.3% – Here's What Happened
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report )'s stock price rose 18.3% on Wednesday . The company traded as high as $10.37 and last traded at $9.23. Approximately 897,286 share...
Quantexa News
03/09
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 4.6% – Should You Sell?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report )'s stock price dropped 4.6% during trading on Friday . The stock traded as low as $13.13 and last traded at $13.95. Approximately 1...
Quantexa News
03/09
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 4.6% – Here's Why
Shares of Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) fell 4.6% during mid-day trading on Friday . The company traded as low as $13.13 and last traded at $13.95. 1,317,190 sh...
Yahoo Finance News
03/09
Why Tonix Pharmaceuticals Holding Corp. (TNXP) Soared Last Week
Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Why Tonix Pharmaceuticals Holding Corp. (TNXP) Soared Last Week Angelica Ballesteros Sun, Mar 9, 2025, 6:44 PM 2 min...
Quantexa News
03/09
Why Tonix Pharmaceuticals Holding Corp. (TNXP) Soared Last Week
We recently compiled a list of the In this article, we are going to take a look at where Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) stands against the other stocks. Micro- and small-cap compan...
Yahoo Finance News
03/10
Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense Consortium (MCDC) for Development of TNX-801, the Company’s Single-Dose Mpox and Smallpox Vaccine Candidate
Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense Consortium (MCDC) for Development of TNX-801, the Comp...
Quantexa News
03/10
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading 6.7% Higher – Still a Buy?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report )'s stock price rose 6.7% during trading on Monday . The stock traded as high as $15.90 and last traded at $13.89. Approximately 1,5...
Polygon News
03/11
Tonix Pharmaceuticals to Present at the Zacks SCR Life Sciences Virtual Investor Forum on March 13th
Tonix Pharmaceuticals, a biopharmaceutical company, announced that its CEO will present at the Zacks SCR Life Sciences Virtual Investor Forum. The company's pipeline includes drug candidates for pain...
Yahoo Finance News
03/11
Tonix Pharmaceuticals to Present at the Zacks SCR Life Sciences Virtual Investor Forum on March 13th
Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Tonix Pharmaceuticals to Present at the Zacks SCR Life Sciences Virtual Investor Forum on March 13th Tonix Pharmaceu...
Quantexa News
03/11
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 1.1% – Here’s What Happened
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) dropped 1.1% on Tuesday . The stock traded as low as $12.35 and last traded at $13.32. Approximately 357,987 shares were traded duri...
Quantexa News
03/11
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 1.1% – Here's Why
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report ) traded down 1.1% on Tuesday . The company traded as low as $12.35 and last traded at $13.32. 357,987 shares traded hands during tr...
Yahoo Finance News
03/12
Tonix’s TNX-1500 Shows Promise in Preventing Organ Transplant Rejections of Either Human or Pig Organs; Autoimmune Diseases Also a Target
Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Tonix’s TNX-1500 Shows Promise in Preventing Organ Transplant Rejections of Either Human or Pig Organs; Autoimmune D...
Quantexa News
03/12
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 6.7% – Here’s What Happened
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report)’s stock price was up 6.7% on Monday . The company traded as high as $15.90 and last traded at $13.89. Approximately 1,577,758 shares...
Yahoo Finance News
03/12
Life Sciences Investor Forum Agenda Announced for March 13th
Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Life Sciences Investor Forum Agenda Announced for March 13th Virtual Investor Conferences Wed, Mar 12, 2025, 10:12 A...
Yahoo Finance News
03/13
Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring 2025
Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring 2025 Tonix Pharmaceuticals Holding Corp. Thu, Mar...
Quantexa News
03/13
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 3.2% – Should You Sell?
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report)’s stock price was down 3.2% on Thursday . The stock traded as low as $12.96 and last traded at $12.98. Approximately 93,077 shares w...
Quantexa News
03/13
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 1.1% – Here's Why
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP – Get Free Report )'s stock price dropped 1.1% on Tuesday . The stock traded as low as $12.35 and last traded at $13.32. Approximately 357,987 shares...
